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ABSTRACT 
Microencapsulation of living cells such as probiotic bacteria can be used for the 
protection of the cells from harsh conditions such as low pH and mechanical stress in 
the digestive system. In this thesis we demonstrate various novel strategies to 
microencapsulate living yeast cells as a model for probiotic bacteria. We prepared and 
used sporopollenin microcapsules to encapsulate yeast cells by compressing the 
sporopollenin particles into a pellet which was exposed to an aqueous suspension of 
yeast cells in the presence of a biocompatible surface active agent. We also 
demonstrate that the viability of the cells is preserved after the microencapsulation. 
 
We fabricated novel shellac-yeast cells composite microcapsules programmed to 
release the cells upon change of pH in a narrow range. This was achieved by either 
spray drying or sprays co-precipitating dispersion of yeast cells in aqueous solution of 
ammonium shellac doped with a pH-sensitive polyelectrolyte. We also demonstrate 
that yeast cells retain their viability even when treated with aqueous solutions of low 
pH. In addition, the pH-triggered release of yeast cells from these composite 
microcapsules and their disintegration rates were investigated. We developed a 
theoretical model for the kinetics of yeast cells release from the microcapsules 
triggered by (i) pH change and (ii) the growth of the cells in a culture media. 
 
In a separate strategy of microencapsulation of living cells, we used templates of 
Pickering emulsions stabilised with latex nanoparticles to fabricate colloidosomes 
loaded with viable probiotics. Depending on the method of transfer, we have shown 
that magnetic colloidosomes containing pH-sensitive polyelectrolyte loaded with 
living cells can be prepared using Pickering emulsion templates. In addition, we 
demonstrate two strategies to strengthen the stability of water-in-oil Pickering 
emulsion droplets by interlocking the adsorbed latex particle monolayer: by (i) using 
oppositely charged polyelectrolyte adsorption or (ii) using polyelectrolyte pre-coated 
yeast cells which act as cross-linkers inside the water-in-oil droplets. 
 
Furthermore, we report the fabrication of 3 D multicellular cellosomes of living cells 
by using water-in-oil emulsion templates as intermediate. We have used two strategies 
to assemble yeast cells pre-coated with polyelectrolytes in water-in-oil emulsion 
8 
 
droplets stabilised with either surfactant or solid particles. The emulsion droplets 
containing oppositely charged yeast cells linked together by electrostatical 
interactions were shrunken to compact structures upon addition of dry octanol and 
subsequently transferred into water to fabricate cellosomes. 
 
In summary, this thesis contributes an arsenal of new methods for microencapsulation 
of living cells for the purpose of their protection and triggered release. The results of 
this thesis can be used in the formulation of better probiotic products, protection and 
release of cells implants, tissue engineering and development of live vaccines. 
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Chapter 1.  
1.1 General introduction and project aim 
The gastrointestinal microflora is an extremely complex ecosystem that coexists in 
equilibrium with the host.
1
 Probiotics have beneficial effects for human being by 
prevention and treatment of specific pathological conditions.
2
 Probiotic bacteria 
cannot survive harsh conditions such as low pH, and mechanical stress in the 
stomach. The aim of this PhD research project is to microencapsulate probiotic 
bacteria in various novel types of microcapsules to protect them from harsh conditions 
of low pH and mechanical stress, thus increasing their viability. We have developed 
and explored several methods for fabrication of microcapsules that can entrap the 
probiotics bacteria at low pH and release them at higher pH of approximately 8. In 
addition, we have used natural biomaterial sources to prepare and use naturally 
occurring sporopollenin microcapsules in encapsulation of probiotics. 
1.2 Encapsulation 
Encapsulation in general involves packaging of active ingredients such as dyes, 
proteins, vitamins, flavours and living cells inside a capsule or the pores of a gel or 
other porous media. Gibbs et al. defined encapsulation as a process which involves 
the coating or entrapment of a pure material or a mixture into another material. The 
coated or entrapped material is usually a liquid but can be a solid or a gas. It is also 
called core material, actives, fill, internal phase or payload, while the coating material 
can also be defined as capsule, wall material, membrane, carrier or shell.
3
  
Vilstrup defined encapsulation as a process of creating a barrier to avoid chemical 
reactions and/or to enable the controlled release of the ingredients.
4
 However, 
Champagne and Fustier defined encapsulation as a technology of packaging solid, 
liquid, and gaseous materials in small capsules that release their contents at controlled 
rates over prolonged of time.
5 
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Encapsulation involves the incorporation of various ingredients within a capsule of 
approximately 5 to 300 µm in diameter.
6
 The accepted size range for capsules in order 
to be classified as microcapsules is not strictly recognised, but some researchers 
consider capsules smaller than 1 µm as nano-capsules and capsules larger than 100 
µm as macrocapsules. Whereas, any capsules with size between 1- 100 µm are called 
microcapsules.
7 
 
Encapsulation can have many different forms such as a membrane coating, a wall or a 
membrane of spherical or irregular shape, and multiwall structure.
3
 The spherical 
geometry can have a continuous core region surrounded by a continuous shell, while 
an irregular geometry can contain a number of dispersed small droplets or particles of 
core material.4,7 Capsules can be a solid as free-flowing powder or suspended in 
water, depending on the applications and the stability of the capsules and the 
encapsulated ingredients. They might have smooth or rough outer appearance too. 
 
 
 
 
Figure 1.1: Schematic diagram of two representative types of microcapsules: (a) 
continuous core/shell microcapsule. (b) Multinuclear microcapsule. Reproduced from 
reference 
7
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1.3 Purpose of encapsulation process 
Gibbs et al. summarised the purpose of encapsulation as protection of its contents 
from the environment which can be destructive while allowing small molecules to 
pass in and out of the membrane.
3
 Encapsulation can improve the retention time of the 
nutrient in food and allow controlled release at specific times, because some nutrient 
do not remain in food for a long time or may react with the other food components 
causing undesirable effects.
8
 
 
Microcapsules should protect the active ingredient from its surrounding environment 
until an appropriate time or a triggering event. Then, the material escapes through the 
capsule wall by various means, including rupture, dissolution and changing pH and 
temperature. Microencapsulation offers many opportunities for exciting 
breakthroughs in medicine, cosmetic and industrial applications. It can be used in 
preventing chemical reactions, masking undesirable flavour, enhance stability of 
formulations, and to improve, control and delay delivery. It has been also used to 
encapsulate prescription drugs, over-the counter drugs, vitamins, living cells and 
minerals.
3,9
 Varieties of core materials have been encapsulated in suitable 
microcapsules including adhesives, agrochemicals, live cells, active enzymes, 
flavours, pharmaceuticals and inks. Microcapsules are key components of all 
carbonless copy papers
10
 and are present in oral and injected drug formulations. 
Microcapsules are also used for several long-acting commercial pesticide and 
herbicide products.
7
 
 
Microencapsulation is becoming increasingly important for a wide variety of 
applications therefore, a versatile technique should be invented to produce capsules, 
whose size, permeability, mechanical strength and compatibility can be easily 
controlled. Control of the microcapsules size allows flexibility in applications and 
choice of encapsulated materials. Control of the permeability allows selective and 
timed release. Control of the mechanical strength allows the yield stress to be adjusted 
to withstand varying of mechanical loads and to enable release. Control of 
compatibility allows encapsulation of fragile and sensitive materials such as 
biomolecules and cells. Ideally, it should be feasible to construct microcapsules from 
18 
 
a wide variety of inorganic, organic or polymeric materials to provide flexibility in 
their uses.
11
 
 
1.4 Methods of microcapsules preparation 
Here we review in a brief format a variety of microencapsulation methods used in the 
literature to prepare microcapsules, several of which are applicable for 
microencapsulation of probiotics. To classify the methods of microcapsules 
preparation, one has to consider the nature of the phenomena that has been used to 
make the microcapsules. Generally the methods for preparing microcapsules are 
based on physical phenomena while, polymerisation reactions can be used to produce 
a capsule shell, or both physical and chemical phenomena can be combined together 
to prepare microcapsules. On that base some researchers classify methods of making 
microcapsules as chemical and mechanical process, whereas others just divide them 
into group A and group B processes.
7
 Scientists have prepared microcapsules using 
both methods and variety ranges of chemical compounds including natural polymers 
have been employed.
12
  
 
Chemical encapsulation (group A processes) can produce microcapsules which are 
found entirely in a liquid-filled stirred tank or tubular reactor; and itself can be 
classified into several subgroups. The first truly significant commercial product used 
microencapsulation was carbonless copy paper. The microcapsules for this product 
were made by complex coacervation, which involves the separation of a liquid phase 
of coating material from a polymeric solution and the wrapping of that phase as a 
uniform layer around the suspended core particles.
10
  
 
Complex coacervation method is based on the capability of cationic and anionic 
water-soluble polymers to interact in water and form a liquid, polymer-rich phase 
called complex coacervate. This lays the foundations of complex coacervation 
process, which commonly uses gelatin as the cationic polymer and several other 
natural synthetic anionic water-soluble polymers interact with gelatin to form 
complex coacervates used for microencapsulation. The overall process includes 
several steps. The first step begins by dispersing the core material in an aqueous 
19 
 
gelatin solution this is normally done at 40-60 ºC temperature range at which the 
gelatin solution is melted to liquid. After that the second step involves the addition of 
a polyanion or negatively charged polymer into the system. The pH and concentration 
of the polymer are adjusted in order that a liquid complex coacervate forms. Once the 
complex is formed, the system is then cooled to room temperature, and the gelatin in 
the coacervate gels and forms capsules with a very rubbery shell. Then the capsules 
are cooled further to 10 ºC and treated with glutaraldehyde to increase the strength of 
the water swollen shell and create a thermally irreversible gel structure. The 
glutaraldehyde cross-links the gelatin by reacting with amino groups on the gelatin 
chain. In the final step, glutaraldehyde treated capsules can be dried in to a powder.
7
  
  
The chemical understanding of the coacervation process is that the complex is in 
equilibrium with a dilute solution called the supernatant and this in return acts as the 
continuous phase while the complex coacervate acts as a dispersed phase. When a 
water-soluble core material is dispersed in the system and the complex coacervate 
wets this core material, each droplet or particle of dispersed core material is coated 
with a thin film of coacervate and when this liquid film is solidified, capsules are 
formed. The complex coacervation process has been used in the encapsulation of 
many water-immiscible liquids and is used in a variety of products, including inks for 
carbonless paper, perfume for industry inserts, and liquid crystals for display 
devices.
7-8
 
 
The microcapsules produced by this technology are between 20-800 µm in diameter 
size range,
3
 which contain 80-90 weight percent core material. The capsules are 
moisture sensitive. When stored at humidity above 70 % or immersed in water, the 
shell of the capsule swell greatly and facilitate the transport of material into or out of 
the capsules. Therefore, to reduce their moisture sensitivity, the capsules can be post-
treated with urea and formaldehyde under acidic conditions.
13
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Figure 1.2: Schematic flow diagram of encapsulation process based on complex 
coacervation. Reproduced from reference 
7
. 
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Polymer-polymer incompatibility method is based on incompatibility of two 
incompatible polymers which dissolve in a common solvent and do not mix in 
solution, as they essentially phase separate into two different liquid phases, one rich in 
one polymer, and the other phase is rich in the other polymer. This phenomenon can 
be exploited to make microcapsules by using one of the incompatible polymers to act 
as the capsule shell.
7
 In a general example, the process starts with dispersing the core 
material in a hot (80 ºC) solution of ethylcellulose in cylohexane, and an addition of 
low molecular weight polyethylene into the system. Polyethylene is a polymer soluble 
in hot cylohexane and incompatible with ethyl cellulose; this induces phase separation 
with formation of ethyl cellulose-rich phase and a polyethylene-rich phase, then a 
core material which is a solid unaffected by 80 ºC cylohexane is dispersed in this two-
phase system. Ethyl cellulose is more polar than polyethylene; therefore, it adsorbs 
preferentially on the surface of the core material and produces a thin coating of the 
shell material around the particles of the core material. To solidify the ethyl cellulose 
solution and forming solid microcapsules, the system then cooled down to room 
temperature and the ethyl cellulose precipitates.
7
 
 
Several commercially encapsulated pharmaceutical products are produced by this 
method.
14
 Aspirin and potassium chloride are two examples of encapsulated 
pharmaceuticals based on polymer-polymer incompatibility technique. Polymer-
polymer incompatibility process is generally performed in organic solvents and is 
used for encapsulation of solids with a degree of water solubility.  The majority of 
capsules that have ethyl cellulose shell are irregularly shaped with 200-800 µm in 
diameter and are loaded with solid drug particles, or used for taste masking and 
increasing oral drug delivery.
15
  
 
Interfacial polymerisation technique was evolved to be a versatile technology able to 
encapsulate a variety of core materials, including aqueous solution, water-immiscible 
liquids and solids. The particular feature of this technology is that the capsule shell is 
formed at or on the interface of droplets or particles by utilising polymerisation of 
reactive monomers. In this technique many types of interfacial polymerisation 
reactions are used. The process involves the dissolution of a multifunctional monomer 
in the liquid core material and then the solution is dispersed to the desired drop size in 
an aqueous phase that contains a dispersing agent. Then a rapid polymerisation 
22 
 
reaction at the interface generates the capsule shell by an addition of a co-reactant, 
usually a multifunctional amine into the aqueous phase. If the reaction uses isocyanate 
and an amine, then a polyurea capsule shell is produced, but if an acid chloride and an 
amine are used, then the result is a polyamide or nylon capsule.
16
 
 
“In situ” polymerisation is another method which is closely related to interfacial 
polymerisation in a way that it involves the formation of capsules because of 
polymerisation of monomers added to the encapsulated reactor. However, with “in 
situ” polymerisation, reactive agents have not been added to the core material and 
polymerisation happens in the continuous phase and on the continuous phase side of 
the interface formed by the dispersed core material and continuous phase. When 
polymerisation begins, a low molecular weight pre-polymer is produced and this pre-
polymer grows in size and deposits on the surface of the dispersed core material being 
encapsulated. As polymerisation with cross-linking continues to occur, it generates a 
solid capsule shell. Cakshaee et al. in 1985 first reported the formation of 
microcapsules loaded with water-immiscible liquids with shells formed by the 
reaction of urea with formaldehyde in aqueous media at acidic pH.
16b,c,17
 
 
The process of mechanical encapsulation method normally involves using mechanical 
phenomena to produce microcapsules loaded with designed core material; therefore, 
the principal means by which this type of microcapsules are made are centrifugal 
force, extrusion, co-extrusion, and formation of sprays. This type of encapsulation 
process is predating chemical encapsulation process as it was developed in 1930s.
18
  
 
The first one to be invented was spray drying which generally involves the 
emulsification or dispersion of core material in a concentrated (40-60 weight percent 
solid) solution of shell material. The droplets produced normally have diameters of 1-
3 µm. The core materials can be water-immiscible liquids and the shell material is 
usually a soluble polymer. The emulsion droplets are then passed into the heated 
chamber of a spray drier, where they rapidly dehydrate and then produce dry capsules. 
The capsules are harvested in the bottom of the spray-drying chamber.
7-8,16b,19
 Another 
form of spray drying includes atomising a liquid mixture in a vessel with a nozzle or 
spinning wheel and the solvent is then evaporated by contacting with hot air or gas. 
The resulting particles are then collected after their sedimentation.
12,16d,20
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Freeze-drying is performed by freezing probiotics in the presence of carrier material 
at low temperatures, followed by sublimation of the water under vacuum. In this way, 
water phase transition and oxidations are avoided. The addition of cryoprotectant 
helps to retain probiotics activity upon freeze-drying and stabilise them during 
storage. Vacuum drying is a similar process as freeze-drying but it takes place at 0-40 
°C for 30 min to a few hours. The advantages are that the products are not frozen, 
which prevents freezing damage and energy consumption, and that the drying is 
fast.
16d,19
 
 
In spray-cooling, a molten matrix with low melting point containing any bioactive 
compound is atomised through a pneumatic nozzle into a vessel. This process is 
similar to spray-drying with respect to the production of fine droplets. However, it is 
based on the injection of cold air into the vessel to enable solidification of the gel 
particles rather than on hot air which dries the droplets into fine powder particles. The 
liquid droplets solidify and entrap the bioactive product.
5,12
 
 
Meanwhile, in fluidised bed coating a liquid coating material is sprayed through a 
nozzle over the core material in a hot environment. The film formation then begins, 
followed by successive wetting and drying or solidification stages which results in a 
solid, homogenous layer on the surface of a core. The small droplets of the sprayed 
liquid contact the particle surface, spread on the surface and coalesce. The spray 
liquid, also referred as shell, wall or coat material can be a solution, a suspension, an 
emulsion or a melt. Any edible material with a stable molten phase can be sprayed at 
high deposition rates, allowing coatings with a thickness of 100 µm up to 10 mm. The 
coating material can be injected from many angles and this influences the properties 
of the coating.
3,7-8,12
 
 
In extrusion method a jet of core liquid is surrounded by a sheath of wall solution or 
melt. The liquid breaks into droplets core coated with wall solution as the jet moves 
through the air. The molten wall may be solidified or a solvent may be evaporated 
from the wall solution. 
7,12,16b,16d
 Extrusion is the oldest and most common method for 
making capsules with hydrocolloids.
21
 In addition it is a simple and cheap method that 
uses a gentle operation which causes no damage to encapsulants.
22
 (see Figure 1.3 for 
more details). 
24 
 
Emulsification Technique involves homogenising a mixture of small volume of the 
encapsulant in a polymer suspension into a larger volume of a vegetable oil to form a 
w/o emulsion. Then, the water soluble polymer is cross-linked to form tiny gel 
particles within the oil phase. The beads are collected by filtration later on. The 
method of cross-linking depends on the type of the supporting material used. The size 
of the beads can be controlled by the speed of homogenisation, and can range from 25 
µm to 2 mm.
23
 (see Figure 1.4 for more details).  
 
Lacroix et al. and Audet et al. have both used emulsification technique to successfully 
encapsulate lactic acid bacteria in both batch and continuous fermentation 
respectively.
24
  
 
 
 
Figure 1.3: Extrusion technologies: simple needle droplet-generator that usually is air 
driven (a) and pinning disk device (b). The probiotic cells are added to the 
hydrocolloid solution and dripped through a syringe needle or a nozzle spray machine 
in the form of droplets which are allowed to free-fall into a hardening solution such as 
calcium chloride.
16d
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Figure 1.4: Schematic presentation of the emulsification procedure. A small volume 
of the cell-polymer suspension (i.e., the discontinuous phase) is added to a large 
volume of vegetable oil (i.e., the continuous phase). The mixture is then homogenized 
to form a water-in-oil emulsion. Once the water-in-oil emulsion is formed, the water-
soluble polymer must be insolubilised to form tiny gel particles within the oil 
phase.
16d
 
 
1.5 Materials used for microencapsulation 
Sultana et al. incorporated Hi-Maize starch into alginate solution for the purpose of 
encapsulation of probiotic bacteria. They reported an improvement in the viability of 
probiotic bacteria compared to when the bacteria were encapsulated without the 
starch. The survival of the bacteria was also increased at -20 °C by inclusion of 
glycerol ( cryo-protectant) with alginate mix.
25
 
  
Alginates are naturally derived linear copolymers of 1, 4-linked β-D-mannuronic acid 
(M) and α-L-guluronic acid (G) residues.16d Aqueous solutions of polysaccharides 
form hydrogel in the presence of divalent calcium ions via ionic interactions between 
the acid groups on G blocks and the bridging ions. As a result, calcium alginate gels 
are physically cross-linked polymers with mechanical and hosting properties 
dependent on the alginate composition.
12
 Alginate hydrogel are extensively used in 
cell encapsulation.
26
 Calcium alginate is preferred for encapsulation because it is 
simple, non-toxic, biocompatible, and cheap.
22
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Alginate hydrogel beads produced by mixing a suspension of the encapsulant with a 
solution sodium alginate solution, and then the mixture dripped into a solution of 
multivalent ions such as calcium chloride. The encapsulant is entrapped in the gel 
spheres instantaneously in a three-dimensional lattice of ionically cross-linked 
alginate.
3,19,22,27
 
 
Cook et al. have produced alginate gels by external gelation, followed by subsequent 
dip-coating into chitosan solution. The polymers associated via electrostatic 
interactions between the acid and amine groups. The microcapsules are suitable for 
enteric delivery because the alginate microcapsules will form acid gels at low pH of 
(2-5). However, at higher pH values of approximately 7 in the intestine, and higher 
amount of phosphates should result in the dissolution of the microcapsules. Alginate 
microcapsules coated with chitosan improved the survival of B. Breve during 
exposure to stimulated gastric juice.
28
 
 
Due to its favourable properties, such as good biocompatibility, biodegradability, and 
non-toxicity, chitosan is an important biomaterial in food and pharmaceutical 
applications.
12,19
 Chitosan is a positively charged linear polysaccharide formed by 
deacetylation of chitin. It is soluble in water below pH 6 and forms a gel by ionotropic 
gelation. Chitosan, a polycation with amine groups, can be cross-linked by anions or 
polyanions, such as polyphosphates, polyaldehydrocarbonic acid.
16d,22,29
 
 
Talwalkar and Kailasapathy produced alginate-starch gel beads by dropping a mixture 
of alginate-starch-bacteria into a calcium chloride coagulation bath. They found that 
encapsulation prevented cell death from oxygen toxicity.
30
 Starch is a polysaccharide 
consisting of large number of glucose units joined together by glucosidic bonds. It 
consists mainly of amylase. Resistant starch cannot be digested by pancreatic 
enzymes and can reach the colon where it will be fermented.
19
 This property provides 
good enteric delivery characteristic of starch.
3,16d
  
 
Other materials that have been used for microencapsulation include gelatine and κ-
carrageenan which is a natural polysaccharide extracted from marine macroalgae and 
used as food additives. The polymer dissolves at high temperature (60-80 °C) in 
concentrations of (2-5 % wt.).
31
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The procedure for encapsulation using carrageenan includes adding the encapsulated 
slurry to heat-sterilised carrageenan solution at 40-45 °C (dependent on the type of the 
encapsulant). Gelation occurs by cooling to room temperature. Dropping the mixture 
of the encapsulant and the polymer into a solution of potassium chloride resulted in 
formation of the beads.
19
 
 
1.6 Encapsulation of cells and therapeutic drugs 
Many diseases are closely tied with deficient or subnormal metabolic cell functions. 
Hemophilia, Parkinson’s disease, diabetes and hepatic failure belong to this kind of 
degenerative and disability disorder. Milder forms of these diseases can be managed 
with treatments but it is complicated to mimic the precise regulation and the complex 
roles of the hormones, factors, or enzymes that are not produced by the body. 
Production of therapeutic drugs by encapsulated cells can be an answer for treatment 
of chronic diseases. Cell encapsulation technology is based on the immobilisation of 
cells within a semi permeable membrane. This membrane protects the cells from both 
mechanical stress and the host’s immune system while allowing diffusion of nutrients, 
oxygen and waste as can be seen in Figure 1.5. This can result in a reduction or even 
lack of chronic administration of immunosuppressant, which is an important issue to 
be considered in organ transplantation. Encapsulation of cells allows the delivery of 
the product for a longer period of time as cells release the products continuously. 
Moreover, cell encapsulation allows the transplantation of non-human cells which 
could be considered as an alternative to the limited supply of donor tissue.
32
 
 
Diaspro et al. have encapsulated single living yeast cells by the alternate adsorption of 
oppositely charged polyelectrolyte. They have demonstrated that after encapsulation, 
cells preserve their metabolic activities and they are still able to divide.
33
 
 
Dusseault et al. described a method for microencapsulation of living cells in alginate-
poly-L-lysine (PLL)-alginate membranes with covalent links between adjacent layers 
of microcapsules membranes, while preserving the desired membrane molecular 
weight cut-off and cell viability. They immobilised islets of Langerhans in alginate 
beads by using N-5-azido-2-nitrobenzoyloxy succinimide (ANB-NOS) as a cross 
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linker, where N-hydroxy succinimide ester group was covalently linked to PLL. The 
microcapsules are very unlikely to be damaged or destroyed in the environment found 
in the living body. In addition to protect the transplant from the recipient immune 
system, these microcapsules can protect the recipient from the risks associated with 
the transplant.
34
 
 
In this present thesis we have used yeast cells as a model for probiotics cells because 
they are extremely important as model organism in modern cell biology research, and 
are the most thoroughly researched eukaryotic microorganism. They are robust, easily 
obtained and handled in research laboratories. They are classified in the kingdom of 
Fungi, and most of them reproduce asexually by budding. Yeast cells are unicellular, 
although some species with yeast forms may become multicellular through the 
formation of a string of connected budding cells. Yeast cell size can vary greatly 
depending on the species, typically measuring 3-4 µm in diameter, although some 
yeast cells can reach over 40 µm. Yeast is found in the stomach and the colon. The 
presence of yeast cells can only explain their resistance to pH variation. Most yeast 
cells can grow at pH 3 , and some species can tolerate highly acidic conditions with a 
pH as low as 1.5.
1
 The yeast species Saccharomyces Cerevisiae has been used in 
baking and fermenting of sugars for alcoholic beverages for thousands of years. 
 
 
Figure 1.5: Cell microencapsulation. (a)Nutrients, oxygen and stimuli diffuse across 
the membrane, whereas antibodies and immune cells are excluded. (b) Pre-
vascularised solid support system to facilitate optimal nutrition of the enclosed cells.
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Budding is the most common mode of vegetative growth in yeasts and multilateral 
budding is a typical reproductive characteristic of ascomycetous yeasts, including 
Saccharomyces Cerevisiae. Yeast buds are initiated when mother cells achieve a 
critical cell size at a time coinciding with the beginning of DNA synthesis. The 
ultimate goal of yeast cell division is to separate mother and daughter cells into two 
individual units with appropriately segregated sets of chromosomes, organelles and 
vesicles. Once all mitotic events have been completed, protein complexes at the 
division site act in a dynamic way to complete cell division. This is followed by a 
localized weakening of the cell wall and this, together with tension exerted by turgor, 
allows extrusion of cytoplasm into an area bounded by new cell wall material. The 
regulation of particular cell wall synthetic enzymes and transport of specific bud 
plasma membrane receptors are key steps in the emergence of a bud. Chitin forms a 
ring at the junction between the mother cell and forms the so-called bud scar and birth 
scar at the surface of the daughter. During bud formation, only the bud but not the 
mother cell will grow. Once mitosis is complete and the bud nucleus and other 
organelles have been migrated into the bud, cytokinesis commences and a septum is 
formed in the neck between mother and daughter. In Saccharomyces cerevisiae, cell 
size at division is asymmetrical with buds being smaller than mother cells when they 
separate.
36
 
 
Meanwhile, encapsulation of therapeutic drugs into microcapsules provides several 
advantages over traditional formulations. Prior to release, the physical barrier 
provided by the encapsulation device protects the drug from degradation or premature 
metabolism. Release of the therapeutic products can be technologically controlled in 
order to achieve different kinetic profile. An ideal system should be able to achieve an 
effective drug concentration at the target tissue for an extended period of time. In 
addition, the system should provide a tight control over the device in case of side-
effects. The small size (100-500 µm) of the capsules allows their implantation in close 
contact to the blood stream, which could be beneficial in specific applications for the 
long-term functionality of the enclosed cells due to an enhanced oxygen transfer into 
the capsules.
32
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1.7 Microencapsulation of probiotics 
Probiotics have been defined by scientists in numerous ways such as being “mono or 
mixed cultures of live micro-organisms which, when applied to a man or animal, 
beneficially affect the host by improving the properties of the indigenous microflora” 
37
 or as viable microorganisms that when ingested have a beneficial effect in the 
prevention and treatment of specific pathological conditions.
2
 Del Piano et al. 
believed that probiotics are living microorganisms which survive gastric, bile, and 
pancreatic secretions, attach to epithelial cells and colonise the human intestine.
38
  
 
The population of living microorganisms in an adult human intestine was estimated to 
be more than 400 different bacterial species and approximately 10
14
 bacterial cells.
39
 
The bacterial cells are classified into beneficial, neutral, and harmful, with respect to 
human health. Yeast are part of the residual microflora that makes up < 0.1 % of 
microbiota, but their diameter is 10 times larger than that of bacteria and they could 
represent a significant steric hindrance for bacteria.
40
 The third most common genus 
in the gastrointestinal tract represented by Bifidobacteria, whereas, 86 % of the flora 
in the adult gut is predominantly Bacteroides followed by Eubacterium. Different 
factors such as weaning, ageing, stress, diet, drugs, bacterial contamination and 
constipation affect the intestinal microflora by decreasing the number of 
Bifidobacteria and increasing certain kinds of harmful bacteria.
12
  
 
The beneficial effect and therapeutic applications of probiotic bacteria in humans 
claimed by scientists include maintenance of normal intestinal microflora, 
improvement of constipation, treatment of diarrhoea, enhancement of the immune 
system, reduction of lactose-intolerance, reduction of serum cholesterol levels, 
anticarcinogenic activity, and improved nutritional value of foods.
16a,17,33,41
 The 
mechanism by which probiotics have their effect on the host may involve modifying 
gut pH, antagonising pathogens through  production of antimicrobial and antibacterial 
compounds, competing for pathogen binding and receptor cites, as well as for 
available nutrients and growth factors, stimulating immunomodulatory cells and 
producing lactose.
42
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Probiotics products are available in the market in the form of milk, drinking and 
frozen yogurts, probiotic cheeses, ice-creams, spreads and fermented soya products. 
International standards require that products claimed to be probiotics products contain 
a minimum of 10
7
 viable probiotic bacteria per gram of product.
43
 Despite the 
important role of these probiotic bacteria, their beneficial effects is dependent on their 
survival in the harsh stomach conditions such as low pH of 2.5 to 3.5, presence of 
aggressive intestinal fluids ( e.g. bile and pancreatic juice), short transit time in 
duodenum, and mechanical stress which creates a hostile environment for probiotics 
survival. To protect probiotics from chemical and biological conditions in the GI tract 
and increase their viability, and provide sufficient amount of these probiotics in the 
lower intestine, a technique had to be developed.
44
 
 
Microencapsulation technology has been invented and successfully applied to protect 
probiotics from such conditions caused by the external environment
12
. Different types 
of encapsulating materials have been used to trap probiotics bacteria. However, the 
most popular encapsulating material is alginate because it has the benefits of being 
nontoxic and being readily available. This method is routinely used to generate 20-30 
µm in diameter capsules loaded with pesticides and herbicides as well as that it has 
been used to prepare 3-6 µm in diameter carbonless paper ink microcapsules.
45
 
Several microcapsules loaded with core materials of biological interest e.g. active 
enzymes have also been generated with this particular technique.
46
  
 
Cook et al. produced alginate, and alginate-chitosan microcapsules loaded with dry 
probiotics in a matter of scalable and uniform, granular product by a drying method. 
The microcapsules were shown to improve the survival of the encapsulated probiotics 
during exposure to stimulated gastric juice.
28
 Ding and Shah developed a method for 
applying an extra coating of palm oil and poly-L-lysine (POPL) to alginate (ALG) 
microcapsules to enhance the survival of probiotic bacteria. Eight strains of probiotic 
bacteria were encapsulated using both alginate alone and alginate with (POPL). The 
results were shown that alginate microcapsules can protect probiotic bacteria from 
acidic conditions and bile salts. However, POPL microcapsules provided better 
protection.
45
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Kailasapathy investigated the effect of incorporating microencapsulated probiotics 
cultures with encapsulant polymers such as alginate and starch and their effect on the 
survival of the probiotics cultures in yoghurt. The results showed that the addition of 
probiotics cultures either in the free or encapsulated forms tend to slow down the 
postacidification during storage of yoghurt. Microencapsulation enhanced the survival 
of probiotics cultures compared to free cells in yoghurt stored over 7 weeks. Addition 
of probiotics capsules didn’t change the appearance, colour, acidity, flavour, and after 
taste attributes of the yoghurt, however, significantly altered the textural properties 
(smoothness) of yoghurt, which might occur because of the production of EPS 
(Exopolysaccharide) by the probiotics cultures, incorporation of sodium alginate and 
filler material (starch).
47
 The other materials that have been used in the process of 
encapsulation of probiotics include, κ-Carrageenan, Chitosan.47 
 
Probiotics in any food products from the time of production, processing and 
consumption need to be protected against: high temperature and shear, moisture, 
oxygen, most importantly degradation in the stomach especially the low pH, and bile 
salts. Several reviews 
3,16b,16d,19,22,38,43,48
 collected and presented the methods of 
probiotics encapsulation. 
 
Natural examples of encapsulation include bird’s egg shells, plant seeds, bacterial 
spores, skin and seashells.
3
 However, various types of means for probiotic 
encapsulation have been developed artificially by using different types of natural and 
synthetic polymer materials, colloidal particles, lipids, and other organic and 
inorganic materials. Examples of those encapsulation vesicles are polymer 
microspheres, liposome, sporopollenin microcapsules, colloidosomes, and 
cellosomes. The definition, method of preparation, and applications of sporopollenin 
microcapsules, composite microcapsules, colloidosomes, and cellosomes are 
explained in chapters, 3, 4, 5, and 6 of this thesis, however, below we have briefly 
described polymer microspheres and liposome. 
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1.7.1 Polymer Microspheres 
One of the methods of microsphere preparation is solvent evaporation method. The 
method depends on the hydrophobicity and hydrophilicity of the encapsulant. For 
hydrophobic active (drug) o/w emulsion method is widely used. This method includes 
four main steps, first the hydrophobic drug is dissolved in an organic solvent 
containing a polymer material, then the dispersed phase (organic) is emulsified into 
the continuous phase (aqueous). The third step involves the evaporation of the solvent 
in the dispersed phase through the continuous phase which transforms the droplets of 
the dispersed phase into solid particles. Finally, the microspheres recovered and dried 
to remove residual solvent. For hydrophilic drugs, alternative methods such as w/o/w 
double emulsion system has been proposed, where the aqueous solution of 
hydrophilic drug is emulsified with organic phase to yield w/o emulsion, which in 
return is dispersed into a second solution to prepare w/o/w double emulsion.
49
 
PLGA (poly lactic-co-glycolic acid) is frequently used as the polymer for microsphere 
preparation by solvent evaporation, because of its biodegradable properties. 
Methylene chloride is the most used solvent, and the reason for that is because it is 
highly volatile and capable of dissolving many polymers.
49a
 
1.7.2 Liposomes 
Liposomes are single or multi-layered spherical lipid bilayers, which involve the 
complete enclosure of an aqueous phase within phospholipids, based membrane.
50
 
When phospholipids are dispersed in an aqueous media, liposomes spontaneously 
form.
51
 The hydrophilic part of the phospholipids associated themselves with the 
aqueous media, and the hydrophobic groups interact with other hydrophobic moieties 
of other lipid molecules. A very stable capsule forms as the lipid bilayer sheet formed 
folds into a spherical shape. Separately, both aqueous and lipid-soluble materials can 
be entrapped in liposomes.
3,8
 The size of liposomes can range from a few tens of 
nanometres to several microns.
51
 Negatively charged phospholipids, lecithin, and 
cholesterol produce the most stable liposomes, which can be prepared by the 
dehydration-rehydration method as long as organic solvents are not used.
3,8
 King et al. 
encapsulated ascorbic acid in liposomes with high efficiency and stability.
52
 
Liposomes have been used for delivery of vaccines, hormones, enzymes and vitamins 
into the body.
53
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1.8 Lay out of the present thesis 
This thesis is presented in 8 chapters, and every chapter include a short introduction 
of the subject. In Chapter 2 all the different materials that have been used during this 
research project are described. In addition, Chapter 2 contains the detailed description 
of the methods associated with most of the work in this thesis; however, each separate 
chapter contains more specific details of the experimental procedures. 
 
In Chapter 3, sporopollenin microcapsules were prepared in-house by alkaline 
extraction, and were also used for encapsulation of living yeast cells. The cell intake 
by the microcapsules was observed by using scanning electron, and confocal laser 
fluorescence microscopy. Viability of the encapsulated cells was tested by using “in-
gel” growth experiment. 
 
In Chapter 4, formulations of yeast cells/ammonium shellac solution in various ratios 
and concentrations were either spray dried or spray co-precipitated to fabricate 
composite shellac/yeast cells microcapsules. The morphology of the microcapsules 
was observed by optical, confocal and scanning electron microscopy. The viability of 
the yeast cells inside the composite microcapsules was tested by treating the cells with 
fluorescein diacetate (FDA) and live/dead kit and observing them by confocal and 
optical fluorescence microscopy. Meanwhile, the rate of microcapsules disintegration 
and release of the cells in aqueous solution of 0.1 M sodium bicarbonate at different 
pHs were examined. The kinetics of cells release upon pH-trigger and growth-trigger 
is also explored. 
 
In Chapter 5, we encapsulated yeast cells in colloidosomes fabricated by templating 
w/o Pickering emulsions stabilised with amidine functionalised polystyrene latex 
nanoparticles. The water phase contained either native or polyelectrolyte pre-coated 
yeast cells. Various techniques were used to interlock the adsorbed nanoparticles at 
the interface, such as cross-linking with oppositely charged polyelectrolytes, or using 
anionic pre-coated yeast cells. To enhance the stability of the water droplets and 
hence, increase the efficiency of transferring w/o droplets from oil phase into water to 
yield colloidosomes, the aqueous core of the droplets contained either magnetic 
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nanoparticle to be manipulated by external magnetic field, or gelled up with the help 
of temperature sensitive gel such as agarose. 
 
Chapter 6 includes the fabrication of three-dimensional multicellular structures of 
living cells resembling cellosomes by using w/o emulsion templated stabilised with 
either surfactant or solid nanoparticles. The w/o emulsion droplets which were used in 
the building blocks of the multicellular structures contained living yeast cells and 
transferred into water from the oil phase by using the freezing process. 
 
In Chapter 7 we develop a theoretical model of the kinetics of cell release from 
composite shellac/cell microcapsules discussed in chapter 4. 
 
Chapter 8 includes the summary of the main achievements and conclusions of this 
thesis. 
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Chapter 2.  
2.1 Materials and methods 
2.1.1 Materials 
2.1.1.1 Water 
Water was purified by reverse osmosis and by passage through a Milli-Q reagent 
water system (Millipore, UK). Surface tension was typically measured between (71.5 
and 72.5 mN/ m) at 25 °C, and the measured resistivity always exceeded 18 m Ώ/cm. 
2.1.1.2 Latex nanoparticles 
Cationic 0.3 µm (4 % w/v) polystyrene latex particles which have surface 
functionality of amidine (CH3-C (NH)-NH2) groups were purchased from Invitrogen, 
Molecular Probes USA. They were transferred into oil by using ethanol as 
intermediate solvent. 
2.1.1.3 Shellac  
Shellac is biocompatible and biodegradable polyester produced from self-
esterification of a mixture of polyhydroxy acids such as polyhydroxy polycarboxylic 
esters. It is insoluble in aqueous solution at neutral pH; therefore it was used in a 
soluble form of ammonium salt at pH > 7 which is commercially available as SSB 
Aqua Gold (solid content 25 % wt.). The alkaline solution was a gift from HARK 
Group, Germany. 
2.1.1.4 Sporopollenin microcapsules 
Sporopollenin microcapsules were prepared in house by phosphoric acid extraction 
from Lycopodium Clavatum pollen grains powder purchased from Fagron UK; the 
procedure was invented by Barrier et al.
9a
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Figure 2.1: Simple structure of  one of the main components of shellac.
54
 
 
 
2.1.1.5 Magnetic nanoparticles 
Magnetite nanoparticles were produced by the procedure published in a paper by 
García-Alonso et al. 
55
. Iron (II) Chloride (99 %), and Iron (III) chloride (99 %) were 
used as purchased from Sigma-Aldrich; and ammonia (99.99 %) was purchased from 
Sigma-Aldrich. 
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2.1.1.6 Gelling agents 
In some of the experiments gelling agents such as oxidised starch and agarose were 
used. Oxidised starch (Perfectamyl gel food grade modified starch E1404) was 
purchased from AVEBE in Netherlands. It was used in the process of in-gel growing 
encapsulated yeast cells inside Lycopodium Clavatum sporopollenin microcapsules. 
Agarose with low melting point for electrophoresis (CAS number: 9012-36-6) was 
used as purchased from Sigma in the experiment of fabrication gel-cored magnetic 
colloidosomes. 
2.1.1.7 Oils 
Various short and long chains hydrocarbons were used, some as oil phase to prepare 
water-in-oil emulsions. 
Complete name Purity Supplier 
Undecane 99 % Aldrich 
Tridecane 99 + % Aldrich 
Hexane 99 % Sigma 
Table 2.1: Specification of oils used in the emulsion templates. 
 
2.1.1.8 Alcohols 
All organic solvents and alcohols were used as received without further purification. 
 
Complete name Purity Supplier 
Ethanol “ ethyl alcohol” Absolute 99 % Bottled by the University 
of Hull 
Isopropanol “ isopropyl 
alcohol, Propan-2-ol” 
99.8+% (GLC) 0.785g/mL 
for analysis CertiFied AR 
 
Fisher scientific 
Hexanol 99 % Avocado 
Methanol 99.8 % Aldrich 
Octanol 99 % Alfa Aesar 
Table 2.2: Specification of alcohols used as solvents in our experiments. 
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2.1.1.9 Surfactants 
Several different surfactants were used in stabilising water-in-oil emulsions. In 
addition aqueous solution of Tween20 was used to promote surface wetting of 
sporopollenin microcapsules in the encapsulation of living yeast cells. 
 
Complete name HLB Structure Supplier 
 
Span60 “Sorbitan 
monostearate” 
 
4.7 
 
 
Sigma 
Tween20 
“Polyethylene 
glycol sorbitan 
monolaurate ” 
 
 
16.7 
 
 
 
Sigma 
Table 2.3: Specification of surfactants used in our experiments. 
 
2.1.1.10 Polyelectrolytes 
Polyelectrolytes were used for different purposes in some of the experiments, such as 
coating native yeast cells with cationic and anionic polyelectrolytes to enhance their 
surface charge. Sodium polyacrylate and carboxymethyl cellulose were integrated into 
ammonium shellac solution in order to enhance the disintegration of the produced 
composite microcapsules and create a pH-triggered release of the encapsulated yeast 
cells. (See table 2.4 for details). 
 
2.1.1.11 Buffers 
All buffers (0.1 M) were freshly prepared by mixing the components listed in the 
composition column in table 2.6. The pH was measured using a Fisher brand Hydrus 
400 pH meter. The pH of un-buffered solutions was adjusted by adding a few drops of 
0.1 M sodium hydroxide or 0.1 M hydrochloric acid. 
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Complete name Average 
MW 
Structure Supplier 
 
Carboxymethyl 
cellulose sodium 
 
Medium 
viscosity 
 
 
 
Fluka 
 
Sodium 
polyacrylate 
86-92 % purity 
 
 
5100 
g/mol by 
GPC 
 
 
 
Aldrich 
 
Polyallylamine 
hydrochloride 
GPC vs. PEG 
std. 
 
 
15,000 
g/mol 
 
 
 
Aldrich 
Polystyrene 
sulfonate 
sodium salt 
15-55 cP, 20 % 
at 25 °C 
 
 
 
70,000 
g/mol 
 
 
 
 
Aldrich 
Table 2.4: Specification of polyelectrolytes used in our experiments. 
 
2.1.1.12 General chemicals 
During this PhD research project a wide range of general chemicals were used. The 
following table summarises the characteristics of those chemicals. 
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Complete name Purity Supplier 
Sodium chloride 
“pellets” 
99.5 % wt. VWR international Ltd 
Ammonium sulfate 98.5 % BDH Chemicals Ltd 
Acetic acid “ glacial” 99 % specified Fisher chemicals 
Hydrochloric acid 1.16 S.G. 37 % for analysis 
CertiFied AR 
Fisher chemicals 
Calcium carbonate 
microparticles 
Surface modified by fatty 
acid. Purity undetermined. 
Socal® and Winnofil® 
Used as supplied 
Glucose 99.5 % Fisher chemicals 
Yeast extract - OXIOD LP0021 
o-phosphoric acid 99.99 % Aldrich 
Calcium chloride 
dihydrate 
99 % for analysis certiFied 
AR 
Fisher chemicals 
Sodium hydroxide “ 
pellets” 
98 % for analysis certified 
AR 
Fisher chemicals 
Sodium bicarbonate 99.5 % for analysis certified 
AR 
Fisher chemicals 
Lyophilised baker’s 
yeast powder 
Saccharomyces cerevisiae 
 
Purchased from local 
supermarket 
Oleic acid 97 % Fisher chemicals 
Acetone Absolute Bottled by University of 
Hull 
Sodium acetate 
trihydrate 
99 % Alfa Aesar 
di-Potassium hydrogen 
orthophosphate, 
anhydrous “K2HPO4” 
99 + %  
Fisher scientific 
Potassium dihydrogen 
orthophosphate 
“KH2PO4” 
 
98-100 % 
 
BDH Chemicals Ltd 
Table 2.5: Specification of general chemicals used in our experiments. 
42 
 
Complete name pH Composition 
Phosphate buffer 6.6 (38.1 mL of 0.1 M K2HPO4) + (61.9 mL of 0.1 M 
KH2PO4) 
Phosphate buffer 7 (61.5 mL of 0.1 M K2HPO4) + (38.5 mL of 0.1 M 
KH2PO4) 
Phosphate buffer 7.6 (86.6 mL of 0.1 M K2HPO4) + (13.4 mL of 0.1 M 
KH2PO4) 
Phosphate buffer 8 (94 mL of 0.1 M K2HPO4) + (6 mL of 0.1 M KH2PO4) 
Acetate buffer 5 (357 mL of 0.1 M acetic acid) + (643 mL of 0.1 M 
sodium acetate tri-hydrate) 
Table 2.6: Specification of buffer solutions. 
 
 
2.1.1.13 Fluorescent dyes 
We have used several fluorescent dyes during this research project including 
fluorescein diacetate (FDA), Calcein-AM, and Propidium iodide to test the viability 
of the living cells. We have used Nile Red to pre-stain aqueous solution of ammonium 
shellac solution used in the preparation of shellac/yeast cells formulations. 
Fluorescein diacetate powder with 98 % purity (HPLC) was purchased from Fluka. 
Nile Red technical grade was purchased from Sigma. The following Figure 2.2 shows 
the structure of FDA and Nile Red. 
 
 
 
Figure 2.2: (a) Chemical structure of FDA, and (b) chemicals structure of Nile Red. 
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Live/Dead Cell Double Staining Kit was purchased from Sigma-Aldrich. The 
following specifications were taken from the supplier’s website.56 The Live/Dead Cell 
Double Staining Kit is utilized for simultaneous fluorescence staining of viable and 
dead cells. This kit contains Calcein-AM and Propidium iodide (PI) solutions, which 
stain viable and dead cells, respectively. Calcein-AM, acetoxymethyl ester of Calcein, 
is highly lipophilic and cell membrane permeable. Though Calcein-AM itself is not a 
fluorescent molecule, the Calcein generated from Calcein-AM by esterase in a viable 
cell emits a strong green fluorescence (λex 490 nm, λem 515 nm). Therefore, Calcein-
AM only stains viable cells. Alternatively, the nuclei staining dye PI cannot pass 
through a viable cell’s membrane. It reaches the nucleus by passing through 
disordered areas of dead cell membrane, and intercalates with the DNA double helix 
of the cell to emit red fluorescence light (λex 535 nm, λem 617 nm). Since both Calcein 
and PI-DNA can be excited with 490 nm light, simultaneous monitoring of viable and 
dead cells is possible with a fluorescence microscope with dual fluorescence filter set. 
Using λex 545 nm, only dead cells can be observed. 
 
 
 
Figure 2.3: (a) Structure of Propidium iodide, and (b) structure of Calcein-AM. 
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2.2 Methods 
Images were taken using a range of microscopes including confocal fluorescent and 
scanning electron microscopes. 
2.2.1 Microscopy 
2.2.1.1 Olympus BX51  
Optical and fluorescent images were taken by using Olympus microscope fitted with a  
digital camera system DP70 using a 1.5 million pixel CCD colour camera recording at 
5.8-million pixel equivalent. Images were processed using Image Pro-plus software. 
This microscope is fitted with a series of filter sets corresponding to the absorption 
and emission wavelengths of specific dyes (table 2.8). It is used with a series of 
objectives 4x, 10x, 20x, 40x and 100x magnification. 
 
Filter name 
 
Description λ excitation 
(nm) 
λ emission 
(nm) 
 
Fluorescent dye 
 
U-MNUA2 
 
Narrow-band with 
band pass barrier 
filter 
 
360-370 
 
 
420-460 
 
 
Perylene 
 
U-
MWIBA2 
 
Wide-band with 
band pass barrier 
filter 
460-490 
 
510 IF 
 
FITC, Neuro-
DiO, 
Fluorescein 
U-MWIG2 
 
Wide-band with 
interference barrier 
filter 
520-550 
 
580 IF 
 
Rhodamine, 
Nile Red 
U-
M51004V2 
 
FITC/TRITC filter 
set 
~ 490-510 
~ 560-585 
~ 525-545 
~ 600-635 
FITC, Neuro-
DiO, 
Rhodamine, 
Nile Red 
Table 2.7: Characteristics of the different filter sets fitted on the Olympus 
fluorescence microscope and names of the corresponding dyes. 
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2.2.1.2 Nikon Eclipse (Confocal) microscope  
Confocal images were obtained with a Nikon Eclipse TE 300 inverted microscope 
(Bio-Rad) using Kr/Ar gas laser (488 or 568nm excitation wavelengths) with the 
following objectives: 10x, 16.4x, and 40x. 
2.2.1.3 Scanning Electron Microscopy (SEM) 
SEM images were obtained using an Evo 60 field emission scanning electron 
microscope (Carl Zeiss, Gmbh). The samples were pre-coated with either carbon or 
gold monolayers to enhance their surface electro-conductivity. 
2.2.2 Haemocytometer 
The number of the yeast cells either grown or released from the shellac/yeast cells 
composite microcapsules were counted using a haemacytometer with 0.1 mm 
chamber depth, which was used as purchased from MARIENFELD. Figure 2.4 
illustrates a micrograph of the grids of the haemacytometer used for counting the 
released cells. 
 
Figure 2.4:  Number of released yeast cells from shellac/cells microcapsules counted 
using a Haemacytometer.  
46 
 
2.2.3 General equipments  
Equipment Make and model 
Thermostat water bath A Grant thermostat bath OLS200 
Centrifuge A Baird & Tatlock Auto Bench Centrifuge Mark IV 
Centrifuge B Eppendorf mini spin plus AG 
Homogeniser IKA® T25 digital ULTRA TURRAX® 
Ultrasonic bath Decon FS3006 
Ultrasound JENCONS scientific LTD VIBRA cellTM 
Magnetic stirrer STUART SCIENTIFIC SM24 
Diaphragm Vacuum 
pump 
Vacuum brand MS 2C 
pH meter Fisher brand Hydrus 400 
Micropipettes Eppendorf research 
Basic shaker IKA® VIBRAX VXR basic 
Mini shaker IKA® MS 3 basic 
Thermostat water bath B Grant thermostat bath LTD6G 
Table 2.8: Make and model of some the instruments used in this research project. 
 
2.2.4 Dispersing of yeast cells in milli-Q water 
Dry yeast powder was washed with milli-Q water several times; the suspension was 
centrifuged on 4,000 rpm for 5 minutes and then the supernatant was discarded after 
every wash. The yeast cells were finally redispersed in aqueous solutions depending 
on the type of the process. 
2.2.5 Preparation of culture media 
Yeast cells both free and encapsulated in microcapsules were exposed to culture 
media which was prepared by dissolving 2 g glucose, 0.3 g ammonium sulphate, 0.1 g 
sodium chloride and 0.5 g yeast extracts in 100 mL milli-Q water. The solution was 
sterilised by boiling at 100 °C for 1 hour and passed through 0.2 µm in diameter filter 
after  it was cooled down to room temperature. 
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2.2.6 Transfer of amidine latex nanoparticles into oil phase 
Hydrophobic positively charged amidine latex nanoparticles were supplied in aqueous 
suspension 4 % wt. by the manufacturer. These cationic latex nanoparticles would 
electrostatically bind to anionic yeast cells (native or PAH/PSS pre-coated) in the 
water phase. Therefore, they were transferred into the oil phase in order to be used to 
stabilise water-in-oil Pickering emulsions. 1 mL of the latex aqueous suspension was 
centrifuged in an Eppendorf plastic tube using Eppendorf, mini Spin Plus centrifuge. 
The supernatant was discarded, followed by addition of 1 mL of absolute ethanol. The 
suspension was mixed on a shaker to disperse the latex particles. This procedure was 
repeated twice to transfer the latex particles into ethanol. Finally 1 mL ethanolic 
suspension of the amidine latex nanoparticles was transferred into 8 mL of oil using a 
similar procedure. 
2.2.7 Testing the viability of yeast cells using FDA solution 
Fluorescein diacetate (FDA) solution was prepared by dissolving 10 mg powder in 1 
mL acetone and the working solution was stored at –20 °C and protected from 
sunlight by wrapping the sample tube in aluminium foil. The viability of the yeast 
cells was tested at various conditions such as extremely low pH, low temperature of 
(–20 °C), ethanol concentrations of (10, 20, and 40) % vol., aqueous solution of 0.5 M 
calcium chloride, and Tween20 solution (0.18 mM). 
 
In all cases, the yeast cells were washed with milli-Q water several times after 
exposing them to the studied conditions and were redispersed in 490 L milli-Q 
water. Then 10 L of FDA working solution was added into the dispersion, which 
was shaken on a mini shaker for 20 minutes followed by washing with milli-Q water 
several times to remove the excess FDA. The stained cells were observed by optical 
fluorescence microscopy using FITC filter set. Stock suspension of 1 % wt. native 
yeast cells was prepared as follows: 0.01 g dry yeast powder was washed several 
times by using 5 mL in milli-Q water, and the suspension was centrifuged at 5,000 
rpm for 5 minutes followed by discarding of the supernatant.  
48 
 
(i) Freezing native yeast cells at –20 °C. Yeast cells dispersion was frozen overnight 
in a freezer at –20 °C. The frozen dispersion was melted at room temperature and then 
the FDA test was performed to check the cells viability. 
(ii) Exposing native yeast cells to low pH and concentrated calcium chloride 
solution. Prepared stock suspension of 1 % wt. native yeast cells was centrifuged and 
the supernatant was discarded. The sedimented yeast cells were redispersed in both 
0.1 M hydrochloric acid and 0.5 M calcium chloride aqueous solutions separately and 
the suspensions were shaken for 30 minutes on a mini shaker. The dispersions were 
later centrifuged and washed with milli-Q water several times followed by the FDA 
test. 
(ii) Exposure of native yeast cells to aqueous ethanolic solution. Yeast cells were 
washed with milli-Q water for several times and they were redispersed in aqueous 
ethanolic solutions in concentrations of (10, 20, and 40) % vol. the suspensions were 
shaken for one hour on a mini shaker followed by washing with milli-Q water and 
testing the yeast cells viability with FDA solution. 
(iv) Viability of native yeast cells in Tween20 aqueous solution. A stock solution of 
0.18 mM (3x CMC) Tween20 was prepared by dissolving 0.022 g Tween20 in 100 
mL milli-Q water. Native yeast cells were redispersed in stock solution of Tween20. 
The dispersion was shaken on a mini shaker for one hour followed by washing with 
milli-Q water to remove excess Tween20. Finally, the yeast cells were treated with 
FDA solution for viability test. 
2.2.8 Coating yeast cells with polyelectrolytes 
Dry yeast powder was washed with milli-Q water several times, by centrifugation at 
5,000 rpm for 5 minutes and discarding of the supernatant.  Aqueous dispersion of a 
known amount yeast cells was prepared by redispersing the washed yeast cells in 
milli-Q water. 0.02 g of (polyallyamine hydrochloride) PAH was dissolved in 4 mL 
milli-Q water. The solution was divided into 4 equal portions (1 mL each). 500 µL of 
yeast dispersion was added dropwise into 1 mL of PAH solution with stirring on a 
magnetic stirrer, followed by stirring the dispersion for 5 more minutes after the 
complete mixing. All the portions of the PAH pre-coated yeast cells were mixed 
together and stirred at 700 rpm for 20 minutes on a magnetic stirrer. The final 
suspension was centrifuged at 4,000 rpm for 5 minutes and washed with water several 
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times to remove excess PAH, while the supernatant was discarded. The sedimented, 
PAH pre-coated yeast cells were redispersed in 1 mL milli-Q water. The same 
procedure was repeated using 0.02 g PSS dissolved in 4 mL milli-Q water divided 
into 4 portions. 500 µL of the PAH pre-coated yeast cells were added dropwise into 1 
mL of PSS solution with stirring. All the portions were mixed together and the 
suspension was stirred at 700 rpm for 20 minutes on a magnetic stirrer. The 
suspension was centrifuged and the PAH/PSS pre-coated yeast cells were washed 
with milli-Q water several times to remove excess PSS. 
2.2.9 Preparation of magnetite nanoparticles 
Iron oxide magnetic ( Fe3O4) nanoparticles stabilised with PAH, magnetic nano-rods 
were produced following a procedure similar to that described elsewhere.
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2 mL of 1 M FeCl3 and 0.5 mL of 2 M FeCl2 aqueous solutions were mixed (a ratio 
4:1, total volume 2.5 mL) and stirred vigorously. Then 25 mL of 1 M aqueous 
ammonia solution was added rapidly while stirring and the appearance of a dark iron 
oxide precipitate was immediately observed. After the subsequent incubation for 30 
mints the precipitate was separated using a permanent magnet and washed several 
times with water until pH~7 was detected in the supernatant. Aqueous suspension of 
magnetic nanoparticles was produced by using PAH as a stabiliser. 100 µL of 
suspension of magnetic nanoparticles obtained as described above was diluted in 10 
mL of 10 mg mL-1 PAH aqueous solution and sonicated for 30 min at 50 % power of 
the Sonifier (Branson Digital Sonifier Model 450, 5 mm tip, 400 W maximal power) 
and immediately filtered with Milli-pore cartridge (pore size 0.2 µm) which produced 
a stable aqueous suspension of magnetic nanoparticles. 
2.2.10 Preparation of sporopollenin microcapsules  
Sporopollenin microcapsules were prepared from Lycopodium clavatum pollen grains 
by suspending 50 g dry pollen powder in 375 mL acetone. Then the pollen suspension 
was stirred under reflux for 4 hours. The de-fatted pollen was filtered off and treated 
with 375 mL 6 % wt. potassium hydroxide under reflux for 12 hours while the 
solution was filtered and replaced after 6 hours. Then the mixture was filtered through 
Whatman filter paper 20–25 µm, washed with hot water and hot absolute ethanol on 
the filter. The solid residue was re-suspended in 375 mL 85 % wt. ortho-phosphoric 
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acid and stirred under reflux for 7 days. Then, it was filtered again and washed with 
water, acetone, 2 M hydrochloric acid and 2 M sodium hydroxide, water and acetone 
and finally washed with absolute ethanol and dried at 60 °C until constant weight. 
2.2.11 Encapsulation of yeast cells in sporopollenin microcapsules 
To encapsulate the yeast cells in sporopollenin microcapsules, a disc-like pellet was 
prepared by compressing 0.05 g loose dry sporopollenin powder with a mechanical 
press (15 tonnes) pressing force. The yeast cells were hydrated in Milli-Q water and 
subsequently washed several times. To infuse the cells into the sporopollenin 
microcapsules, the pellet was added into 1.5 g of freshly prepared dispersion of 30 % 
wt. concentrated yeast aqueous dispersion which contained either (i) a surfactant 
Tween20 (at concentration 0.18 mM, equivalent to 3 CMC) or (ii) ethanol (13 % wt. 
). The mixture was immediately stirred for a few seconds to form a thick paste-like 
dispersion. The residual air trapped in the sporopollenin microparticles was evacuated 
by putting the sample under vacuum. The non-encapsulated yeast cells were washed 
off by replacing the supernatant with Milli-Q water ten times, after leaving the 
sporopollenin microcapsules to sediment under gravity. Finally, the sample was 
lyophilised at room temperature. 
2.2.12 Growth process of yeast cells inside sporopollenin microcapsules using 
“in-gel” fermentation 
Oxidised starch powder was dissolved in the prepared sterilised culture medium. For 
the purpose of the growth process of yeast cells encapsulated in sporopollenin 
microcapsules, four different samples were prepared in (14 mL Greiner® culture tube 
with screw on cap) as follows, sample (a) only contained the culture media and starch, 
sample (b) contained 1 %  wt. native yeast cells dispersed in the culture media and 
starch, while, sample (c) composed of only 0.1 g of sporopollenin dispersed in the 
culture media and the starch, the last sample (d) was mainly 0.1 g sporopollenin with 
the encapsulated yeast cells inside, dispersed in the culture media plus the starch to 
act as the gel phase. All four samples were put together in a holder and then they were 
photographed with a digital camera, after which they were incubated at 37 ºC in a 
Grant OLS200 thermostat bath, and then it was photographed at different time 
intervals to determine the effect of released carbon dioxide due to the cell growth. 
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2.2.13 Encapsulation of magnetized yeast cells in sporopollenin microcapsules 
Baker’s yeast cells were washed several times with milli-Q water and then coated 
with polyelectrolytes using alternating deposition of PAH and PSS (from 10 mg/mL 
solution in 0.5 M NaCl) by the layer by layer methods. Since the hydrated yeast cells 
in water are negatively charged, they were coated first with PAH. 300 µL of the cell 
suspension was combined with 1 mL of PAH (aqueous) solution during constant 
shaking, incubated during 10 min and then centrifuged. The remaining excess 
polyelectrolyte was removed and the cells were redispersed and washed three times 
with Milli-Q water. The cells were then combined with the PSS solution and the same 
steps repeated as before PAH coating. 100 µL of PAH/PSS coated yeast cells were 
introduced into 1 mL of PAH-coated magnetic nanoparticles, incubated for 15 min 
and washed with water. The magnetised yeast cells were collected with a permanent 
magnet. 10 % wt. of magnetised yeast cells were encapsulated in sporopollenin 
microcapsules using the same procedure used for uncoated (native) cells in section 
2.2.11. 
2.2.14 Spray co-precipitating ammonium shellac solution/yeast cells formulation 
Baker’s yeast cells were washed several times with milli-Q water and then re-
dispersed in aqueous solutions of ammonium shellac at different concentrations. 
Three different shellac-yeast formulations were prepared: (i) shellac-yeast dispersion 
at pH 8; (ii) shellac-yeast dispersion doped with 0.52 % wt. carboxymethylcellulose at 
pH 8; The pH of the final dispersion was adjusted to 8 by adding (drop-wise) 0.01 M 
sodium hydroxide solution. (iii) shellac-yeast dispersion was doped with 4 % wt. 
sodium polyacrylate at pH 6.7 supported by acetate buffer. The spraying of the 
shellac-cells aqueous dispersion in all experiments was performed with push-sprayer 
with metal nozzle of internal diameter 380 µm. The spraying frequency was 43 sprays 
per minute and each spray dose contained 0.03 g of shellac-cells dispersion. Each of 
the aforementioned dispersions was sprayed over either 3 % vol. aqueous acetic acid 
or 0.5 M aqueous calcium chloride solution, which produced composite “shellac-yeast 
cells” microcapsules. The microcapsules were stirred in the precipitating medium for 
2 hours to test the viability of the yeast cells upon exposure to the acetic acid and 
calcium chloride solutions. Then they were isolated from these media by 
centrifugation and multiple washing with milli-Q water. 
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2.2.15 Spray drying yeast cells/ammonium shellac solution formulation 
Dispersions of yeast cells in ammonium shellac solution prepared as described in 
(section 2.2.14) (i)-(iii) were sprayed into an “in house” designed spray-dryer column 
in counter-flow of hot air. The produced microcapsules were collected in a Petri dish 
containing milli-Q water placed at the base of the column. 
2.2.16 Testing the viability of yeast cells inside the composite microcapsules 
The viability of the yeast cells inside the microcapsules was tested by using 
fluorescence optical and confocal microscopy, by treating the aqueous suspension of 
yeast cells released from the microcapsules with a small amount (typically 1-2 drops 
of 10 mg/mL solution of fluorescein diacetate (FDA) in acetone per 10 mL of cell 
suspension). The same test was also performed on the encapsulated cells after the 
microcapsules were stirred in acetic acid or calcium chloride solutions for 2 hours. 
For determining the fraction of the dead cells, the suspension of the released yeast 
cells (200 µL) was treated with 100 µL of PI and shaken for 20 minutes at 37 °C. 
Then the cells were washed several times with milli-Q water and observed with 
TRITC filter optical fluorescence microscopy. 
2.2.17 Disintegration of the microcapsules and triggered release of the cells 
The disintegration of the composite shellac-yeast microcapsules was monitored in 0.1 
M aqueous phosphate buffer solution of various pHs, to mimic the physiological 
conditions in the stomach and the lower intestines; by transferring the microcapsules 
into the solution followed by stirring on 300 rpm with a magnetic stirrer at 37 °C. In 
all our experiments we have used the same beakers and magnetic stirrers, and kept the 
stirring speed constant. It is expected that without stirring, the results would have poor 
reproducibility. The disintegration processes was monitored by withdrawing small 
aliquots at regular periods and observing them using optical brightfield and 
fluorescence microscopy.  
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2.2.18 Preparation of Pickering emulsions stabilised with latex nanoparticles 
Water-in-oil Pickering emulsions were stabilised with 300 nm amidine latex 
nanoparticles and the adsorbed particles monolayer was interlocked by using either 
PSS solution or PAH/PSS pre-coated yeast cells suspension in the water phase. The 
oil phases were prepared by dispersing amidine latex nanoparticles the procedure 
described in this thesis (section 2.2.6). The water phases were prepared as follows: (i) 
to interlock the particle monolayer with PSS in the w/o interface an aqueous 
suspension of 1 % wt. native yeast cells was prepared in 0.1 M sodium chloride 
solution which contained 1 % wt. PSS. (ii) To interlock the monolayer of the particles 
with PAH/PSS pre-coated yeast cells at the w/o interface a suspension of 15 % wt. 
yeast cells pre-coated with PAH/PSS was prepared in 0.1 M sodium chloride solution.  
The water phase was emulsified into the oil phase at 8,000 rpm for 30 seconds by 
using ultraturrax homogeniser.  
2.2.19 Transfer of the w/o Pickering emulsion droplets into water 
Colloidosomes were prepared by templating w/o Pickering emulsions droplets and 
subsequent transfer of the water droplets from the undecane phase to water phase by 
employing three different approaches as described below:  
(i) Exchange of the oil phase followed by centrifugation. In this approach the 
undecane phase was replaced with 3 mL hexanol twice, and the emulsion droplets in 
hexanol were left to settle followed by removing the excess hexanol. 1 mL of the 
concentrated emulsion in hexanol was added on top of 5 mL milli-Q water, and then 
the mixture was centrifuged on 1,500 rpm for 3 minutes. 
(ii) Exchange of the oil phase followed by evaporation of the new oil phase. In this 
method approach the undecane phase was replaced with hexane twice and the w/o 
emulsions droplets in hexane were left to settle. The excess hexane was removed and 
1 mL of the concentrated emulsion in hexane was added on top of 5 mL of milli-Q 
water. The hexane phase was evaporated at 40 °C in a Grant thermostat water bath. 
(iii) Freezing process. Calcium carbonate microparticles (0.2 g) were dispersed in 5 
mL ethanol. The suspension was centrifuged on 5,000 rpm for 5 minutes followed by 
discarding of the supernatant. The calcium carbonate microparticles were redispersed 
in 1 mL ethanol and then 5 mL hexane was added into the suspension. The mixture 
was stirred to disperse the calcium carbonate microparticles properly. The undecane 
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phase of the original emulsion was replaced with hexane twice. The excess hexane 
was removed after the w/o emulsion droplets were settled and replaced by 5 mL of 
calcium carbonate microparticles suspension in hexane. The emulsion-calcium 
carbonate microparticles mixture was stirred to spread the microparticles 
homogeneously followed by freezing at -20 °C overnight. The frozen emulsion-
microparticles mixture in hexane was filtered off and the frozen w/o emulsions 
droplets were redispersed in 3 mL cold aqueous solution of 1 % vol. glacial acetic 
acid to dissolve the calcium carbonate spacer microparticles. Finally the frozen-core 
of the colloidosomes was melted by increasing the temperature to 30 °C in a Grant 
thermostat water bath. 
2.2.20 Preparation of w/o emulsion stabilised with oleic acid 
3D multicellular cellosomes of living cells were prepared by templating w/o emulsion 
droplets stabilised with oleic acid. Both undecane and octanol equilibrated with water 
were used as an oil phase which was prepared by dispersing different amounts of oleic 
acid in the oil phases followed by vortexing the mixture for 20 minutes on a magnetic 
stirrer. The water phase was prepared by dispersing different amounts of yeast cells 
pre-coated with PAH in milli-Q water. Finally the water phase (1:9 ratios) was 
emulsified into the oil phase at 8,000 rpm for 30 seconds by using ultraturrax 
homogeniser. 
2.2.21 Preparation of w/o emulsion stabilised by Span60 
We used water-in-oil emulsion templates stabilised with Span60 to fabricate 3D 
multicellular living cellosomes by mixing and re-emulsifying two emulsions, one 
containing 10 % wt. PAH pre-coated yeast cells in the water droplets and the other 
containing 5 % wt. PSS solution in the water phase. The emulsions were prepared by 
emulsifying (1:9) ratio of the water phase into octanol equilibrated with water which 
contained 2 % wt. Span60 at 11,000 rpm for 30 seconds. In the case of water-in-
octanol emulsion containing PSS solution in the water phase the emulsion was 
homogenised at 13,000 rpm for 1 minute by using ultraturrax homogeniser. 
The two emulsions were mixed in a ratio of (50:50) and re-emulsified at 11,000 rpm 
for 30 seconds. The emulsion was left to settle for several minutes followed by 
shrinking the water emulsion droplets upon addition of dry octanol after removing the 
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original continuous phase. The shrinking procedure was repeated 3 times and the 
water-in-dry octanol emulsion droplets containing PAH pre-coated yeast cells linked 
together by PSS were transferred by using freezing process described in section 
2.2.23. 
2.2.22 Fabrication of cellosomes from w/o Pickering emulsion templates 
We have fabricated 3D multicellular living cellosomes by employing the 
colloidosomes fabrication strategy which includes using templates of water-in-oil 
Pickering emulsions stabilised with solid latex particles. Two Pickering emulsions 
were prepared, one containing yeast cells pre-coated with PAH and the other 
containing yeast cells pre-coated with PAH/PSS. The two emulsions were mixed and 
re-emulsified to yield a new Pickering emulsion containing both cationic and anionic 
yeast cells pre-coated with polyelectrolytes linked together by electrostatic 
interaction. Here, we have also used both undecane and octanol equilibrated with 
water as the oil phase which was prepared by dispersing 1 mL 300 nm amidine latex 
nanoparticles suspension in ethanol (4 % wt.) into 8 mL of the oil phase. The water 
phase contained 10 % wt. yeast cells pre-coated with either PAH or PAH/PSS in 0.5 
M sodium chloride solution. 
 
In all cases, the Pickering emulsions were prepared by emulsifying 1:9 ratio of water 
phase into the oil phase at 8,000 rpm for 30 seconds. The combination of the two 
Pickering emulsions was done by mixing 50:50 ratios of both emulsions and re-
emulsifying the mixture at 8,000 rpm for 30 seconds. Finally, the cellosomes were 
prepared by transferring the w/o Pickering emulsions droplets containing both PAH 
and PAH/PSS pre-coated yeast cells from the oil phase into water phase by using  the 
freezing process approach described in section 2.2.23. 
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2.2.23 Transfer of w/o emulsion droplets into water using freezing process 
Fabrication of the 3D multicellular cellosomes of living cells were achieved by 
transferring the w/o emulsion droplets from the oil continuous phase into water phase 
by using the freezing process.  The w/o emulsions droplets were first shrunken upon 
addition of dry octanol and then they were transferred into water. Octanol is a long 
chain alcohol, and thus contains both a hydrophobic hydrocarbon chain and a 
hydrophilic end group. The solubility of water in octanol is 2.2 ± 0.2 M at 25 °C.
58
  
The shrinking process gave closely packed yeast cells inside the water droplets and 
hence increased their stability to withstand the transfer process. This was done by 
leaving the emulsion droplets to settle and removing the excess oil, followed by 
replacing it with 5 mL dry octanol with gentle stirring. The emulsion in dry octanol 
was left for 30 minutes and then another 5 mL of dry octanol was added after the 
octanol phase was removed again. The octanol phase was replaced with 5 mL of 
calcium carbonate microparticles suspension in dry octanol prepared by dispersing 0.1 
g calcium carbonate microparticles in 5 mL ethanol followed by centrifugation on 
5,000 rpm for 3 minutes and discarding of the supernatant. The sedimented 
microparticles were redispersed in 0.5 mL ethanol and then 4.5 mL of dry octanol was 
added. The emulsion-microparticles mixture was vortexed for 30 seconds followed by 
freezing at – 20 °C overnight. The frozen w/o emulsion droplets were transferred 
from the octanol phase into water phase by removing the excess dry octanol and 
adding 100 L of the concentrated frozen emulsion-microparticles mixture on top of 1 
mL milli-Q water in an Eppendorf tube followed by centrifugation at 1,500 rpm for 3 
minutes. 
2.2.24 Counting the numbers of released cells from composite microcapsules 
We have prepared composite microcapsules which contained only shellac and yeast 
cells without any pH sensitive polyelectrolytes as follows: Baker’s yeast cells were 
washed several times with milli-Q water and then re-dispersed in aqueous solutions of 
ammonium shellac 6 % wt. at pH 9; the pH of the final ammonium shellac/yeast cells 
formulation was measured to be 8. The spraying of the shellac-cells aqueous 
dispersion was performed with push-sprayer with metal nozzle of internal diameter 
380 µm. The spraying frequency was 43 sprays per minute and each spray dose 
contained 0.03 g of shellac-cells dispersion. The dispersion was sprayed over 3 % vol. 
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aqueous acetic acid solution, which produced composite “shellac-yeast cells” 
microcapsules which were isolated from the acidic media by multiple washing with 
milli-Q water. 
 
The disintegration of the composite shellac-yeast microcapsules was monitored in 0.1 
M aqueous phosphate buffer solution of various pHs, to mimic the physiological 
conditions in the stomach and the lower intestines; by transferring the microcapsules 
into the solution followed by stirring on 300 rpm with a magnetic stirrer at 37 °C. In 
all our experiments we have used the same beakers and magnetic stirrers, and kept the 
stirring speed constant. It is expected that without stirring, the results would have poor 
reproducibility. The number of the released cells from the composite microcapsules 
was counted using a Haemacytometer which was observed by optical microscopy. 
 
The growth of the encapsulated yeast cells inside the composite microcapsules were 
monitored by incubating the microcapsules in a culture medium of pH 5 containing 2 
% wt. glucose, 0.5 % wt. yeast extract, 0.1 % wt. sodium chloride and 0.3 % wt. 
ammonium sulphate at 37 °C with stirring at 300 rpm on a magnetic stirrer. The 
number of released cells because of growth was counted in different times using a 
Haemacytometer which was observed by optical microscopy. 
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Chapter 3.  
Encapsulation of living cells into sporopollenin microcapsules 
3.1.1 Introduction 
The term sporopollenin was first coined by Zetzsche
59
 to describe the material which 
essentially forms the major part of the outer highly resistant coat (exine) of pollen 
grains. Pollen powder consists of monodispersed pollen grains, which contains the 
sperm cells of seed plants. Each pollen grain contains vegetative (non-productive) 
cells and generative (reproductive) cells containing two nuclei, a tube nucleus and a 
generative nucleus. The group of cells are surrounded by a cellulose (intine) wall and 
the outer exine coat. 
 
Sporopollenin has been recognised as one of the most resistant material of bioorganic 
origin 
60
 against both chemical and biological decay. Individual sporopollenin grains 
have been isolated from 500 million year old sedimentary rocks and also from 
Precambrian rocks dated up to about 3.5x10
9
 years in the form of microspores.
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Pollen grains come in variety of morphologies, where the shapes, size and surface 
marking characteristics depend on the plant species. Most but not all are spherical, the 
smallest pollen grains are around 6 µm in diameter. The spores of Lycopodium 
clavatum plant are shaped like a three-sided pyramid with distal face rounded 
triangular in outline and have particle size of about 28 µm in diameter (see Figure 
3.1a).
62
 
 
Sporopollenin can be isolated from the pollens by consecutive alkaline and acidic 
solvent treatment, which remove the inner cellulose wall but morphologically 
preserve the exine. Although the exact chemical structure of sporopollenin is still 
debated, the analytical evidence suggest that at large it is an oxidised polymer of 
carotenoids and their esters.
61f
  
Bohne et al. 
63
 investigated the structure and diffusion properties of sporopollenin 
microcapsules prepared from pine pollen. It was demonstrated that, sporopollenin 
exine formed from three main layers, two inner and an outer membrane. The external 
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membrane represents the part of the exine termed the sexine, while the two inner 
layers covering the lumen of the central microcapsule (endexine and foot layer) have 
been named nexine.
64
 (See Figure 3.1b) 
 
 
 
Figure 3.1: (a) Scanning Electron Microscopy image of the distal face of a 
Lycopodium clavatum spore.
62
, scale bar is 10 µm in diameter(b) Schematic diagram 
of the sporopollenin strata of the pine exine, the two outer layers of the ectexine are 
detached from the foot layer, thus forming a saccus.
63
 
 
The sexine is detached from the foot layer thus forming a saccus. The external wall of 
the sacci consists of a thin sporopollenin membrane (tectum), which covers a thick but 
macro-porous layer formed by honeycomb-shaped support structures, which are open 
to the lumen. The tectum is perforated by scattering pores of submicrometer size. The 
lumen of the central microcapsule is bordered by a continuous dense sporopollenin 
envelop. The pine nexine and sexine proved to be very different in terms of their 
permeability with respect to organic molecules. The nexine is an ultrafilter membrane, 
which is impermeable to most proteins, and its permeability to sugar is low indicating 
that the pores through the nexine are inhomogeneous with respect to their size and 
that most pores are too narrow for free diffusion of sugar molecules. The purified 
sexine at the external surface of the sacci is a micro-filter that is highly permeable for 
even larger polymer molecules and diffusible submicrometer particles. With respect 
of chromatography and immobilisation, the most interesting properties of the sacci are 
rapid polymer exchange, large and well accessible inner sporopollenin surface and 
high mechanical rigidity. The slow exchange of the central microcapsule for polymer 
and polyvalent anions might be of interest for controlled release applications.
63
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3.1.2 Applications of sporopollenin microcapsules 
Sporopollenin microcapsules are monodispersed i.e. have the same particle diameter 
to within ± 1 µm. This narrow size distribution makes sporopollenin a potential 
vehicle to encapsulate drugs. The spores and pollens are naturally occurring 
renewable materials, with very high resistance to highly acidic or alkaline conditions 
and are relatively elastic. This means they can pass into the stomach largely 
unchanged and therefore, protect any medically active ingredients that have been 
attached to, or contained within them, and would otherwise be destroyed in the 
stomach.
9b,65
 Sporopollenin has the potential to be used as a drug delivery vehicle, 
because sporopollenin is capable of crossing the gut wall, largely intact, but is then 
destroyed within the blood stream, thereby releasing its contents.
9b,65
  
 
Blackwell has investigated the process of absorption of both the raw spores of 
Lycopodium clavatum and their empty exines in man following oral ingestion. 
Patients were given the pollen or the exines randomly using a labelled envelope in a 
double blind trial where both the patient and the investigator were blind to the 
treatment given. Human volunteers from both sex aged between 20 to 59 years 
ingested an oral dose of approximately 12.66 x 10
6
 particles suspended in milk on 
different occasions. Quantification was determined by haemacytometery of the 
respective particles in venous blood taken from the arm of a volunteer at time 
intervals up to 1 hour following peroral administration. The volunteer’s venous blood 
was examined and the particles were detected as rapidly as 5 minutes after ingestion 
and the counts reached a maximum at 15-30 minutes after ingestion.
9b
 Confocal 
microscopy also confirmed the presence of exine particles in the recovered blood 
plasma and pellet samples.
9b
 (see Figure 3.2). 
 
The effect of the sporopollenin vehicle on cells has been investigated by adding the 
sporopollenin microcapsules into a culture of growing human endothelial cells. 
Proliferation, apoptosis and necrosis were assessed, together with direct microscopic 
examination. No differences were seen at any concentration of sporopollenin used, 
suggesting that no direct toxic effect of the vehicle was present.
9b
 Sporopollenin 
microcapsules have the advantage of being non-toxic and non-allergenic, because 
they do not have proteins or carbohydrates on their surface. 
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The exine shells appear to have nano-sized holes running through them
63
 which allow 
their core to be removed and replaced by a suitable active compound or nutraceutical. 
Certain surface active substances such as ethanol greatly enhance the sporopollenin 
filling rate. 
 
Mackenzie et al.
9a-c,66
 has developed chemical and physical methods by which a large 
variety of chemical entities including peptides, nucleotides and metals can be attached 
or encapsulated within the empty exine coating of sporopollenin. Large sporopollenin 
microcapsules > 25 µm in diameter, do not transfer into the blood stream, and 
therefore, can be used to release their contents over a period of time lower down in 
the lower intestine and thus deliver nutraceutical and other food additives such as 
probiotics. The active ingredient which it is to be encapsulated must be in liquid form, 
either naturally or in solution, other materials such as proteins, vitamins or enzymes 
are dissolved in aqueous or organic solvents, which can be evaporated or simply 
filtered off after encapsulation. 
 
The potential use of sporopollenin exine to enhance medical imaging was reported by 
Lorch et al. 
65
 and the principle behind this process is, the exine coatings concentrate 
a contrast material in a particular part of the body, where it then shows up brightly 
within the scanner. Sporopollenin has also been used as a novel natural taste masker 
for materials such as sunflower oil, and cod liver oil. The exine could be loaded with 
high amount of the material and still remain as dry as powder and retain flavour 
masking.
9a
 The high loading, taste masking and anti-oxidant properties of 
sporopollenin exine, therefore, make this technology ideal for the delivery of 
unpleasant tasting, easily oxidisible substances such as fish oil. 
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Figure 3.2: Confocal images of exines recovered in blood after 5 minutes in plasma 
(a), 45 minutes in plasma (b), 5 minutes in lysed blood pellet (c) and 30 minutes in 
lysed blood pellet (d). Image reproduced from the reference 
9b
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Paunov et al. 
67
 reported a simple and robust method for loading sporopollenin exine 
of Lycopodium Clavatum with inorganic and organic nanoparticles synthesised in situ. 
The technique uses sporopollenin microcapsules as chemical micro-reactors where a 
chemical reaction is generating a large amount of the product (e.g. of low solubility) 
inside the microcapsule shells. The procedure begins by loading the microcapsules 
with a solution of the reagent (A) or a mixture of soluble reagents. 
 
The loaded microcapsules can be filtered off quickly and washed with pure solvent on 
the filter to remove the excess of the reagent (A) and then redisperse the 
microcapsules in a solution of reagent (B) to conduct a chemical reaction. A + B = C, 
where (C) is a product of low solubility. Filtering and washing the “filled” 
sporopollenin with a pure solvent to remove the excess of reagent (B), followed by re-
dispersion in water. In case of a chemical reaction producing nano-particles of 
average diameter larger than the pore size, the particles remain trapped in the capsules 
but the solvent can still access them through the sporopollenin pores. This method has 
been used to load sporopollenin with variety of chemical compounds including 
fabricated magnetic sporopollenin nanoparticles (Fe3O4), which brought the idea of 
using the prepared microcapsules for direct drug delivery by using an external field. 
This can be done by loading the magnetic sporopollenin with additional component 
(e.g. drug, vaccine, food supplements).
67
 In this chapter we describe novel technique 
for encapsulation and protection of living cells into sporopollenin microcapsules. 
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Figure 3.3: Schematic representation of the method for loading sporopollenin 
microcapsules with nanoparticles as a result of a chemical reaction. (a) A compressed 
tablet of sporopollenin is dispersed in a solution of reagent A to load the capsules with 
this solution. (b) The sporopollenin capsules loaded with solution A are filtered and 
quickly washed with pure solvent to remove the excess of reagent A in the continuous 
phase followed by their redispersion in a solution of reagent B. (c) The chemical 
reaction A + B gives a product C of low solubility which results in the formation of 
nanoparticles growing inside the sporopollenin. (d) The loaded capsules are filtered 
and washed on the filter with a pure solvent to remove the excess of reagent B, 
followed by redispersion in water.
67
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3.1.3 Results and discussion 
In this chapter, hollow sporopollenin microcapsules prepared in-house from 
Lycopodium Clavatum plant powder by a consecutive alkaline and acidic extraction. 
This leads to the removal of the cellulosic inner intine but morphologically preserved 
the outer robust exine shell. Baker’s yeast cells Saccharomyces cerevisiae which are 
used as model for living cells, and probiotics culture, were selected for this study 
because they are robust and resilient microorganism, easy to obtain and handle in 
laboratory. Similar results are expected with most commonly used probiotic cultures. 
The method of encapsulating of yeast cells has been demonstrated on the basis of the 
fact that each pollen micro-particle from Lycopodium clavatum has a trilite scar on its 
surface which also exists in the sporopollenin microcapsules produced from this 
material. Upon compression, the sporopollenin particles are ‘‘squashed’’ which opens 
their trilite scars. 
 
In this experiment the sporopollenin powder was compressed into a thin pellet which 
was then incubated into a concentrated aqueous suspension of living cells in the 
presence of a surface active agent. The latter is needed to promote wetting of the 
sporopollenin by the liquid phase. The capillary effect causes an influx of liquid 
through the opened trilite scars of the compressed sporopollenin and facilitates their 
closure after they are fully ‘‘re-inflated’’ with the liquid media (See Figure 3.4 for 
more information). This liquid influx drags some of the cells from the suspension into 
the sporopollenin microcapsules where they remain trapped after the microcapsules 
re-inflates and can be grown further in a suitable culture medium. This process, for 
example, can be used for encapsulation and protection of probiotics upon food 
processing and storage. This procedure could also find applications in oral delivery of 
live vaccines as the sporopollenin shells have been reported to cross the gut wall but 
the living cells encapsulated inside them may remain isolated from the body’s 
immune system. 
Although, yeast cells can be encapsulated in sporopollenin using passive filling over a 
period of 2 hours, however, vacuum enhanced filling has been employed to ensure the 
efficient encapsulation. The vacuum treatment de-gases the empty microcapsules and 
this in return should enhance the influx of the cells into their core through the opened 
scars. 
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3.1.3.1 Growth of yeast cells in culture media 
The most common mode of vegetative growth in yeasts is by a process called budding 
which is a typical reproductive characteristic of ascomycetous yeasts, including 
Saccharomyces cerevisiae.
36
 Native unprotected yeast cells were incubated at 
different temperature using a culture media which is suitably prepared for yeast cells 
growth from materials that contained glucose, a source of nitrogen and some 
inorganic salts.( see chapter 2 for the preparation procedure) Figure 3.5a-c 
demonstrates the growth of native yeast cells, where (a) is 1 % wt. yeast cells 
dispersed in milli-Q water before incubation, while (c, and d) show the yeast cells 
after 19 hours of incubation in the media at 25 and 37 °C, respectively. It is clearly 
demonstrated that the cells can grow faster in the same media at higher temperature of 
37 °C. 
3.1.3.2 Yeast cells viability during the encapsulation process 
The viability of unprotected yeast cells has been tested by using fluorescence 
microscopy after treating the cells with FDA. The test is based on the fact that FDA is 
a non-fluorescent derivative that readily diffuses through the cell membrane, where 
intracellular FDA is hydrolyzed by nonspecific de-esterases resulting in release of 
fluorescein which accumulates into living cells if their lipid membrane is intact and 
can be detected by fluorescence microscopy. Fluorescein diacetate appears to be 
passively transported through the cells membrane and because fluorescein 
accumulation depends upon an intact membrane and active metabolism, only active 
living cells should fluoresce.
68
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Figure 3.4: (a) Schematic representation of the process of encapsulating yeast cells 
into sporopollenin microcapsules. (b) Scanning electron microscopy images of 
sporopollenin from Lycopodium clavatum pollens. Each sporopollenin particle is 
hollow and has a trilite scar which can be opened upon compression. Scale bar is 15 
µm. 
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The work described in this chapter, involves using two different types of surface 
active agents to promote wetting of the sporopollenin surface by the cell dispersion. 
Here both a low molecular weight alcohol (food grade) and a classical non-ionic 
surfactant (Tween20) at low concentration (3 times CMC) were used. These surface 
active agents might have an effect on the viability of the cells at a particular 
concentration, therefore, investigation of the yeast cells viability in both aqueous 
solutions, was performed. First, the viability of yeast cells in water–ethanol mixture at 
various ethanol concentrations was tested, where the cell dispersion was kept in the 
water ethanol solution for one hour and then was treated with a solution of 1 mM 
fluorescein diacetate (FDA). Then the cells were washed with Milli-Q water to 
remove the excess FDA and observed by fluorescence microscopy with FITC filter 
set. 
 
We demonstrated with the FDA test that the yeast cells did not have their viability 
impaired after short time exposure to the alcohol solution at concentration of up to 20 
% vol. while our experiments using 40 % vol. ethanol in water mixture resulted in 
completely destruction of all yeast cells. The use of ethanol as a wetting agent is not 
essential for the cell encapsulation process and other biocompatible surface active 
agents could also be good for this purpose, as similar results have been obtained using 
0.18 mM Tween20 solution which is equal to 3 times the CMC of this surfactant, 
therefore it is not necessary to use ethanol, as the latter is presented here only as an 
example. Other surface active agents, such as sodium dodecyl sulfate, natural 
surfactants like saponins, at concentrations close to their CMC can also be used to 
achieve the same effect. Higher concentrations of surfactants, however, could be toxic 
for the cells as they interact adversely with the cells membranes. 
Figure 3.5d-f shows the fluorescence microscopy image of the individual yeast cells 
stained with FDA after being treated with aqueous solution of ethanol (d, and e) and 
Tween20 (f) before their encapsulation into the sporopollenin capsules. The results 
show that short time incubation in the aqueous solution of either ethanol or Tween20 
does not show an adverse effect on the yeast cells and does not significantly impair 
their viability. Unfortunately, direct observation of the fluorescence from the FDA-
stained cells encapsulated inside the sporopollenin cannot be achieved due to the 
natural fluorescence of the sporopollenin material which is much stronger than the 
fluorescence signal from the entrapped yeast cells. 
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Figure 3.5: (a) 1 % wt. native yeast cells before growing in culture media, (b) the cells 
incubated in culture media for 19 hours at 25 °C, (c) cells incubated at 37 °C, (d) 
native yeast cells exposed to 20 % vol. ethanol for one hour, (e) 40 % vol. ethanol was 
used, (f) the cells were dispersed in 3 times CMC Tween20 solution for one hour. 
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3.1.3.3 Analysis of the cell intake of sporopollenin microcapsules   
Direct observation of the encapsulated yeast cells inside the sporopollenin 
microcapsules using optical or even fluorescence microscopy was found to be 
technically very challenging. Therefore, other means has to be employed to study the 
cell intake by the microcapsules. Several methods have been used; one of them was 
using Scanning Electron Microscopy to observe the cells in cracked-open 
microcapsules. For this purpose a sample of sporopollenin loaded with yeast cells was 
treated with liquid nitrogen to make it brittle and then grinded by pestle and mortar to 
crack the microcapsules open. The cracked open shells with encapsulated cells were 
visualised using scanning electron microscopy. Figure 3.6 and 3.8 show typical SEM 
images of cracked-open sporopollenin from Lycopodium clavatum with encapsulated 
yeast cells. The SEM images show that the sporopollenin contains a significant 
number of cells which can be grown further on the inside of the microcapsules if the 
yeast is exposed to a suitable growth medium. 
 
In our experiments we remove all the non-encapsulated cells outside the 
sporopollenin microcapsules before grinding the sample to prevent them from moving 
into the inside of the microcapsules after they were cracked open. To remove the non-
encapsulated yeast cells the sample was excessively washed with milli-Q water and 
then left still until the microcapsules and the encapsulated yeast cells inside 
sedimented under gravity, after which, the dispersion of the non encapsulated cells 
was decanted. This has achieved because the non-encapsulated yeast cells are smaller 
in size and lighter than the sporopollenin microcapsules, therefore, the microcapsules 
will sediment much faster than the non-encapsulated cells. Figure 3.7 illustrates 
several steps in the removal of non-encapsulated yeast cells. 
 
The sporopollenin loaded with live yeast cells was also examined by using confocal 
fluorescence microscopy following the exposure of the sample to a solution of 
fluorescein diacetate. A series of fluorescence images of the cross-section of a 
sporopollenin in Figure 3.9 shows clusters of fluorescing cells which indicates that the 
yeast cells remain viable after a successful encapsulation process. 
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Figure 3.6: Scanning electron microscopy images of encapsulated yeast inside 
sporopollenin microcapsules (28 m in diameter) prepared from Lycopodium 
clavatum pollens using 20 % vol. ethanol water mixture as a surface active agent. The 
sample was treated with liquid nitrogen and then the microcapsules were cracked 
open by pestle and mortar. 
 
 
 
Figure 3.7: Optical microscopic images of a mixture of non-encapsulated yeast cells 
with Lycopodium clavatum sporopollenin microcapsules loaded with yeast cells. (a) 
represents before washing, (b) represents after 3 times washing, and (c) is after 10 
times washing and sedimenting the microcapsules under gravity. 
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Figure 3.8; Scanning Electron Microscopy images of yeast cells encapsulated inside 
sporopollenin microcapsules (28 m in diameter) using aqueous solution of Tween20 
as surface active agent. The Tween20 concentration was 3 times CMC (0.18 mM). 
 
3.1.3.4 Encapsulation of magnetic yeast in sporopollenin 
One relatively novel method of targeted delivery of active ingredients is based on 
using magnetic particles encapsulated within a delivery vehicle. This way the cost 
preparation of such materials can be reduced and the drug toxicity can be minimised 
as the active compound can be transported directly to the purposed location in the 
body. The following experiment was designed for two purposes; one was for targeted 
deliveries of living cells especially live probiotics into lower intestines by conjugating 
the cells with magnetic nanoparticles and using a magnetic field for external 
manipulation. The other purpose of this experiment was to confirm the presence of 
encapsulated yeast cells in the sporopollenin microcapsules. Yeast cells were 
magnetically functionalised by coating them with magnetic nanoparticles as described 
by Fakhrulin et al. 
69
 and then encapsulated in sporopollenin microcapsules as an 
aqueous dispersion with the non-ionic surfactant Tween20 (at concentration 3 times 
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the CMC). The sporopollenin suspension was washed off thoroughly by multiple 
cycles of sedimentation and replacement of supernatant to remove the non-
encapsulated yeast cells which yielded a result similar to the sample shown in Figure 
3.7. The presence of magnetised yeast cells inside the microcapsules was confirmed 
by using an external magnet by which we were able to collect the suspension of the 
sporopollenin with encapsulated cells which indicates that the magnetically 
functionalised yeast cells are entrapped inside the microcapsules as it is shown in 
Figure 3.10. 
 
 
Figure 3.9: Confocal fluorescence microscope image of a cluster of encapsulated 
yeast cells inside a sporopollenin microcapsule. Each micrograph shows different 
depths in the Z position as follows: (a) 13.1 m, (b) 13.6 m, (c) 14.0 m, and (d) 
15.8 m. 
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3.1.3.5 Examining cell activity inside sporopollenin microcapsules  
To check whether the cells can grow and function inside the sporopollenin 
microcapsules, a fixed amount of the sporopollenin loaded with yeast cells was added 
into an aqueous gel prepared from oxidised starch containing sterilised yeast growth 
media. 3 control experiments were conducted where yeast cells alone and 
sporopollenin alone were encapsulated into the gel. 
Figure 3.11 presents the results of the biological activity of the yeast cells 
encapsulated in the sporopollenin microcapsules which is indicated by the carbon 
dioxide released during the growth. This was detected by breaking (puffing) of the 
starch gel in which the sporopollenin was dispersed. The top image of Figure 3.11 
corresponds to the beginning of the experiment and the bottom image shows the 
results of the biological activity of the cells. To make the experiment rigorous 3 
control experiments were conducted, (the first 3 tubes, (a)–(c)) which contain only the 
starch gel (a), the yeast alone in a starch gel (b) and the sporopollenin alone in a starch 
gel (c). As it becomes clear from the images, only the yeast alone (b) and the yeast in 
the sporopollenin (d) puff the gel, hence the yeast in the sporopollenin is biologically 
active. The top marks on tubes (b) and (d) indicate the position of the expanded gel 
due to the carbon dioxide produced by the yeast cells. 
 
It is worth mentioning that although the direct observation of the cells encapsulated in 
sporopollenin was challenging one can see that, microencapsulation of yeast cells 
inside sporopollenin was successfully achieved. The mechanism of this process can be 
summarised as follows. The trilite scars on the sporopollenin microcapsules opens up 
by compressing the dry sporopollenin powder into a tablet. This is then exposed to a 
concentrated dispersion of cells in the presence of a surface active agent such as 
aqueous solution of Tween20 or ethanol, which enhances the wetting of the interior of 
the dry sporopollenin microcapsules by the aqueous suspension of the cells. This 
process allows the microcapsules to be re-inflated by infusing them with significant 
amount of cells in their cavities before their trilite scars are closed.  
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Figure 3.10: (A) Re-dispersed suspension of sporopollenin with entrapped magnetic 
yeast cells; (B) the sporopollenin particles are attracted to the external magnet due to 
the presence of magnetically functionalised yeast cells inside the capsules. 
 
The process is driven by the wetting action of the surface-active agent. As the 
sporopollenin fills in with the aqueous media, the original volume of the 
sporopollenin pellet in the solution increases up to five fold and the trilite scars close 
up as the sporopollenin capsules re-inflate which gives rise to trapping the yeast cells 
inside the capsules. It has been found that the method works efficiently only if the 
sporopollenin tablet is exposed to a minimal amount of concentrated suspension of 
cells. Another significant point is that, after mixing the yeast dispersion and the 
sporopollenin disc, the mixture has to be stirred for a few seconds until a paste is 
produced and then put under vacuum for at least an hour. The later helps to evacuate 
the trapped air from the inside of the sporopollenin, facilitates the closing of the trilite 
scars and results in efficient cells encapsulation. 
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Figure 3.11: Top image: the culture medium was sterilised by boiling at 100 °C for 1 
hour and then cooled down to room temperature, after which the starch powder was 
dissolved in it before incubation at 37 °C for 24 hours; here (a) is just starch gel with 
the culture medium, (b) starch gel with the culture medium and 1 %  wt. native yeast 
cells, while, (c) 0.1 g sporopollenin in the culture medium with starch gel and (d) 0.1 
g sporopollenin with yeast cells encapsulated inside with starch gel. Bottom image: 
the samples were incubated at 37 °C in a Grant thermostat for 24 hours. Samples (a, 
and c) which are controls and contain no yeast cells are not grown but samples (b and 
d) which contain yeast cells are grown and carbon dioxide gas has puffed the gel. 
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3.1.4 Conclusions 
In summary, encapsulation of living yeast cells into the exine of pollens from 
Lycopodium Clavatum plant has been achieved. The sporopollenin particles produced 
from this plant are approximately 28 m in diameter and have trilite scars on their 
surface which can be opened up after compression which allowed us to encapsulate 
live cells inside the sporopollenin microcapsules cavities. For efficient encapsulation, 
the sporopollenin powder needs to be compressed into a pellet so as to force the trilite 
scars to open up. Exposing the dry sporopollenin pellet to a concentrated aqueous 
dispersion of cells in the presence of a surface active agent helps the process of 
efficient encapsulation by facilitating the capillary suction of cells suspension inside 
the compressed sporopollenin microcapsules, inducing their ‘‘re-inflating’’ with the 
cells dispersion and closing the opened trilite scars. The viability of the cells was 
demonstrated after the encapsulation procedure and it was shown that the 
sporopollenin microcapsules contain a significant amount of entrapped cells. 
 
We were successful in growing encapsulated cells further inside the sporopollenin by 
placing the loaded sporopollenin into a culture medium. The latter is possible due to 
the fact that nano-pores of the sporopollenin allow nutrient transport across its 
membrane. The cells inside the pollens can grow until they fill all the space, after 
which their growth will be impaired. This could be used for controlling the rate of 
fermentation reactions or for using sporopollenin as bioreactors to generate and load 
the active ingredient in situ. The encapsulation of living cells inside sporopollenin can 
be used for many different applications in the food and pharmaceutical industries, 
including protection of probiotics in food formulations and delivery of live vaccines 
for pharmaceutical applications. 
In addition, by using the method developed previously the pollens could be loaded 
with magnetic nanoparticles and live cultures simultaneously. This can allow remote 
manipulation, like fixation, removal or targeted delivery of such bio-reactors. Yet 
another potential application of this method could be to encapsulate two or more 
symbiotic cells forming a food chain inside the pollen grains and study their growth 
and behaviour. 
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Chapter 4.  
Triggered Cell Release from Shellac-Cells Composite Microcapsules  
4.1.1 Introduction 
Shellac is biodegradable and renewable resin of the insect (Kerria Lacca)
70
 formed by 
self-esterification of a mixture of polyhydroxy acids
71
 such as polyhydroxy 
polycarboxylic esters, lactones and anhydrides, and the main components are aleuritic 
and shellolic acids.
72
 Shellac can be purified from its source “a natural polymer” 
called Lac, the resinous secretion of the insect found on several species of trees in 
Asian countries such as India, Thailand and China. The physico-chemical properties 
of shellac are variable depending on the strain of insect, host trees and refining 
methods. Because of its natural origin, shellac is an acceptable coating material for 
food supplement products. In general, shellac possesses good resistance to gastric 
fluid, suggesting its use for enteric coating purposes.
73
 Shellac is soluble in ethanol 
and insoluble in water but it can be dissolved in alkaline solution above pH 7, below 
this pH starts to precipitate. Shellac has density around 1.0619 g/mL close to the 
density of water and refractive index of 1.367. 
 
Changes in the mechanical and physicochemical properties of shellac have been 
observed by partial hydrolysis. Films prepared from hydrolysed shellac are more 
flexible and soft than those prepared from native shellac. Meanwhile, the solubility of 
shellac was increased to pH 7 and the ability of the hydrolysed shellac to form 
ammonium salt has been enhanced. Treating shellac with alkaline solutions should be 
an easy approach for modifying shellac that possesses better enteric properties.
73b
 
Successful fabrication of food-grade shellac micro-rods which contained a range of 
micro-particle inclusions to use as efficient foaming agent and production of shellac 
micro-rods with yeast cells “lumps” to improve steric stability of food-grade foams 
have been reported by Campbell et al.
74
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Encapsulation using shellac was recently reported by Law et al. which include 
stabilisation and targeted delivery of Nattokinase (NKCP) in shellac beads prepared 
by cross-linking aqueous solution of ammonium shellac salt with divalent calcium 
ion.
70
 While, more recently a systematic study of the mechanical properties of thin-
walled liquid-filled pectinate capsules and the influence of the addition of shellac to 
the polymer solution was made. The measurements showed that precipitation of 
shellac under acidic conditions increased the flexibility and softness of the capsules 
against deformations.
75
 
 
In two separate studies Xue et al. 
76
 prepared and characterised calcium-shellac 
microspheres loaded with carbamide peroxide (CP) as tooth whitening agent. In their 
first study they used extrusion technique based on dropping aqueous ammonium 
shellac solution into calcium chloride solution, whereas, emulsifying aqueous solution 
of ammonium shellac in sunflower oil with calcium chloride powders, followed by 
gelation between shellac and calcium resulted in preparation of micro-spheres loaded 
with (CP) in their subsequent study. 
 
The most important work involving encapsulation of probiotics using shellac was 
carried out by Stummer et al. by coating individual fluid-bed dried bacterial species 
with formulation of shellac and various plasticisers such as glycerol, sodium alginate 
and polyvinylpyrrolidine. The enteric coating has increased elasticity, and solubility 
of shellac was increased at pH 7.5. In addition the enteric coating provided protection 
for the individual microorganisms against acidic pH of stimulated intestinal fluid.
73a
  
 
Despite the efforts made to use shellac as a protective cover for microorganisms 
especially probiotics, coating and protecting the bulk of such microorganism in a 
suitable composite microcapsule made out of shellac derivatives, which has ability to 
transfer viable probiotics to the lower intestine and release them through 
disintegrating in pH of approximately 8 has not been reported to our knowledge. 
Therefore, in this chapter, we report the fabrication and subsequent disintegration of 
composite shellac/yeast cells microcapsules by manipulation of spraying techniques. 
Here yeast cells have been used as a model for probiotics because they are the most 
researched, robust and easy to obtain and handle microorganisms in laboratory. 
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The fabrication process of the desired composite microcapsules that can protect the 
probiotics from the mechanical stress of the stomach and low pH of gastric juice, has 
been accomplished by two spraying techniques, which have been employed as 
follows: dispersion of native yeast cells in ammonium shellac solution was either 
spray co-precipitated in acetic acid or calcium chloride solutions or spray dried in a 
designed spray dryer of hot air at 80 °C. Improving the ability of the composite 
microcapsules to disintegrate at pH nearby 8 provided the idea of doping the 
ammonium shellac solution with both carboxymethylcellulose and sodium 
polyacrylate solutions separately. 
4.1.2 Results and discussion 
Composite shellac-yeast cells microcapsules were fabricated by either spray drying or 
spray co-precipitating a dispersion of yeast cells in ammonium shellac solution as 
shown in Figure 4.1 Dispersions of 10 % wt. yeast cells in aqueous solutions of 
different concentrations of ammonium shellac were co-precipitated by either pH 
change (to acidic pH) or by using calcium chloride solution. In both cases, rigid and 
stable composite microcapsules were fabricated, which were capable of disintegrating 
at pH greater than 7. 
 
The spherical aqueous droplets of yeast cells dispersed in ammonium shellac solution 
produced by the spray co precipitation method faced a rapid precipitation upon their 
contact with the solution of the precipitating agent (acetic acid or calcium chloride), 
which allowed them to retain their shape upon contact with the solution.  
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Figure 4.1: Schematic diagram of fabricating composite shellac-cells microcapsules 
by spray drying and co-precipitating of aqueous dispersion of yeast cells in 
ammonium shellac solution. The aqueous cell dispersion was doped with pH sensitive 
polyelectrolytes to control the rate of cells release from the microcapsules in aqueous 
media at specified pH. 
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4.1.2.1 Spray co-precipitating of yeast cells/ammonium shellac formulation into 
acetic acid 
Rigid, and stable composite microcapsules were fabricated by spray co-precipitating 
aqueous dispersion of 10 % wt. yeast cells in 7 % wt. ammonium shellac solution into 
3 % vol. acetic acid solution. The microcapsules were stirred in the acidic medium for 
30 minutes then they were filtered off and washed with milli-Q water several times to 
be characterised by optical and fluorescence ( confocal) microscopy. Figure 4.2 shows 
optical microscopy images of the obtained composite microcapsules from a range of 
ammonium shellac concentrations which are reflected in the capsule morphology. We 
found that 7 % wt. ammonium shellac in the initial dispersion was the optimal 
concentration yielding rigid microcapsules of sufficient integrity, mechanical stability 
and consistent size range. Some of the microcapsules had semi-spherical shape as the 
micro-drops shape was “arrested” upon impact with the precipitating solution. The 
inner structure of the fabricated microcapsules was revealed using confocal 
fluorescence microscopy by imaging the fabricated microcapsules after staining the 
ammonium shellac solution with traces of Nile Red (10
-4
 M) before it was used in the 
spraying process, while the yeast cells inside the fabricated microcapsules were 
treated with FDA solution. 
 
Positive FDA test indicates that the yeast cells membranes are intact and the enzymes 
in the cell interior are active. Typical images of composite microcapsules observed by 
fluorescence confocal microscopy are shown in Figure 4.3. One can see that the co-
precipitated shellac is enclosing the yeast cells producing linking bridges between the 
individual cells. As shown in Figure 4.3, the red domains represent the pre-stained co-
precipitated shellac with traces of Nile Red and the green spheres are the live yeast 
cells stained with FDA. The confocal microscope images also confirm the viability of 
the yeast cells inside the microcapsules after exposing them to 3 % vol. acetic acid. 
These tests combined with FDA staining of cells obtained from the disintegrated 
microcapsules (see the following pages) confirm that the encapsulated yeast cells are 
still viable and survive the experimental conditions of the microcapsule fabrication. 
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Figure 4.2: Composite shellac-yeast cells microcapsules fabricated by spray co-
precipitating a dispersion of 10 % wt. yeast cells in 3 % vol. acetic acid where 
different concentrations of ammonium shellac solution at pH 8 used as follows, (a= 
3.5, b= 5, c= 6 , d, and e = 7, f= 14 ) % wt. All scale bars are 60 µm. 
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Figure 4.3: Confocal fluorescence microscope images of composite shellac-yeast 
microcapsules fabricated by spray co-precipitating 10 % wt. yeast cells dispersion in 7 
% wt. ammonium shellac solution using 3 % vol. acetic acid solution. The images (a, 
and b) show a microcapsule observed by confocal fluorescence microscopy with the 
simultaneous fluorescence by the shellac matrix (doped with Nile Red) and the cells 
(treated with FDA) at different resolutions. 
 
 
We also tested the viability of the microencapsulated yeast cells upon exposure to 0.1 
M hydrochloric acid at pH 1, which is close to the acidity in the stomach. Native 
unprotected yeast cells were used as control samples. The results of this experiment, 
shown in Figure 4.5, confirm that the encapsulated cells can survive exposure to pH 1 
without loss of viability, while the mortality of the unprotected cells is 100%. 
 
Scanning Electron Microscopy (SEM) images of the composite shellac-yeast 
microcapsules showed several typical types of composite microcapsules with diverse 
morphologies and size distributions. Figure 4.6a-b show typical microcapsules with 
“mushroom”-like morphology of diameter approximately 100 µm. This reveals fast 
precipitation of the drops of dispersion of ammonium shellac and yeast cells upon 
contact with the acetic acid solution. Another example of composite shellac-yeast 
microcapsule of diameter of approximately 60 µm and different morphology is  
shown in Figure 4.6c where high percentage of coated yeast cells are exposed on its 
rough surface. In contrast, smaller microcapsules (around 30 µm in diameter) 
possessed smoother surface without exposed yeast cells (Figure 4.6d). 
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Figure 4.4: Composite shellac/yeast cells microcapsules fabricated by spray co-
precipitating a dispersion of yeast cells 10 % wt in ammonium shellac solution 7 % 
wt. at pH 8 using 3 % vol. acetic acid solution placed in a Petri dish. Micrographs (c, 
d) microcapsules observed by TRIC fluorescence microscopy, while, in (e, f) FTIC 
filter was used. 
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Figure 4.5: Fluorescence microscopy image of native unprotected yeast cells at (a) pH 
7 and (b) after being exposed to 0.1 M HCl solution at pH 1 for 30 minutes and then 
tested for viability with FDA. (c) Composite shellac-yeast cells microcapsules 
exposed to 0.1 M HCl solution at pH 1 for 30 minutes then washed with milli-Q water 
and incubated with FDA. (d) Fluorescence microscopy image of the released yeast 
cells from composite microcapsules incubated at pH 1 for 30 minutes followed by 
their complete disintegration at pH 8 and incubating with FDA solution. 
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Figure 4.6: SEM images of composite shellac/yeast cells microcapsules fabricated by 
spray co-precipitating dispersion of 10 % wt. yeast cells in 7 % wt. ammonium shellac 
solution at pH 8 using 3 % vol. acetic acid placed in a Petri dish. Micrographs (b-d) 
show microcapsules with different size and morphology. 
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4.1.2.2 pH-triggered release of encapsulated living cells from the composite 
microcapsules  
Shellac dissolves at pH > 7 and starts to precipitate in lower pH; therefore it is a good 
candidate to be used in the production of protective cover for probiotics against low 
pH values and mechanical stress. Microcapsules fabricated from spray co-precipitated 
dispersions of yeast cells in ammonium shellac at low pH should consequently 
disintegrate at pH > 7 and release their payload of yeast cells. In a series of 
experiments we studied the disintegration profile of the composite microcapsules after 
transferring them into an aqueous solution of 0.1 M sodium bicarbonate at pH 8 to 
mimic the physiological condition of the lower intestines. 
 
It was found (see Figure 4.7) that the disintegration process of the composite shellac-
yeast microcapsules was surprisingly slow as it took up to several hours for their 
complete disintegration to occur. Therefore, to control the disintegration rate we 
doped the ammonium shellac solution with hydrophilic pH sensitive polyelectrolytes. 
It was expected that such polyelectrolyte inclusions would produce voids in the 
structure of the shellac-yeast microcapsules upon swelling and subsequently 
accelerate their breakdown to smaller fragments and individual cells. 
 
In one series of experiments, the shellac solution was doped with 
carboxymethylcellulose sodium salt (CMC). Below 0.5 % wt. CMC, the spray co-
precipitation also resulted in stable and rigid composite shellac-yeast microcapsules. 
These microcapsules were capable of much faster disintegration and release of the 
yeast cells at pH 8 as shown in Figures 4.8, and 4.9 the microcapsules started to 
disintegrate first by losing their spherical morphology and producing a lump of 
aggregated yeast cells, and then the individual yeast cells started to separate from each 
other because the precipitated shellac which interconnected the yeast cells started to 
dissolve.  
 
 
 
 
 
89 
 
 
 
 
Figure 4.7: Composite shellac/yeast microcapsules fabricated by co-precipitating 10 
% wt. yeast cells dispersion in 7 % wt. ammonium shellac solution transferred to 
aqueous solution of 0.1 M sodium bicarbonate at pH 8 for (1, 2, 3, and 4) hours in (a, 
b, c, and d) respectively, and at pH 10 for ( 1 and 2 ) hours in ( e-f) respectively. 
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In Figure 4.8 and 4.9, where 7 % wt. ammonium shellac solution was used, the 
composite microcapsules start to disintegrate after stirring them in the aqueous 
solution of sodium bicarbonate for 20 minutes and as the stirring times increase, more 
microcapsules disintegrate until after approximately 90 minutes of stirring all the 
microcapsules successfully disintegrated and released the yeast cells. The 
disintegration process was shortened by doping the ammonium shellac solution with 
0.52 % wt. carboxymethyl cellulose. The idea is, when carboxymethyl cellulose starts 
to swell at pH > 7, it would produce voids in the structure of the microcapsules by co-
swelling them and this increase the speed of disintegration, because the microcapsules 
will be more accessible for the aqueous solution. 
 
The disintegrated microcapsules (released yeast cells) washed with milli-Q water and 
then treated with FDA solution to test the viability of the released yeast cells by 
fluorescence microscopy. Figure 4.10e-f shows the released yeast cells from the 
disintegrated composite shellac/yeast microcapsules are still viable.  
 
Using images similar to those in Figures 4.9 and 4.10, the numbers of the remaining 
microcapsules counted and then the data was used to plot a graph ( see Figure 4.11) to 
illustrate the trend of the triggered release of the yeast cells inside the fabricated 
microcapsules in different stirring times. For example according to Figure 4.9b , 
approximately 19 microcapsules were remaining intact at 0 min of transferring the 
microcapsules into the aqueous solution of sodium bicarbonate, whereas, when the 
microcapsules stirred for further  10 min in Figure 10b , the number of the remaining 
intact microcapsules decreased to approximately 10. Then as the microcapsules was 
further stirred in the alkaline solution, an extra number of the remaining 
microcapsules disintegrated, and then after 90 min of stirring the suspension, the 
number of remaining microcapsules decreased to approximately one in Figure 4.10d. 
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Figure 4.8: Disintegration of composite shellac/yeast cells microcapsules fabricated 
by co-precipitating a dispersion of 10 % wt. yeast cells in 5 % wt. ammonium shellac 
solution doped with 0.52 % wt. carboxymethylcellulose using acetic acid solution. 
Micrographs (b, c, and d) represent the microcapsules after 20, 40, and 60 minutes 
passed over stirring them in the alkaline medium respectively. 
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Figure 4.9: Disintegration of composite shellac/yeast microcapsules fabricated by 
spray co-precipitating dispersion of 10 % wt. yeast cells in 7 % wt. ammonium shellac 
solution doped with 0.52 % wt. carboxymethylcellulose using acetic acid solution. 
The microcapsules transferred followed by stirring in aqueous solution of 0.1 M 
sodium bicarbonate at pH 8 for 0, 10, 20, 30, 40, and 50 minutes in a-f. 
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Figure 4.10: Disintegration of composite shellac-yeast microcapsules fabricated by 
spray co-precipitating dispersion of 10 % wt. yeast cells in 7 % wt. ammonium shellac 
solution doped with 0.52 % wt. carboxymethyl cellulose sprayed over 3% wt acetic 
acid aqueous solution. The microcapsules were transferred in a solution of sodium 
bicarbonate at pH 8 with stirring. Images were taken after: (a) 0 min, (b) 20 min, (c) 
40 min, (d) 60 min. (e) 70 min, and (f) 80 min, while (g) and (h) show the viable yeast 
cells released from the disintegrated microcapsules, using fluorescence microscopy 
after treating them with FDA solution. 
 
94 
 
 
 
 
Figure 4.11: The relationship between remaining composite shellac-yeast cell 
microcapsules and time of transferring and stirring them in 0.1 M aqueous solution of 
sodium bicarbonate at pH 8. 
 
 
 
4.1.2.3 pH triggered release of cells from microcapsules based on doping of 
shellac with PAA.  
Our attempts to accelerate the disintegration of the microcapsules by increasing the 
CMC content did not produce microcapsules with sufficient integrity as the CMC 
interfered with the spray precipitation of the shellac at the production stage. Due to 
this restriction we replaced CMC with sodium polyacrylate (PAA) which as we 
demonstrate below in a proof of concept study showed dramatically better results with 
pH induced cell release. PAA is an anionic polymer which swells in aqueous solutions 
above pH 7-7.5 and can absorb water up to 400 times its own weight. High salt levels 
swell the polymer more by causing the formation of globular structures, which holds 
ions and increase the possibility of entanglement.
77
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In this experiment 5 % wt. aqueous solution of ammonium shellac was doped with 4 
% wt. PAA and then the native yeast cells were dispersed in the mixture at pH 6.7 
supported by acetate buffer and the dispersion was spray co-precipitated in 3 % vol. 
acetic acid. The produced composite microcapsules were tested for swelling upon 
exposure to aqueous sodium bicarbonate solution. Figures 4.12 and 4.13 show 
microcapsules exposed to a drop of 1 M sodium bicarbonate which show a profound 
and rapid swelling as the composite shellac microcapsules started to dissolve. 
 
 
 
Figure 4.12: The composite shellac-yeast cells microcapsules fabricated by spray co-
precipitating yeast cells in ammonium shellac solution doped with 4 % wt. sodium 
polyacrylate in 3 % vol. acetic acid. The microcapsules swelled and started to 
disintegrate with slow release of cells, a-d show different times. 
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Figure 4.13: The composite shellac/yeast cells microcapsules fabricated by spray co-
precipitating yeast cells in ammonium shellac solution doped with 4 % wt. sodium 
polyacrylate in 3 % vol. aqueous solution of acetic acid. The micrographs are 
captured in different times showing the microcapsules swelled at pH 8 when exposed 
to a drop of 1 M sodium bicarbonate and they started to disintegrate and release the 
yeast cells.  
 
Figure 4.14 illustrates the disintegration process of the microcapsules within 20 
minutes time period as they were transferred into a beaker containing 0.1 M sodium 
bicarbonate aqueous solution with stirring, while small aliquots were examined by 
optical microscopy. The results show that the disintegration process is much faster 
than in the case of bare shellac-yeast and CMC doped shellac-yeast microcapsules. 
Figure 4.14e shows the results of the FDA test on the released cells which confirm 
that the shellac and the PAA have no visible adverse effects on their viability. 
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Figure 4.14: Disintegration of composite shellac-yeast cell microcapsules fabricated 
by spray co-precipitating dispersion of 10 % wt. yeast cells in 5 % wt. ammonium 
shellac solution doped with 4 % wt. sodium polyacrylate in 3 % vol. acetic acid 
solution. The washed microcapsules were stirred in a solution of 0.1 M sodium 
bicarbonate at pH 8 for (a) 0 min, (b) 10 min, (c) 15 min, (d) 20 min, (e) 15 min (same 
as (c) but with FITC fluorescence filter), and (f) 118 min. (e) shows a fluorescence 
microscopy image of viable yeast cells released from the disintegrated microcapsules 
after treatment with FDA. 
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4.1.2.4 Effect of pH on the disintegration time of shellac-yeast cells 
microcapsules and the cell viability 
The fabricated composite shellac-yeast cells microcapsules were transferred into 0.1 
M phosphate buffer solutions of different pH values at constant stirring and small 
aliquots were taken and checked by optical microscopy to study the disintegration 
profile in the pH range of 5-9. Figure 4.16 shows the microcapsules after a certain 
time elapsed over stirring them in the buffer solutions of different pH. The pH of the 
medium was constantly monitored while the microcapsules were disintegrating 
because of the possible buffering effect of the dissolving shellac. However, no 
measurable pH change was observed in the solution during the microcapsules 
disintegration in all studied cases. Figure 4.15 represents the time (in hours) required 
for the shellac/PAA/yeast composite microcapsules to completely disintegrate as a 
function of pH of the medium. One sees that the disintegration time is increasing 
sharply as the pH decreases. This experiment shows that disintegration times of the 
order of 2-3h can be achieved at pH of the medium of around 7-7.5 
 
 
Figure 4.15: Relationship between the times it takes for the complete disintegration of 
the composite shellac-yeast cells microcapsules at different pH values.  
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Figure 4.16: Composite microcapsules of shellac-yeast cells transferred into 0.1 M of 
phosphate buffer solutions at different pH and stirred on a magnetic stirrer while 
aliquots were withdrawn at regular intervals and checked by optical microscopy. The 
above micrographs illustrate the time it takes for the complete disintegration of the 
microcapsules at different pH. (a is after 24 hours at pH = 5, the microcapsules 
remained intact), (b is after 7 hours at pH = 6.5) (c is 3.2 hours at pH = 7), ( d is 2 
hours at pH = 7.5), (e is 1 hour at pH = 7.9) , ( f is 0.3 hours at pH = 9). 
100 
 
4.1.2.5 Growth triggered release of encapsulated living cells from composite 
shellac-yeast microcapsules in a culture medium 
The growth and viability of the encapsulated yeast cells inside the composite 
microcapsules were tested by incubating the microcapsules in a culture medium of pH 
5 containing 2 % wt. glucose, 0.5 % wt. yeast extract, 0.1 % wt. sodium chloride and 
0.3 % wt. ammonium sulphate at 37 °C in a thermostat. The yeast growth was 
monitored for over 48 hours. Figures 4.17 and 4.18 show the evolution of the cells 
with time, which confirm that the yeast cells are still viable as they grow through a 
budding process and the microcapsules gradually started to crack as the cells growing 
on their surface expand. Figure 4.18c-f shows a large number of individual yeast cells 
released from the microcapsules after 48 hours of incubation of the sample in the 
culture medium. The viability of the released cells was reconfirmed by staining them 
with FDA and observation using fluorescence microscopy. This includes both the 
released and the grown cells into the medium. This procedure is a demonstration of an 
alternative way of triggered release of living cells from composite microcapsules, i.e. 
cell growth triggered release. 
 
The growing process in this experiment was performed at pH 5 to preserve the 
integrity of the shellac microcapsules where the cell release is triggered only by the 
growth of the yeast cells. We tested the viability of the encapsulated cells inside the 
composite microcapsules by dispersing a sample of microcapsules (washed with milli-
Q water) in a culture medium at pH 5, which was sterilised at 100 °C for 1 hour and 
cooled down to 37 °C. A gel of 10 % wt. of oxidised starch was prepared in culture 
medium and after adding a sample of the composite microcapsules to it the gel was 
incubated at 37°C for 12 hours to observe the effect of the release and growth of the 
encapsulated yeast cells. The carbon dioxide produced from the growing yeast cells, 
released from the microcapsules consequently puffed up the gel as it is evident from 
the Figure 4.17. A blank sample (a2) containing only culture medium and starch was 
also prepared, while, tube (b1) contained the microcapsules. The results of this 
experiment reconfirm that the yeast cells inside the composite microcapsules have 
preserved their viability hence as they are released in the culture medium and grow, 
they produced carbon dioxide gas which break up the gel. In contrast, the blank 
sample shows no growth, since it does not contain yeast cells. 
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In addition to this experiment, we performed a DNA test with a live/dead cells kit 
(purchased from Sigma) on the yeast cells sample produced after growth triggered 
release from the disintegrated shellac-yeast microcapsules incubated in a culture 
medium. The results are presented in Figure 4.18e-f where the cells treated with 
Propidium Iodide (PI). Since the later intercalates with the DNA of dead cells by 
crossing through their open membrane only the dead cells fluoresce in red. As one can 
see in Figure 4.18f, only a very small fraction of the total cell population is 
fluorescent hence most of the cells are viable, which is also confirmed by the FDA 
test, as presented in Figure 4.18d. 
 
 
Figure 4.17: The culture medium was sterilised by boiling at 100 °C for 1 hour and 
then cooled down to 37 °C. Micrograph (a) represents the gel systems before 
incubation. (a1) composite microcapsules were dispersed in the sterilised culture 
medium after they were washed with milli-Q water several times. A gel was prepared 
from the suspension of the microcapsules in culture medium by dissolving starch 
powder. (a2) Starch powder was dissolved in the sterilised culture medium without 
the composite microcapsules. Micrograph (b) shows the gel systems after incubation 
at 37 °C for 12 hours; only (b1) which contained encapsulated yeast cells is grown, 
while (c) is a zoomed in image of (b1). 
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Figure 4.18: The composite shellac-yeast cells microcapsules transferred and 
incubated in a culture medium at 37 °C, at pH 5 for over 48 hours. Micrographs (a-d) 
show the disintegration of the microcapsules at 0h, 10h, 24h, and 36h. Micrographs 
(e, and f) the released yeast cells (at 48 hours incubation) were treated with Propidium 
Iodide (PI) solutions to stain the dead cells. (e) is an optical image of (f). PI, a nuclei 
staining dye, cannot pass through a viable cell membrane. It reaches the nucleus by 
passing through disordered areas of dead cell membrane, and intercalates with the 
DNA double helix of the cell to emit red fluorescence (excitation: 535 nm, emission: 
617 nm). With 545 nm excitation, only dead cells can be observed. The image (f) is a 
superposition of the fluorescence image and the brightfield image which helps to 
compare the non-fluorescent cells (darker) with the fluorescent ones (bright red). One 
sees only a small fraction of dead cells (bright red). 
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4.1.2.6 Fabrication of composite shellac/yeast cells microcapsules by spray co-
precipitating with calcium chloride solution 
Previously calcium–shellac microspheres with encapsulated carbamide peroxide (CP) 
have been made by emulsification to generate an emulsion including shellac 
ammonium salt aqueous solution with soluble CP dispersed in sunflower oil with 
calcium chloride powder, followed by gelation between shellac and calcium.
76a
 
Meanwhile, it has been reported that Calcium-shellac spheres were successfully 
prepared using an extrusion technique based on dropping aqueous ammonium shellac 
solution into calcium chloride solution.
76b
 Nevertheless, the fabrication of composite 
shellac/yeast cells microcapsules by co-precipitating dispersion of yeast cells in 
ammonium shellac solution using calcium chloride precipitation approach has not 
been tried before. Therefore, attempts to prepare such microcapsules by using spray 
co-precipitation method were made. The process essentially includes spraying a 
dispersion of known amount of yeast cells in known concentration of ammonium 
shellac solution into a Petri dish which contained known concentration of calcium 
chloride solution. 
 
The spray co-precipitation method with 0.5 M calcium chloride as a precipitating 
agent yielded hemi-spherical, rigid, and relatively stable composite shellac-yeast cell 
microcapsules. Figure 4.19 shows the results of the spray co-precipitating a dispersion 
of 10 % wt. yeast cells at different concentrations of ammonium shellac solution at 
pH 8. The microcapsules with higher shellac content had substantially longer 
disintegration times. Although good results were achieved in co-precipitating yeast 
cells and ammonium shellac solution using acetic acid solution, unfortunately, it 
cannot be concluded that the same results were achieved for fabricating microcapsules 
by spray co-precipitating yeast cells in ammonium shellac solution using calcium 
chloride solution, especially when  5 % wt. ammonium shellac solution was used. 
Although microcapsules still fabricated, but they had stability issues, and the cells 
were separated from each other as it is shown in Figure 4.19a, high percentage of 
yeast cells surrounded a small stable microcapsule inside another less stable one. 
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Figure 4.19: Composite shellac-yeast microcapsules prepared from a dispersion of 10 
% wt. yeast cells at pH 8 and different concentrations of ammonium shellac: (a, b, c, 
and d) represent (5, 6, 7, and 14) % wt. ammonium shellac solution, respectively. The 
dispersion was spray co-precipitated in 0.5 M calcium chloride solution. 
 
 
 
The falling composite microcapsules were filtered off and dried at 50 °C and then 
coated with gold nanoparticles to be observed by Scanning electron microscopy. 
Figure 4.20 shows the SEM images obtained from the filtered and dried 
microcapsules which demonstrate hemi-spherical morphologies similar to those of 
acetic acid co-precipitated dispersion. 
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Figure 4.20: SEM images of dried composite shellac-yeast microcapsules fabricated 
by spray co-precipitating dispersion of 10 % wt. yeast cells in 7 % wt. ammonium 
shellac solution using 0.5 M calcium chloride solution. 
 
 
4.1.2.7 Spray-drying of yeast cells/ammonium shellac formulation 
To wrap up probiotic and protect them from harsh GI tract conditions of mechanical 
stress and extremely low pH, various types of microcapsules have been designed but 
the most successful microcapsule should be capable of disintegrating  in pH of lower 
intestines (pH >7). We developed novel magnetic “shellac-yeast” microcapsules 
suitable for directed delivery of cells by using external magnetic field, which are 
capable of disintegrating at pH > 7 and release their load. 
 
 
106 
 
Magnetically directed delivery would allow significant amount of cells to be 
positioned at a targeted location inside the host. This may reduce amount of cells to 
deliver, prevent side effects and minimise the amount of materials used. Here we 
show our results with magnetically functionalised microcapsules loaded with yeast 
cells which can be manipulated with an external magnetic field. If a dispersion of 
yeast in ammonium shellac solution was sprayed through a column with hot air, the 
water content of the droplets start to evaporate and the droplets dry up which result in 
the increase of the concentration of the shellac solution which starts to precipitate and 
produce microcapsules loaded with high percentage of yeast cells with dried solid 
shellac. 
 
We collected the falling dry microcapsules in a Petri dish which contains milli-Q 
water at the base of the spray-drying column. Figure 4.21 includes images of such 
stable and rigid magnetised microcapsules fabricated by using this strategy. We 
demonstrated that they can be collected and manipulated by an external magnetic field 
as shown in Figure 4.21f. Figure 4.21c and 4.21e show that the encapsulated yeast 
cells preserved their viability. Magnetite particles were produced as described in ref. 
17 and mixed with the aqueous shellac solution. Magnetic shellac-yeast 
microcapsules were produced by spray drying 10 % wt. yeast cells in 7 % wt. 
ammonium shellac solution doped with 1 % wt. magnetite nanoparticles.
20
 (see Figure 
4.1 for more details). 
 
The microcapsules were transferred into an aqueous solution of sodium bicarbonate at 
pH 8 followed by stirring, and then samples were collected from the medium after 
washing with milli-Q water and examined by optical microscopy.  Figure 4.22 shows 
the morphology of the microcapsules after stirring them for 2 hours in the alkaline 
solution at pH 8. The microcapsules started to open up which provided more access of 
their surface to the aqueous solution which continued until their complete 
disintegration after stirring in the solution for 2 hours.  
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Figure 4.21: Composite shellac-yeast microcapsules fabricated by spray drying a 
dispersion of 10 % wt. yeast cells in 7 % wt. ammonium shellac aqueous solution. 
The yeast cells inside the microcapsules were treated with FDA solution and observed 
by fluorescence microscopy with FITC filter set in micrographs (c) and (e). 
Micrographs (d) and (f) show magnetised microcapsule containing 1% vol. magnetite 
nanoparticles. 
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Figure 4.22: The magnetised composite shellac-yeast microcapsules transferred into 
0.1 M aqueous solution of sodium bicarbonate at pH 8 and stirred for one hour in (a, 
and b) and two hours in (c-f) then small samples were collected to be imaged by 
optical microscopy. 
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4.1.2.8 Viability of yeast cells in acetic acid and calcium chloride solution 
Yeast cells washed with milli-Q water several times, and they were centrifuged and 
the supernatant was discarded after every wash. The sedimented yeast cells were re-
dispersed in either 3 % vol acetic acid solution or 0.5 M calcium chloride solution, 
and the dispersions were shaken on a mini shaker for one hour, then the yeast cells 
were washed again with milli-Q water then FDA viability test was done for each 
sample and the result showed that in case of transferring the yeast cells in acetic acid 
solution almost every single cell has died but in the case of dispersing the cells in 0.5 
M calcium chloride solution the chance of survival was higher and relatively high 
percentage of yeast cells still viable as it is illustrated in Figure 4.23. 
 
 
Figure 4.23: Yeast cells dispersed in a solution of 10 % vol. acetic acid solution for 
one hour in micrographs (a and b), while in micrographs (c and d) the yeast cells 
dispersed in a solution of 0.5 M calcium chloride for one hour, then the samples were 
washed and the yeast cells were treated with FDA solution and observed by optical 
and FTIC fluorescence microscopy. 
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4.1.3 Conclusions 
Composite microcapsules of shellac and yeast cells were fabricated by both spray co-
precipitating and spray-drying dispersions of yeast cells in ammonium shellac 
solution. Two alternative techniques were used: (i) spray co-precipitating a dispersion 
of yeast cells in aqueous solution of ammonium shellac at pH > 7, into either acetic 
acid or calcium chloride aqueous solution; or (ii) spray-drying the shellac-yeast 
dispersion. Different concentrations of ammonium shellac solution were used to 
produce rigid and stable microcapsules which can disintegrate at pH > 7 for specified 
time interval and release viable cells into the solution. The pH trigger for cell release 
and the time of disintegration were controlled by (a) the shellac concentration and (b) 
doping the solution with pH sensitive polymers. 
 
We demonstrate as a proof of concept how carboxymethylcellulose and sodium 
polyacrylate can be used to trigger the cell release from the microcapsules at neutral 
and higher pH and to speed up the shellac-cell microcapsule disintegration process. 
Doping of the shellac solutions with carboxymethylcellulose significantly enhanced 
the rate of releaseing the yeast cells from the composite microcapsules at neutral and 
higher pH. The inclusion of sodium polyacrylate in the shellac resulted in much faster 
disintegration of the microcapsules upon increase of the pH above 7 and in some 
cases instant cell release. We show that the released and encapsulated yeast cells have 
preserved their viability during the microencapsulation and the release process. The 
produced composite microcapsules were capable of protecting the cells at extremely 
low pH (pH 1) and still produce viable cells upon disintegration at neutral and higher 
pH. We discovered that shellac-cell microcapsules can produce triggered release of 
cells upon exposure to growth media, i.e. growth induced release. 
 
We also produced magnetically functionalised shellac-cell microcapsules which can 
be used for delivery of encapsulated cells directed by an external magnetic field. We 
demonstrate the robustness and versatility of shellac as microencapsulating material 
for protection of cells in acidic environments. The composite shellac-cell 
microcapsules reported here could be used in formulations for protection and delivery 
of probiotics and other cell cultures with programmed and triggered release of the 
encapsulated cells by using a variety of pH sensitive food grade polymers as cell 
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release triggers. Such microcapsules could also be used in other application involving 
triggered release of the encapsulated cells in cell implants, including stem cell 
delivery and live vaccines release. 
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Chapter 5.  
Fabrication of novel colloidosomes loaded with viable yeast cells 
In this chapter, we explored the possibilities of fabricating novel colloidosomes 
microcapsules loaded with viable yeast cells as a model for probiotics. Colloidosomes 
have been fabricated from various materials including polymers and gel beads. Here 
we have developed two main strategies to fabricate colloidosomes depending on the 
mode of triggered release, the type of emulsion templates, and the method of transfer 
of the templated emulsion drops from oil into water. The first strategy includes 
fabrication of magnetic colloidosomes with gel-cores which contains pH-sensitive and 
swellable polyacrylate. The second method involves fabrication of colloidosomes 
structures interlocked with either anionic polyelectrolytes or yeast cells pre-coated 
with anionic polyelectrolytes. 
5.1.1 Introduction 
Spherical shells of micron-sized colloidal particles can be formed by introducing 
colloidal particles to emulsion templates. The particles adsorbed and self-assemble on 
the surface of the droplets in order to minimise the total interfacial energy forming 
Pickering emulsion drops as precursor of colloidosomes, which are mainly prepared 
from w/o emulsion templates stabilised by solid particles.
78
 Although the term 
colloidosomes was first used by Dinsmore et al. 
11
 but Velev et al. were considered to 
be the first to produce colloidosomes-like structures. In a series of papers 
78
 on 
assembly of latex particles by using emulsion droplets as templates, they prepared 
spherical shell-like supraparticles and ball-like composite assemblies (see Figure 5.1). 
 
In the first paper, ordered empty latex balls were prepared by assembling lysine-
functionalised sulfate latex particles in octanol-water emulsion droplets. The particles 
were locked in the interface by adding casein solution which gently binds them 
together within the shells of the droplets. Then the octanol core of the droplets was 
dissolved by using ethanol to produce the empty shells of latex particles. The strength 
of this bridging was not sufficient to protect the superaparticle structures during the 
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dissolution of the core; therefore, a mixture of hydrochloric acid and calcium chloride 
was used to coagulate the latex particles in the interface.
78a
 
 
In the second paper, octanol in water emulsion droplets were stabilised by SDS-
treated amidine latex particles, and the particles were locked inside the droplets by 
addition of casein solution. Then the octanol core was dissolved by injecting ethanol 
but the droplets/particle complexes could not withstand the ethanol extraction, 
therefore, more SDS solution was added to coagulate the particles within the octanol 
droplets, which were removed from the surrounding environment by centrifuging, 
washing and suspending the aggregates in the casein/SDS solution. Meanwhile, to 
prepare composite supraparticles, an octanol in water emulsion stabilised with SDS-
treated amidine latex particles was homogenised with a suspension of lysine-
sensitised sulfate latex particles. The sulfate particles were fixed within the droplets 
by adding casein solution. Then hydrochloric acid and calcium chloride were used to 
induce the coagulation of the sulfate latex shells, and “fortify” the composite 
supraparticles, which were finally removed from the environment by dissolution of 
the octanol core using ethanol extraction.
78b
 
 
Dinsmore et al. 
11
 produced colloidosomes by emulsifying a suspension of the 
materials to be encapsulated in an immiscible fluid containing colloidal particles that 
adsorb on the surface of the emulsion droplets. After the droplet surface was 
completely covered by particles; the adsorbed particles were interlocked together to 
form an elastic shell. This interlocking is essential to ensure that the capsules remain 
intact when they are transferred to a water phase. It was further reported that the 
interlocking of the adsorbed particles monolayer around the water droplets can be 
achieved by either lightly sintering the particles or electrostatically binding a 
polyelectrolyte of the opposite charge to the particles. Upon heating to the polystyrene 
glassifying temperature (Tg), the particles partially bridged thus creating 
approximately 150 nm diameter bridges or “necks” between them. The resultant 
colloidosomes, therefore, contained a precise array of uniform pores in an elastic 
shell.
11
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In a separate formulation the bridging is done by using a polyelectrolyte such as poly 
–L- lysine or polystyrene sulfonate that will adsorb onto the particles at the interface; 
the polyelectrolyte molecules bridge neighbouring particles and lock them together. 
The adsorption of polyelectrolyte significantly enhances the elastic properties of the 
colloidosomes. The final step of the assembly process involves removing the fluid 
interface by exchanging the continuous phase (oil) with one that is miscible with the 
fluid inside the colloidosome (water). This ensures that the pores in the elastic shell 
control the permeability by allowing exchange by diffusion across the colloidosome 
shell. This fluid exchange step can readily be accomplished by transferring the 
capsules from the oil to the water phase by gentle centrifugation of the Pickering 
emulsion over a water phase. The resultant colloidosome structures provide a rigid 
elastic shell that serves as a protective coating for the interior material. Colloidosomes 
can be used to efficiently encapsulate and provide a rigid shell of controllable 
elasticity and permeability. An important feature of colloidosomes which makes them 
promising as encapsulants, is the wide variety of potential mechanisms for release. 
Constant release through the controlled pores is the most direct release mechanism. 
Although as they are elastic shells, release may be triggered by rupture through shear 
stress.
11  
5.1.1.1 Pickering emulsions as templates for colloidosomes 
Finely divided solid particles can act as emulsifiers for o/w or w/o emulsions by 
residing at the interface. The credit being usually given to Pickering hence, the name 
Pickering emulsions.
79
 Pickering emulsions can be remarkably stable to coalescence 
due, in part, to the high energies of detachment for particles adsorbed at liquid-liquid 
interfaces.
80
 Low molar mass surfactants and surface-active polymers can form a 
variety of aggregated structures in aqueous or non-aqueous media and are commonly 
employed as emulsifiers in the preparation of emulsions and as stabilisers in the 
preparation of foams. Solid particles can function in similar ways to surfactants but 
certain differences in behaviour are noticeable. Individual solid particles do not 
assemble to give aggregates in the same way that surfactant molecules form micelles. 
For surfactant present in oil and water mixtures, the system of hydrophilic-lipophilic 
balance (HLB) is the most important variable in determining whether aggregated 
surfactants, micelles or microemulsion droplets reside in water, oil or a third phase.
81
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Figure 5.1: Possible modifications of the “emulsion template” method for 
supraparticle assembly. Schematic was used as it has been published in reference
78a
. 
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For hydrophilic surfactants, the area per head group is larger than that of the chain and 
the monolayer curve around oil resulting in o/w micro and macroemulsions. For 
lipophilic surfactants the area per chain exceeds that of the head group and water 
becomes the dispersed phase in w/o macroemulsions. For conditions in which the 
head group and chain areas are similar, monolayers have a net curvature of zero and 
new aggregates form including lamellar phases and biscontinuous microemulsion.
80-82
 
In case of spherical particles which adsorb to interfaces (water-air or water-oil) the 
relevant parameter is thought to be the contact angle θ which the particle makes with 
the interface (see Figure 5.2). For hydrophilic particles e.g. metal oxides, θ measured 
through the aqueous phase is normally < 90˚ and a larger fraction of the particle’s 
surface resides in the water than in the non-polar phase. For hydrophobic particles e.g. 
suitably treated silica nanoparticles, θ is generally greater than 90˚ and the particle 
resides more in air or oil than in water. By analogy with surfactant molecules, the 
monolayers will curve in a way that larger area of the particle surface remains on the 
external side, giving rise to air in water aqueous foams and o/w emulsions (θ < 90˚) 
and water in air aerosols or w/o emulsions (θ > 90˚).82 
 
If a spherical particle (s) with radius (r) is initially totally in phase (α) and 
subsequently adsorbed to the (αβ) interface, the interfaces (sα, sβ, αβ) have interfacial 
tension (γ) associated with them, adsorption of the particle at the interface results in 
an area of the (sα) interface being lost but being replaced by an equal area of the (sβ) 
interface. More importantly, an area of the (αβ) interface is also lost due to the 
presence of the particle and this area depends on (θ).81 
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Figure 5.2: Position of a small spherical particle at a planar oil–water interface for a 
contact angle (measured through the aqueous phase) less than 90˚(left), equal to 90˚ 
(centre) and greater than 90˚ (right). (Lower)Corresponding probable positioning of 
particles at a curved interface, for θ < 90˚, solid stabilised o/w emulsions may form 
(left), for θ> 90˚ solid-stabilised w/o emulsions may form (right).83 
 
 
The energy of attachment of a particle to a fluid-fluid interface is also related to the 
tension of the interface (γαβ). Assuming the particle is small, so that the effect of 
gravity is negligible, the energy ∆E required to remove the particle from the interface 
is given by  
 
                   
                                                      (5.1) 
 
In which the sign inside the bracket is negative for removal into the water phase and 
positive for removal into the air or oil phase. If the energy of attachment of particle to 
interfaces is higher than the thermal energy (kT), then the particles adsorb to the 
interface effectively irreversibly. This is in a sharp contrast to surfactant molecules 
which adsorb and desorbs on a relatively fast timescale. Since ∆E depends on the 
square of the particle radius, it decreases markedly for smaller particles.
82
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Aveyard et al. 
84
 found out that at air-water surface, compression of the monolayer 
leads to the formation of rafts of hexagonally packed particles and addition of salt to 
the aqueous phase causes 2-D clusters to form. By contrast, at an octane-water 
interface, particle monolayers remain highly ordered as a result of long-range 
repulsion even on concentrated salt solution. The enhanced lateral repulsion was 
attributed to electrostatic interactions, through the oil phase, of residual surface 
charges at the particle-octane interface. The difference between the behaviour at the 
two interfaces was argued to be due to a change in the “wettability” of the particles, in 
that they were more hydrophilic at air-water surface and hence a smaller area of the 
particles was exposed to air resulting in reduced repulsion.
84
 Since close-packed 
arrays of particles can form at a planar oil-water interface, the possibility exists that 
similar arrays occur around curved interfaces such as those in emulsions. The 
properties of latex particles in oil solvents are dependent on whether the solvent is 
“good” (particle solvent interactions are favourable) or “poor” (interactions are 
unfavourable).
80
 
 
Aveyard et al. 
83
 studied the effect of electrolyte on colloidal particles and found out 
that, since the majority of colloidal particles in aqueous dispersions are charged, 
addition of salt not only reduces their surface potentials but can also lead to 
coagulation of the particles into flocs. It is known that good emulsion stabilisation 
was achieved when the particles were weakly flocculated (by salt in the case of o/w or 
by surfactant in the case of w/o); less stable emulsions resulted when the particles 
were completely flocculated. The appearance of flocculated particles initially 
enhances the emulsion stability. Further increase in salt concentration results in 
destabilisation. It may be that small flocs if formed at low salt concentration adsorb to 
drop interfaces resulting in stabilisation, whereas at higher salt concentration the flocs 
size and extent may be larger and adsorption is reduced. A theoretical description of 
the adsorption of charged particles to charged liquid surfaces concludes that 
adsorption is favoured in the presence of salt as particles become more hydrophobic.
83
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Paunov et al. 
85
 developed a new method to fabricate colloidosomes from emulsion 
templates stabilised by either polymeric microrods or polystyrene latex particles and 
gelling the water core to give the droplets extra stability and thus transfer them into 
water with high efficiency. They developed a new method to produce novel “hairy” 
colloidosome microcapsules with shells of polymeric microrods. The work included 
the emulsification of hot aqueous solution of agarose in tricaprylin in the presence of 
SU-8 microrods, and then the system was cooled off to set the agarose gel. The 
obtained suspension of aqueous gel microcapsules was diluted with ethanol and 
centrifuged to separate them from the supernatant. In the final step, the microcapsules 
were washed with ethanol and water and redispersed in water.
85a
 
 
Furthermore, they reported that their technique allows preparation of colloidosomes 
with diameters between several tens to several hundreds of micrometers. Also it was 
emphasised that, the function of the gel cores is to support the particle shells and to 
give the microcapsules enough stiffness to be separated from the oil phase by 
centrifugation. More importantly, the potential use of these capsules as delivery 
vehicles and for control release of drugs, cosmetics and food supplements has been 
mentioned.
85a
 
In another subsequent work of Paunov’s group 85b the fabrication of novel 
colloidosome microcapsules with aqueous gel core has been proved. In this work they 
were mimicking the recently developed “gel trapping technique”86. Except this time 
monodispersed surfactant-free white aliphatic amine latex particles with average 
diameter of 3.9 µm were used instead of polymeric microrods. It was also mentioned 
that the cross-linking of the monolayer of the latex particles around the gelled 
emulsion drops with glutaraldehyde was made to increase the stability of the drops so 
as to sustain therein transfer into water. Meanwhile, it was found that the polystyrene 
(PS) latex particles do not undergo notable swelling when in contact with sunflower 
oil at temperature 75 ºC. That is why sunflower oil has been used as oil phase in a 
series of experiments.
85b
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In addition, Paunov’s group also tested the effect of the aqueous gel core on the 
mechanical stability of the templated emulsion drops upon transfer into water.
85b
 This 
was done by preparing the same emulsion template without using gelling agent. 
However, it was discovered that, upon transfer into water the shells of colloid 
particles collapsed due to the treatment with ethanol even after cross-linking with 
glutaraldehyde. Moreover, it was revealed that, if tricaprylin was used as oil phase, 
the latex particles in the colloidosome membrane partially swell and form a 
membrane of swollen polystyrene on the capsule surface. The process was controlled 
by varying the temperature and the degree of exposure of the emulsion template to 
tripcaprylin, which allows the pore size of the colloidosome membrane to be 
controlled independently of the size of the colloidal particles.
85b
 
In 2004 Ashby et al. produced giant pendant colloidosomes by displacing pendant 
water drops coated with a monolayer of monodispersed sulphate polystyrene latex 
particles (220 nm) through a planar oil-water interface.
87
 Their method is based on 
forming a pendant drop of an aqueous suspension of latex particles in the oil phase 
and then produced a closely packed particles monolayer adsorbed on the drop surface 
by multiple infusion and withdrawal of the particles suspension through the capillary 
in the oil phase. Finally, the pendant water drop in oil, densely coated with adsorbed 
particles, was transferred through a planar oil-water interface to produce giant 
colloidosome. Furthermore, Ashby reported that, in their method no partial fusion of 
the particles is required, as the integrity of the particle monolayer is supported by the 
oil film. They also explained that their methodology can produce colloidosomes 
attached to a capillary which allows the  properties of the colloidosome membrane, 
like membrane tension and elasticity, to be studied as a function of the number of 
adsorbed particles, as this can be easily controlled by changing the volume of the 
inner aqueous phase.
87
 
 
Duan et al. 
88
 for the first time fabricated magnetic colloidosomes by directing self-
assembling of magnetite (Fe3O4) nanoparticles at the interface of w/o droplets. 
Magnetite nanoparticles of different size capped with 2-bromo-2-methylpropionic 
acid were dispersed in toluene, which emulsified with water phase by vigorous 
shaking for a few minutes. The colloidosomes were collected by external magnetic 
field, followed by three times washing with ethanol. The stability of the water-in-oil 
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droplets was improved by gelation of the aqueous phase with 1.5 % wt. agarose gel, 
which was set at room temperature. The colloidosomes with agarose gel core exhibit 
greatly improved mechanical stability, indicated by the fact that they keep spherical 
shape and don not collapse upon drying for a longer time, as compared to those 
without gelled cores. 
 
Kim et al. used colloidal particles that have size range from nm to µm to cover the 
surface of temperature-sensitive microgels to fabricate temperature responsive 
colloidosomes. They demonstrated that these types of colloidosomes can control 
permeability through the size of the adsorbed colloidal particles, the thickness of the 
particle shell, obtained by buckling the microgel surface, or through the use of 
deformable particles.
89
 
 
To overcome the limitations of some experimental conditions that have been 
mentioned in the previous methods, Routh and Laib developed a new method to 
produce stable colloidosomes at low temperatures for the encapsulation of thermally 
sensitive compounds. This method lacks the use of aggressive chemicals, gelling 
agents or filling the capsules through the pores of the shell and more importantly uses 
low temperature conditions. In this technique, the aqueous suspension of 
poly(styrene-co-butylacrylate) latex particles (180 nm) with a low transition 
temperature ( Tg) of 42 ºC was mechanically mixed with an oil media ( dodecane or 
sunflower oil) possibly containing surfactant or electrolyte to produce w/o emulsions, 
and then the copolymer particles have been partially fused by heating them slightly 
above their (Tg). To transfer the water droplets into fresh water to produce 
colloidosomes, Routh and Laib, tried different approaches, one of them was 
centrifugation method and the second was filtration and redispersing in water. The 
third and the most effective method of transfer was sedimentation for several days, 
although, low transfer yield was still reported in all of the transfer approaches 
according to their results.
90
 
 
Prestige and Simovic
91
 investigated the self-assembly of hydrophobic silica 
nanoparticles at the surface of charged submicrometer triglyceride droplets aiming to 
optimise the preparation of stable colloidosomes. They concluded that in controlling 
hydrophilic silica nanoparticles interactions, the droplet charge, oil phase volume 
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fraction, droplet/particle ratio and salt concentration play important roles. This was 
reflected in the colloidosome zeta potential, stability and interfacial structure. They 
subsequently proved that silica nanoparticle interactions with negatively charged 
droplets are weak while, silica nanoparticles strongly covered the positively charged 
triglyceride droplets and undergone charge reversal at specific droplet/particle ratio 
and electrolyte concentration. They also claim that in their work stable 1-3 µm 
colloidosomes were phase separated from hetero-coagulates of droplets and 
nanoparticles.
91
 
 
Shah et al. presented a novel technique to fabricate monodispersed stimuli-responsive 
colloidosomes using stimuli-sensitive microgel particles as building blocks. The 
microgel particles self-assemble themselves along the oil-water interface. According 
to the authors, the technique is highly versatile, as it can be used in conjunction with 
microfluidic devices to produce highly monodispersed colloidosomes, or with any 
other bulk-emulsification techniques to produce colloidosomes in large quantities.
92
 
 
Thompson and Armes have prepared covalently cross-linked colloidosomes from 
templating o/w Pickering emulsion stabilised by near-monodisperse sterically-
stabilised with poly (glycerol monomethacrylate) polystyrene latex particles. The o/w 
droplets were covalently stabilised by cross-linking the hydroxy-functional stabiliser 
chains at the inner surface of the latex particles adsorbed onto the oil droplets using 
toluene 2, 4-diisocyanate-terminated poly (propylene glycol) as a cross-linker. The 
cross-linked colloidosomes are significantly more stable than o/w Pickering emulsion 
droplets, as judged by their treatment with either excess alcohol or a non-ionic 
surfactant.
93
 
 
Alternatively Walsh et al. have used commercially available steric stabiliser poly 
(ethylene imine) (PEI) to produce polyamine-functionalised polystyrene latexes, 
which were used to stabilise o/w Pickering emulsions and they were covalently cross-
linked at the oil droplet interface using commercially available polymeric cross-
linkers, PPG-TDI, PPG-DGE, and PEG-DGE. In each case the internal oil phase was 
removed by washing with excess alcohol.
94
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Yuan et al. reported the preparation of colloidosome microcapsules using sterically 
stabilised PS latex particles through emulsion droplet templates by either thermally 
annealing the adsorbed particles which have a shell formed by adsorption of thermally 
responsive and pH-responsive polymer chains of PDMA-b-PMMA (poly[2-
(dimethylamino)ethylmethacrylate]-b- poly[methylmethacrylate]), or chemically 
cross-linking of the polymer chains from within the emulsion droplets using cross-
linking agent BIEE (1,2-Bis(2-iodoethyloxy)ethane.
95
 
 
Nomura and Routh fabricated water-core colloidosomes at room temperature from 
Pickering emulsions stabilised by poly (methylmethacrylate-co-butylacrylate) latex 
nanoparticles. Adding small amount of ethanol caused the particle aggregation due to 
the diffusion of ethanol into the aqueous latex suspension, which resulted in creating 
an irreversible shell for the colloidosomes.
96
 While, using the above technique Keen 
et al. have recently encapsulated viable Baker’s yeast cells in colloidosomes, where 
use of harsh chemicals and high temperature has been avoided.
97
 
 
5.1.2 Results and discussion 
5.1.2.1 Fabrication of gel-cored magnetic colloidosome from w/o Pickering 
emulsions templates 
 
In this part of the chapter, we demonstrate the fabrication of magnetic colloidosomes 
loaded with living cells. Yeast cells as model for living probiotic cells were 
encapsulated in gel-cored magnetic colloidosome containing a fixed amount of 
sodium polyacrylate which can expand 400 times its original size at pH > 7. This can 
program the loaded colloidosomes to trigger release the cells at pH > 7. All Pickering 
emulsions in our study in this chapter were stabilised by amidine latex particles 
approximately 300 nm in diameter, which were initially dispersed in the oil phase 
(tridecane). 
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In addition the colloidosome cores contained magnetic nanoparticles so that they can 
be manipulated by an external magnet, and facilitate the transfer of the w/o emulsion 
droplets from the oil continuous phase into water and produce colloidosome. Other 
than adjusting the trigger release of the cells, polyacrylate is an anionic 
polyelectrolyte which can bind to the cationic amidine latex nanoparticles from inside 
the droplets and as a result lock the particles in the interface permanently, which in 
return made the transfer process relatively easier. The whole process of fabricating 
gel-cored pH-responsive, magnetic colloidosomes has been illustrated in Figure 5.3. 
 
Amidine latex particles can stabilise water in oil emulsions in which the water phase 
contains dispersed yeast cells. The important point to consider here is that, the latex 
particles should be dispersed in the oil phase to avoid their adsorption on the yeast 
cell’s membrane, which can destroy the cells. Although, amidine latex particles are 
hydrophobic with hydrophilic amidine functional groups, they are not easily 
dispersible in oil, because they are water based from production. The latex needed to 
be centrifuged out of the water then redispersed them in sufficient amount of ethanol 
twice to remove traces of water if any was left, then they were centrifuged out of the 
excess ethanol and redispersed in minimum amount of ethanol, afterwards it was 
mixed with the oil, this way a homogeneous dispersion of the amidine latex particles 
in oil was produced. Water droplets in oil stabilised by amidine latex particles are 
very stable and can be considered a novel method to encapsulate yeast cells in their 
water core. Figure 5.4 shows w/o emulsion droplets in tridecane, after the emulsion 
was cooled down at 4 °C to set the Agarose gel. The droplets observed by optical 
microscopy, which indicates that they have average droplet diameters of 200 µm.   
5.1.2.2 Transfer of the Pickering emulsion droplets into water  
The produced droplets were transferred from the tridecane phase into water to yield 
the colloidosomes, by using external magnet approach. The process included 
removing the excess oil in the emulsion and then adding concentrated emulsion on top 
of milli-Q water phase in a sample tube which was in return fixed on a permanent 
magnet. As the emulsion droplets hit the water surface they were dragged downward 
with the force of the permanent external magnet and settled at the bottom of the tube. 
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The oil phase was separated on the top of the water phase. See Figure 5.5 which 
demonstrates the fabricated colloidosome after transferred into water.  
 
5.1.2.3 Viability of the yeast cells inside colloidosomes 
The whole idea of microencapsulation of living cells is to protect them from harsh 
conditions; therefore, we have performed some viability tests for the encapsulated 
yeast cells. After the colloidosomes were washed several times with milli-Q water, the 
yeast cells inside were treated with both FDA and Calcein-AM/Propidium iodide 
live/dead kit solutions simultaneously. The FDA test shows the yeast cell membrane 
is intact and the enzymes in the cell interior are active (see Figure 5.6b). 
 
 
 
Figure 5.3: Schematic diagram of the fabrication of gel-cored magnetised 
colloidosome by templating w/o Pickering emulsions droplets.  
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Figure 5.4: Emulsion (w/o) droplets stabilised with 300 nm amidine functionalised 
polystyrene latex nanoparticles in tridecane. The water phase contained 10 % wt. 
native yeast cells and 4 % wt. sodium polyacrylate, 0.5 % wt. magnetic nanoparticles, 
and 1 % wt. agarose gel. 
 
In addition to the FDA test, we performed a Calcein/Propidium iodide test with 
live/dead cells kit on the yeast cells encapsulated inside the colloidosomes. The 
results are presented in Figure 5.6c-d, where in (c) the stained cells were observed 
with dual fluorescence filter set of FITC/TRITC and as one can see only the green 
fluorescence is visible, indicating the viability of the encapsulated cells. With dual 
fluorescence filter set of FITC/TRITC both dead (red) and live (green) cells can be 
observed. But with 545 nm excitation which is TRITC filter set only the dead (red) 
cells can be observed as it has shown in Figure 5.6d. There is limited number of cells 
showing in red colour which indicates that high percentage of the encapsulated cells is 
still viable. Calcein-AM works on the same principle as FDA.  
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Figure 5.5: Colloidosomes transferred to water by using external magnet and 
fabricated by using water-in-tridecane emulsion templates stabilised with amidine 
functionalised polystyrene nanoparticles. 
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Figure 5.6: The yeast cells encapsulated inside colloidosomes were treated with 
Calcein-AM/Propidium iodide live/ dead kit as well as FDA and were observed by 
optical fluorescence microscopy to test the viability of the cells. (a) is an optical 
image, (b) is observed using FITC filter, ( c) is dual filter of FITC and TRITC, while, 
(d) is only TRITC filter set. 
 
5.1.2.4 Fabrication of colloidosomes interlocked with polyelectrolytes and 
polyelectrolyte pre-coated yeast cells 
In the second part of this chapter, we report the fabrication and in situ encapsulation 
of yeast cells in colloidosome microcapsules from w/o Pickering emulsion templates 
stabilised by 300 nm polystyrene latex particles functionalised with amidine 
functional groups. The stability of the emulsion droplets was achieved by interlocking 
the adsorbed particles monolayer at the w/o interface with either (i) oppositely 
charged polyelectrolyte adsorption or (ii) using polyelectrolyte precoated yeast cells 
which acts as cross-linker ( see Figures 5.7, and 5.8). These two approaches are the 
base of two strategies of preparation of cells containing colloidosomes. 
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We have enhanced the surface charge of yeast cells by using layer-by-layer 
polyelectrolyte adsorption technique using both (PAH/PSS). PSS is anionic 
polyelectrolyte which can cross-link the monolayer of the adsorbed amidine particles 
at the w/o interface by electrostatically binding to the positively charged latex 
particles, while yeast cells are slightly negatively charged and can adsorbs a layer of 
cationic polyelectrolyte such as PAH. This will result in producing positively charged 
yeast cells which in turn can adsorbs a layer of anionic polyelectrolyte (PSS) and 
produce strongly negatively charged yeast cells. We have also designed a strategy 
where the strongly negatively charged yeast cells act as a cross-linker to the amidine 
latex particles monolayer at the interface of the w/o Pickering emulsion. Increasing 
the stability of the w/o Pickering emulsion droplets by cross-linking the monolayer of 
the adsorbed amidine latex particles at the w/o interface helps the successful transfer 
of emulsion droplets from the oil phase into water phase and hence produce 
colloidosomes. 
 
First of all, to optimise the amount of yeast cells to be encapsulated in the water-in-
undecane droplets, a series of experiments were performed, in which all the 
conditions were kept constant except the amount of yeast cells. To start with, no yeast 
cells were used as it is shown in (Figure 5.9), the emulsion is relatively stable and the 
droplets are polydisperse with relatively narrow size range, and mean diameter of 85 
µm. In the next experiment 1 % wt. yeast cells was added into the water phase. The 
produced water-in-undecane emulsion was still stable but the droplet size is 
dramatically decreased and went down from approximately 85 µm to approximately 
48 µm. Upon further increase of the yeast cells concentration the emulsion drops 
diameter started to increase slowly as the amount of yeast cells increased. From 1 to 
30 % wt. yeast cells at which the largest droplets were obtained and the emulsion was 
at its highest stability. Hence, the droplets size increases with the amount of yeast 
cells in the water phase as illustrated in Figure 5.10-11. 
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Figure 5.7: Strategy (i) aqueous suspension of yeast cells in the presence of negatively 
charged polystyrene sulfonate emulsified with oil phase (undecane) containing 300 
nm amidine latex particles. Stable water droplets in undecane were produced after 
they were interlocked with PSS, then the droplets were transferred into water to 
produce colloidosome using freezing process. 
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Figure 5.8: Strategy (ii) (a) schematic diagram of coating yeast cells with 
polyelectrolytes. (b) Schematic diagram of aqueous suspension of anionic pre-coated 
yeast cells emulsified in oil which contained 300 nm amidine latex particles to 
produce water in oil emulsion droplets. The stability of the w/o emulsion droplets 
increased by cross-linking the monolayer of the adsorbed particles at w/o interface 
using PAH/PSS pre-coated yeast cells. The droplets were transferred into water using 
a freezing process to produce colloidosome. 
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Figure 5.9: Water-in-undecane emulsion stabilised with 0.5 % wt. 300 nm amidine 
latex particles for 30 seconds at 10,000 rpm using 18 mm head IKA
@
 T25 Digital 
Ultra Turrax homogeniser. The water phase contained 1 % wt. PSS dissolved in 0.1 M 
sodium chloride solution. The ratio of water phase to undecane phase was 1:9, a-d 
represent different magnifications. 
 
 
The reason could be related to the fact that the yeast cells are slightly negatively 
charged and when there is a minimum amount of them available in the water phase, 
they might contribute into building the monolayers of particles around the water 
droplets, therefore, more particles would be available to adsorb at the w/o interface at 
higher yeast cells concentration and therefore, produced more droplets with smaller 
average size. Consequently, when the amount of yeast cells increased to 10 % wt., 
then the cells are not used in building the membrane anymore i.e. the excess cells do 
not adsorb at the interface and will remain in the water phase and they start to bulk up 
the droplets due to random packing in the bulk of the drops. 
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Figure 5.10: Aqueous suspension of native yeast cells was emulsified in undecane in 
the presence of 0.5 % wt. 300 nm amidine latex particles for 30 seconds at 10,000 
rpm using 18 mm head IKA
@
 T25 Digital Ultra Turrax homogeniser. (a) is no yeast 
cells in the water phase, (b) is 1 % wt. yeast cells, (c) is 10 % wt. and (d) 20 % wt. 
yeast cells. In all cases the volume fraction of the water phase was 10 % vol. 
 
Yeast cells are slightly negatively charged therefore, when cells mixed with a 
saturated aqueous solution of polyelectrolyte such as polyallylamine hydrochloride a 
layer of positively charged polyelectrolyte will adsorb on the cell surface and making 
the cells positively charged. Meanwhile, a layer of anionic polyelectrolyte such as 
polystyrene sulfonate can absorb on top of the layer of PAH which gives rise to 
negatively charged yeast cells. Negatively charged yeast cells coated with layers of 
polyelectrolyte can be used to increase the stability of water droplets in undecane 
stabilised by amidine latex particles as it is outlined in this work. The coated cells are 
negatively charged, hence they attach themselves to the positively charged amidine 
functional group on the latex particles by electrostatic interaction which is relatively 
strong, therefore it will held the water droplets in the oil together more strongly and 
then produce very stable and relatively large size droplets of up to 500 µm compared 
to the droplets that produced from interlocking the adsorbed particles monolayer with 
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(PSS) which produced droplets around 100 µm. The produced water-in-undecane 
emulsion droplets can be transferred into water successfully but the process is very 
sensitive and extra care need to be taken to prevent their destruction. Nevertheless it is 
feasible, but with limited yield of colloidosomes transferred into the water phase, the 
rest would be destroyed in the process as reported by authors of alternative 
techniques.
11,90
 
 
 
 
Figure 5.11: Aqueous suspension of native yeast cells (30 % wt.) was emulsified in 
undecane in the presence of 0.5 % wt. cationic amidine latex nanoparticles (300 nm) 
for 30 seconds at 10,000 rpm using 18 mm head IKA
@
 T25 Digital Ultra Turrax 
homogeniser. The volume fraction of the water phase was 10 % vol. 
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5.1.2.5 Transfer of w/o Pickering emulsion droplets into water using freezing 
process 
To transfer the water droplets from oil to water and hence producing stable 
colloidosomes, three strategies were taken. In one of these methods the emulsion was 
poured on top of a known amount of water which contained ethanol to reduce the 
surface tension and then gently centrifuged to settle the colloidosomes to the bottom. 
Although it has been reported
11
 that a number of colloidosomes should be seen in the 
water phase by this particular strategy, on this occasion the transfer process was 
unsuccessful as no colloidosomes were seen. Attempts were also made to transfer the 
droplets into water by evaporation method in which the undecane was replaced with 
hexane twice and then removed the excess hexane and poured the concentrated 
emulsion on top of water and evaporated the hexane at 40 ˚C in order to move the 
droplets into the water phase. Unfortunately, this process produced aggregates which 
were not dispersible in water, which indicates that the droplets were aggregated 
together during the evaporation process and produced a bulky mass which was not 
easily observable by optical microscope. 
 
One of the successful strategies used to transfer the droplets was a freezing method 
which we developed. Here the emulsion was frozen in a freezer for 2 days after 
adding a known amount of calcium carbonate microparticles which were playing the 
role of a spacer in the oil between the water droplets. The frozen water droplets were 
filtered off and redispersed in fresh milli-Q water to produce stable colloidosomes. 
The encapsulated yeast cells inside the colloidosomes were treated with fluorescein 
diacetate and observed by fluorescence microscopy; bright green colour indicates the 
viability of the yeast cells. In case of stabilising droplets with amidine latex particles 
and polyelectrolyte coated yeast cells, the droplets are larger and the transfer process 
from oil to water is more efficient as more colloidosomes were visible in the water 
phase compared to the ones the droplets with amidine particle monolayer cross-linked 
with polystyrene sulfonate. 
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Figure 5.12: Schematic diagram of freezing process. Calcium carbonate 
microparticles dispersed in hexane which was then mixed with w/o Pickering 
emulsion. The mixture was frozen at -20 ˚C overnight and then the frozen w/o 
emulsion droplets were redispersed in water containing acetic acid (1 % vol.) after it 
was filtered off. 
 
 
Without addition of calcium carbonate microparticles as spacers between the droplets 
during the freezing process, droplets lost their spherical shape and aggregated together 
and formed solid block of ice which was not easy to redisperse them in water as it can 
be seen in Figure 5.16d. To prove the viability of yeast cells at very low temperature, 
a sample of yeast cells was frozen overnight in the freezer at -20 °C. The frozen yeast 
cells were left to melt at room temperate followed by treating them with FDA solution 
and checking their viability by fluorescence microscopy. 
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As it can be seen from Figure 5.16c, the cells are still viable and can withstand 
temperature as low as – 20 °C. This confirms the fact that the yeast cells encapsulated 
inside the colloidosomes can preserve their viability and withstand freezing at such 
low temperature for approximately 12 hours. Similar green fluorescence signal can be 
detected from intact yeast cells treated with FDA.  
 
 
Figure 5.13: Water droplets in undecane stabilised with 300 nm amidine latex 
particles, the adsorbed monolayer of the particle was interlocked together with PSS( a 
and b). While (c and d) shows the colloidosomes produced from transferring such 
droplets into water by a freezing process, in (d) the encapsulated yeast cells inside the 
colloidosomes were treated with FDA and observed by fluorescence microscopy, 
whereas, (c) is a brightfield optical microscopy image of a colloidosome obtained by 
this method. 
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Figure 5.14: (a and b) show water droplets in undecane stabilised with 300 nm 
amidine latex particles and the stability of the droplets was reinforced by using yeast 
cells coated with polyelectrolytes. While (c and d) are colloidosomes fabricated from 
such emulsion templates. The droplets were transferred into fresh water by freezing 
process and the colloidosomes were stained with FDA and observed under 
fluorescence microscopy. 
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Figure 5.15: (a) shows calcium carbonate microparticles in between the water droplets 
in undecane (b) The encapsulated yeast cells inside the colloidosome were treated 
with FDA solution and observed by fluorescence microscope. (c) Yeast cells 
dispersion was frozen at -20 ºC overnight, followed by treating them with FDA 
solution. (d) Frozen w/o emulsion droplets at -20 °C without addition of calcium 
carbonate microparticles.  
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5.1.3 Conclusions 
Live yeast cells were encapsulated in novel colloidosomes prepared from Pickering 
emulsion templates which where stabilised by 300 nm cationic amidine latex 
nanoparticles. Two strategies were used to fabricate and interlock the structure of the 
Pickering water droplets in oil. (i) The first was to integrate magnetic nanoparticles in 
a gelled water phase with an agarose gel for its successful transfer from oil into water. 
In addition, known amount of polyacrylate was used for two purposes of both pH 
trigger release of the yeast cells upon increasing pH and to electrostatically bind to the 
cationic amidine latex nanoparticles at the w/o interface. (ii) The second approach to 
increase droplet stability was achieved by interlocking the adsorbed amidine latex 
particles monolayer at the w/o interface with either (a) polystyrene sulfonate from the 
inside of the droplets or (b) utilising anionic polyelectrolyte pre-coated yeast cells to 
electrostatically bind to the cationic amidine latex nanoparticles from the inside of the 
droplets.  
 
Water droplets produced from stabilised Pickering emulsions were successfully 
transferred into water to produce colloidosomes for encapsulation of living yeast cells. 
Two main strategies were taken; first was using an external magnetic field to collect 
the magnetic colloidosomes at the bottom of a sample tube and the other was by 
freezing the emulsion after addition of calcium carbonate microparticles followed by 
filtration and redispersing in water which contained acetic acid to dissolve the calcium 
carbonate. Furthermore, viability test for the encapsulated cells were performed using 
both FDA and live/dead cells kit, which indicated viable cells inside the 
colloidosomes. The produced colloidosomes show that living cells like probiotics or 
cell implants can be successfully encapsulated ad protected from the environment/ the 
results from this chapter can be used not only in protection of probiotics but also in 
development of live vaccine formulations, and cell implants. 
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Chapter 6.  
Fabrication of three dimensional living multicellular structures 
“Cellosomes” 
6.1.1 Introduction 
In this chapter we report the fabrication of three-dimensional living multicellular 
structures, which are named cellosomes in analogy with colloidosomes.
57
 Cellosomes 
are novel multicellular assemblies, which consist of a spherical monolayer of living 
cells held together by colloidal interactions. The term yeastosomes which is an 
alternative name for cellosomes from yeast cells was first described by Brandy et al. 
98
. The idea in their study was based on templating microbubbles with cells coated 
with cationic polyelectrolyte using the layer-by-layer technique. Cellosomes not only 
resemble colloidosomes but also spherical colonial multicellular microorganisms such 
as Volvox aureas.
98
 
 
Fakhrulin et al.
99
 have reported the development of celloidosomes as hollow 
microcapsules whose membrane consist of a single monolayer of living cells. By 
analogy with colloidosomes they have been named cellosomes. Other than spherical 
colloidosomes, non-spherical structures were fabricated by these authors by 
immobilising yeast cells pre-coated with PAH and CMC on the surface of calcium 
carbonate microcrystals of rhombohedral and needle-like morphologies which were 
coated with several layers of PAH/PSS. Finally, hollow multicellular structures were 
obtained by dissolving the sacrificial calcium carbonate particles.
99
 
 
Cellosomes may find practical applications in the area of developing biological 
microcontainers, tissue engineering of hollow transplants and in other areas of 
biotechnology, as the yeast cells can be replaced by either plant or mammalian cells. 
To facilitate the separation of the cellosomes from the excess of cells a monolayer of 
magnetic nanoparticles embedded in the polyelectrolyte layer which allows the 
cellosomes to be extracted and further manipulated by an external magnetic field. The 
development of the first primitive multicellular organisms might have been facilitated 
142 
 
by non-specific adsorption of individual cells onto particles of non-biological origin 
which might have been later digested by the by-products of the cell activity.
98-100
 
 
 
 
Figure 6.1: Schematics of the assembly of living yeast cells into living hollow shell 
structures (yeastosomes) by using air bubbles as templates. The bare cells are 
suspended in water and coated with a cationic polyelectrolyte (e.g. PAH) followed by 
vortexing to create microbubbles which act as templates for the cationic cells. The 
cell-coated microbubbles are sealed by further addition of an anionic polyelectrolyte 
(e.g. PSS). These structures are filtered out and rehydrated to produce yeastosomes.
98
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Figure 6.2: Schematic representation of the process of fabrication of magnetic 
cellosomes. I – coating of microcrystals with PAH; II – formation of MNPs layer on 
microcrystals; III – coating of PAH–MNP-coated microcrystals with additional layers 
with PAH/PSS/PAH; IV – immobilization of PAH–CMC-coated yeast cells on the 
surface of modified microcrystals; V – dissolution of CaCO3 cores resulting in 
formation of hollow magnetic cellosomes.
57
 
 
6.1.2 Results and discussions 
In this chapter we report the fabrication of multicellular structures by using w/o 
emulsion templates as intermediate. Different approaches were taken to produce 
intermediate w/o emulsions which were used as templates to produce the final 
multicellular assemblies. We have used two main strategies to assemble yeast cells 
pre-coated with polyelectrolytes in water droplets in various oils stabilised with either 
surfactant or solid particles. In the first strategy, an aqueou dispersion of yeast cells 
coated with cationic polyelectrolytes 
69
 was either emulsified in oil using either  
anionic surfactants such as oleic acid or non-ionic surfactant such as Span60 to 
produce intermediate stable water droplets loaded with coated yeast cells. 
 
Our second strategy included preparation of two water-in-oil (w/o) emulsions 
stabilised with latex nanoparticles, each emulsion contained oppositely charged yeast 
cells coated with polyelectrolytes encapsulated in the water droplets. The two 
emulsions containing cells pre-coated with oppositely charged polyelectrolytes were 
mixed and re-emulsified, followed by shrinking the water droplets in dry octanol and 
subsequently transfer the shrunken droplets into water to fabricate 3D structures of 
cells packaged by a monolayer of latex particles. The cellosomes produced by this 
strategy were transferred from the oil to the water phase by freezing and filtering off 
the oil phase. 
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6.1.2.1 Fabrication of Cellosomes by templating w/o emulsions stabilised with 
oleic acid 
Oleic acid is a mono unsaturated omega-9 fatty acid found in various animal and 
vegetable sources. It is a weak acid with pKa around 5, so it is negatively charged in 
aqueous solution at pH 7. To fabricate 3D living assemblies of yeast cells pre-coated 
with polyelectrolyte through templating w/o emulsions, we have used oleic acid as the 
surfactant to stabilise the water droplets. The hydrophilic head of oleic acid which is 
partially dissociated when in aqueous solutions will electrostatically attract the 
cationic polymer/modified yeast cells and produce stable water droplets in oil. These 
water droplets were transferred into water and produced 3D multicellular assemblies 
(cellosomes). The schematic diagram of the overall process has been outlined in 
Figure 6.3. 
 
 
Figure 6.3: Schematic diagram shows the fabrication of cellosomes by templating w/o 
emulsions stabilised with oleic acid. 
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We optimised the concentration of the oleic acid to prepare the intermediate 
emulsions with highest stability, and desirable size droplets. Therefore, a series of 
emulsions prepared with different concentrations of oleic acid (1, 2,5,10 and 15) % 
vol. (see Figure 6.4). Meanwhile, the weight percentage of yeast cells to be 
encapsulated was assessed by preparing yet another series of emulsions containing 
different concentrations of pre-coated yeast cells. We found that using 15 % wt. oleic 
acid produced emulsions with relatively high stability and suitable average droplet 
size for a successful transfer into the water phase. 
 
Figure 6.4 shows different emulsions prepared by using different concentrations of 
oleic acid and encapsulating different amount of yeast cells pre-coated with PAH. In 
all cases the pH of the water phase was fixed to neutral by using milli-Q water to 
disperse the pre-coated cells. Using (10 or 20) % wt. PAH coated yeast cells produced 
relatively stable emulsions with appropriate droplet sizes. Note that not all the yeast 
cells were encapsulated inside and in the interface of the water droplets; some cells 
were spreaded out in the oil phase in the form of cell clusters. (See Figure 6.5 for 
more details). 
 
To increase the rigidity of the droplets and pack a higher amount of pre-coated yeast 
cells, the concentration of cells was increased to 30 % wt. which produced smaller 
droplets with diameters approximately around 50 µm. As shown in Figure 6.6, highly 
stable emulsion has been produced and the exact position of the yeast cells was 
located by staining them with FDA through the oil phase and observing them by 
fluorescence optical microscopy, which showed that most of the yeast cells were 
situated at the interface, (see Figure 6.6d). 
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Figure 6.4: w/o emulsion droplets stabilised with oleic acid, the water phase contains 
PAH coated yeast cells; (a, b) contained 6 % wt. PAH coated yeast cells, where the 
emulsion was stabilised with 3 % vol. oleic acid, while, (c, d) contained 10 % wt. 
PAH coated yeast cells and 5 % vol. oleic acid was used to stabilise the emulsion, and 
(e, f) the water phase contained 10 % wt. PAH coated yeast cells and 10 % vol. oleic 
acid. 
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Figure 6.5: Emulsions (w/undecane) stabilised with 15 vol % oleic acid, (a, and b) the 
water phase contains 10 wt % yeast cells coated with PAH; water phase contains 20 
wt % PAH coated yeast cells in (c and d). 
 
 
6.1.2.1.1 Transfer of the fabricated multicellular structure from oil into water 
We have successfully transferred the fabricated cellosomes from oil into water by 
using two different approaches; one was an adopted so-called freezing process where 
fabricated cellosomes transferred from the oil phase into water, the other was 
replacing the oil phase (undecane) with dry octanol to shrink the water content of the 
droplets. By doing so, one can decrease the size of the droplets and closely pack the 
cells together and the result is fabrication of more stable cellosomes which can 
withstand the transfer from the oil phase into water phase. However, addition of dry 
octanol made the droplets lose their spherical shape into “potato-shaped” droplets as it 
can be seen in (Figure 6.7 a-b). 
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Figure 6.6: w/o emulsion stabilised with 15 % vol. oleic acid and the water phase 
contained 30 % wt. yeast cells pre-coated with PAH. (d) Shows the stained yeast cells 
with FDA observed by fluorescence optical microscopy to locate the position of the 
encapsulated cells. 
 
 
The reason for this behaviour could be that the pre-coated yeast cells are relatively 
surface active and the energy of their attachment to the interface is affected by the 
type of the oil. We have therefore, used octanol saturated with water as the oil phase 
to fabricate the intermediate emulsions, rather than undecane, this way we could 
prevent the change of oil phase and hence the energy attachment of the 
polyelectrolyte coated cells at the interface can be fixed. Despite the fact that some of 
the droplets lost their spherical shape and some even completely destroyed, we 
prepared relatively stable emulsion droplets, which were subsequently shrunken upon 
addition of dry octanol, and transferred from the dry octanol into water to fabricate 
the final multicellular structures. 
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Figure 6.7: (a) w/o emulsions containing 30 % wt. PAH pre-coated yeast cells 
stabilised with 15 % vol. oleic acid in undecane, (b) after replacing undecane with dry 
octanol. (c) w/octanol saturated with water emulsion containing 30 % wt. PAH pre-
coated yeast cells and 15 % vol. oleic acid before shrinking and (d) after shrinking the 
droplets in dry octanol. 
 
 
We have fabricated and transferred 3D multicellular structures by templating w/o 
emulsions stabilised with oleic acid in undecane. The emulsion was frozen at – 20 °C 
after addition of 2 % wt. calcium carbonate microparticles to the oil phase which in 
return acted as spacers between the water droplets and prevented them from fusing 
together. The frozen emulsion was later added on top of 5 mL of milli-Q water in a 
sample tube and centrifuged. The presence of cellosomes in the water was observed 
and confirmed by optical microscopy (see Figure 6.8). The calcium carbonate 
microparticles were pre-treated with oleic acid to make them hydrophobic and 
dispersible in the oil phase.  
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Figure 6.8: Cellosomes (multicellular structure) observed by optical microscopy 
containing 30 % wt. PAH pre-coated yeast cells fabricated by templating w/o 
emulsion stabilised with 15 % vol. oleic acid in undecane. The fabricated cellosomes 
transferred from undecane to water by freezing the emulsion followed by 
centrifugation. 
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6.1.2.2 Fabrication of cellosomes by templating w/o emulsions stabilised with 
Span60 
In this part of the chapter, we have demonstrated that multicellular assemblies of cells 
in cellosomes can be fabricated by templating w/o emulsions stabilised by non-ionic 
surfactant Span60 (sorbitan monostearate)  which is an ester of sorbitan (a sorbitol 
derivative) and stearic acid. It is primarily used as a surfactant for stabilising water-in-
oil emulsions. Sorbitan monostearate is used in the manufacture of food and 
healthcare products, and is a non-ionic surfactant with emulsifying, dispersion, and 
wetting properties. We have introduced span60 as an active emulsifier to prepare two 
emulsions in octanol saturated with water, one containing yeast cells precoated with 
cationic polyelectrolytes, the other containing concentrated solution of PSS. The two 
emulsions were mixed and re-emulsified together, which caused merging water 
droplets containing PAH/pre-coated cells with water droplets containing PSS. 
 
First, we prepared a blank emulsion by emulsify water saturated with octanol into 
octanol saturated with water 1:9 ratios using 2 % vol. Span60 without adding any 
yeast cells. Figure 6.9a shows the stable emulsion droplets prepared which had 
spherical morphologies and droplet diameters ranging from a few micrometers to 
approximately 20 µm. Furthermore, we have prepared two additional emulsions; one 
containing 10 % wt. yeast cells precoated with PAH (Figure 6.9c-d), and another one, 
containing only 5 % wt. PSS (Figure 6.9b), which produced very small water droplets 
contained concentrated solution of PSS. The latter was mixed and re-emulsified with 
the first emulsion which contained PAH coated yeast cells, and was used to “inject” 
PSS solution into the larger droplets (containing PAH pre-coated yeast cells). This 
electrostatically bound “cationic” yeast cells by the anionic PSS solution sustain the 
cell structure (see Figure 6.10). The water phase used in all cases was water saturated 
with octanol to prevent mass transfer of either octanol or water from one phase to 
another. 
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The water droplets which contained electrostatically bound yeast cells were prepared 
to be transferred from the octanol into water to produce the final 3D cellosomes 
structures by shrinking them up on addition of dry octanol which solubilised the water 
content of the droplets and closely packed the yeast cells in the cores. Although the 
shape of the droplets have not changed to indicate the shrinking, the size of the 
droplets visually decreased and the cells seemed to be closely packed together after 
the emulsion was diluted with dry octanol and leaving it for 2 hours (Figure 6.11). 
 
 
 
Figure 6.9: Water in octanol emulsion stabilised with 2 % vol. Span60, octanol phase 
was equilibrated with the water phase. (a) Without yeast cells. (b) The water phase 
contained 5 % wt. PSS solution. (c, and d) The water phase contained 10 % wt. yeast 
cells pre-coated with PAH. 
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Figure 6.10 : Recombined emulsion prepared from mixing and re-emulsifying the two 
w/o emulsions, one contained PAH pre-coated yeast cells and the other concentrated 
PSS solution.  
 
6.1.2.2.1 Transfer of the shrunken water droplets containing bridged yeast cells 
to the water phase 
We have tried different approaches to transfer the fabricated cellosomes from the oil 
to the water phase. For example, adding a fixed amount of concentrated emulsion 
with shrunken water droplets following the treatment with dry octanol on top of water 
layer which contained PSS followed by centrifugation. However, by this method we 
were not able to successfully transfer the cellosomes into the water phase. We also 
tried another approach by dissolving the oil phase (octanol) in ethanol after the excess 
octanol was removed but this strategy was also proved to be unsuccessful as all the 
droplets were disintegrated and the cells were spread out in the ethanol. We have 
successfully transferred the shrunken emulsion droplets into water and produce the 
cellosomes by adding calcium carbonate microparticles into the shrunken w/o 
emulsion and then filtering it off and redispersing the shrunken droplets back in water 
which contained 1 % vol. acetic acid to dissolve the calcium carbonate microparticles. 
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The process proved to be successful since a high yield of transferred cellosomes were 
observed in the water phase. Calcium carbonate microparticles separated the shrunken 
water droplets from each other and prevented them from fusing together in the 
process of filtration and transfer, (see Figure 6.12). 
 
 
Figure 6.11 : Water droplets containing PAH treated yeast cells electrostatically 
linked together by using PSS. The droplets were shrunken upon addition of 5 mL dry 
octanol and left for 2 hours. 
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Figure 6.12 : Cellosomes transferred in water by using a freezing process. These 
cellosomes were assembled by using electrostatically bridged yeast cells coated with 
PAH and linked together through PSS. 
 
 
6.1.2.3 Fabrication of cellosomes by adopting colloidosomes fabrication 
technique 
In a conventional method, colloidosomes can be prepared from templating Pickering 
emulsions.
11
 We have employed similar strategy in this part of the chapter to fabricate 
three dimensional living multicellular structures of yeast cells. We have prepared two 
Pickering emulsions, (i) one contained cationic yeast cells pre-coated with PAH, and 
(ii)  another emulsion containing water droplets with anionic cells pre-coated with 
PAH/PSS. Both emulsions were stabilised by 300 nm polystyrene latex nanoparticles 
with amidine groups on their surfaces. The polystyrene latex particles were 
transferred to the oil phase before emulsification by using ethanol dispersion. 
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The emulsions were mixed and re-emulsified together to yield another Pickering 
emulsions which contained both cationic and anionic pre-coated yeast cells fused 
together by electrostatic interactions, as illustrated in Figure 6.13. The process has 
increased the stability of the droplets and hence facilitated their transfer from the oil 
phase into water phase to produce cellosomes.  We have used different concentrations 
of yeast cells pre-coated with only PAH and PAH/PSS to optimise the conditions for 
preparation of highly stable emulsion.  First 10 % wt. PAH or PAH/PSS pre-coated 
yeast cells were dispersed in the water phase. 
 
Figure 6.14 shows w/o emulsions of water droplets in undecane stabilised with 300 
nm amidine latex nanoparticles, where the water droplets contained 10 % wt. of both 
PAH and PAH/PSS pre-coated yeast cells, and the volume fraction of water phase 
was 10 % vol. The droplets were relatively stable and had diameters in the range of 
150-200 µm. The pre-coated cells were mainly residing inside the water core. 
However, when we dispersed 20 % wt. pre-coated yeast cells in the water phase, less 
stable emulsion was produced and most of the cells were aggregated and transferred 
from the water drops to the oil phase ( see Figure 6.15). 
 
Transferring the multicellular structures (Cellosomes) from the emulsion into water 
was done by first shrinking the water content of the droplets which was achieved by 
removing the excess oil and adding 5 mL dry octanol. As it can be seen in Figure 6.17 
the addition of dry octanol into the emulsion was successfully shrunken the water 
droplets and closely packed the yeast cells together. This structures the droplets with 
extra stability to withstand their transfer from the emulsion into the water phase. 
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Figure 6.13: Schematic diagram of fabrication of cellosomes loaded with both 
cationic and anionic pre-coated yeast cells by using Pickering emulsions templating 
technique.  
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Figure 6.14: Water-in-undecane emulsions stabilised with 300 nm amidine latex 
particles, the water phases were aqueous suspension of 10 % wt. PAH pre-coated 
yeast cells in (a and b), and 10 % wt. PAH+PSS pre-coated yeast cells in (c and d). 
The volume fraction of the water phase was 10 % vol.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
159 
 
 
Figure 6.15: Water-in-undecane emulsions stabilised with 300 nm amidine latex 
particles, the water phases contained aqueous suspension of 20 % wt. PAH pre-coated 
yeast cells in (a and b), and 20 % wt. PAH+PSS pre-coated yeast cells in (c and d). 
the volume fraction of water phase was 10 % vol. 
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Figure 6.16: The two water-in-undecane emulsions containing PAH pre-coated cells 
and PAH+PSS pre-coated cells after being mixed and re-emulsified to yield a new 
Pickering emulsion which contained both cationic and anionic pre-coated yeast cells 
fused together by electrostatic interactions. The weight percentage of yeast cells 
initially used was 10 % wt. in micrographs (a, and b), while, in micrographs (c, and d) 
20 % wt. yeast cells were dispersed in water initially. The volume fraction of water 
phase was 10 % vol. 
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Figure 6.17: Water droplet in octanol contains both cationic and anionic pre-coated 
yeast cells, after being shrunk upon addition of dry octanol which partially solubilise 
the water inside the droplets. 
 
 
6.1.2.4 Cellosomes based on water-in-octanol Pickering emulsions 
We have used octanol as the oil phase in preparation of the intermediate Pickering 
emulsions and followed the procedure exactly as in the case of undecane. We have 
noticed that water droplets containing yeast cells pre-coated with PAH/PSS layers 
were relatively spherical with average diameters of approximately 200 µm, whereas, 
water droplets contained PAH pre-coated cells are much smaller with average 
diameters of approximately 100 µm with many non-spherical morphologies shown in 
Figure 6.18. The prepared Pickering emulsions containing the aqueous suspension of 
the oppositely charged yeast cells emulsified in octanol were mixed together and re-
emulsified, and the process resulted in the formation of water droplets of irregular or 
ellipsoidal shape. 
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Generally, the emulsion prepared by using octanol is less stable than the emulsion 
prepared by using undecane (see Figure 6.19) as there is some partial coalescence 
between the water drops. Therefore, we concluded that the type of the oil has an 
important effect on the stability of the emulsions. 
 
For solid particles as stabilisers, the interactions between the solid surface and the two 
liquid phases, determines the three-phase contact angle θow. The energy of attachment 
of particles wetted at the interface depends on both θow and the o/w interfacial tension 
γow.  These two parameters are related by the Young equation: 
 
γso – γsw = γow cos θow        (6.1) 
 
Where the indexes, (s: solid particle, o: oil phase, w: water phase). γsw and  γso are the 
solid-water and solid-oil surface energies. 
 
As the type of the oil changes both γow and θow will change; the surface tension of 
undecane and octanol in respect of water are 52 and 8.2 mN/m respectively.
101
 When 
octanol was used instead of undecane the interfacial tension is dramatically reduced 
and the energy of attachment changes. It seems that the attachment of the solid 
particles is weaker in case of octanol and this is why the particle monolayer on the 
emulsion drops is incomplete and coalescence increased. 
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Figure 6.18: Water droplets in octanol prepared from aqueous suspension of 10 % wt. 
(a) PAH/PSS pre-coated yeast cells and (b) PAH pre-coated yeast cells stabilised with 
300 nm amidine latex particles in pre-equilibrated octanol. 
 
 
Figure 6.19: Water droplets in octanol after mixing and re-emulsifying two Pickering 
emulsions containing oppositely charged pre-coated yeast cells stabilised by 300 nm 
amidine latex particles. The volume fraction of the water phase was 10 % vol. the two 
Pickering emulsions were mixed in 50:50 ratios.  
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6.1.3 Conclusions 
Novel classes of bio-colloidal multicellular structures of living yeast cells have been 
fabricated by using w/o emulsion templating technique where the water droplets 
contained the yeast cells and were stabilised by either surfactant or solid particles. In 
first part we have pre-coated yeast cells with cationic polyelectrolyte and used oleic 
acid to stabilise w/o emulsions in which the water phase contained polyelectrolyte 
pre-coated yeast cells. The cells were assembled in cellosomes by shrinking the water 
droplets using dry octanol; the polyelectrolyte pre-coated yeast cells containing water 
droplets were frozen followed by centrifugation of the frozen emulsion on top of 
milli-Q water to transfer the cellosomes from the oil phase into water phase. 
 
We have also fabricated similar cellosomes structures by templating water-in-octanol 
emulsion, in which both phases were pre-equilibrated with each other and the water 
phase contains cationic yeast cells pre-coated with PAH and cross linked with the 
anionic polyelectrolyte PSS. The process was done by preparing two w/o emulsions; 
one contained PAH pre-coated yeast cells and the other contained concentrated 
aqueous solution of PSS, the two emulsions were stabilised with Span60 and were 
mixed and re-emulsified together at the later stage to produce spherical water droplets 
in octanol which contains PAH coated yeast cells fused together by the anionic PSS. 
The water droplets were successfully transferred into water to produce the 
multicellular cellosomes structures by adding calcium carbonate microparticle spacers 
into the shrunken droplets followed by filtration. The produced cellosomes could find 
important applications as drug carriers or biological micro-reactors and can be used to 
preserve the viability of probiotic cells. 
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Chapter 7.  
Kinetics of triggered release of cells from composite polymer-cell 
microcapsules 
7.1.1 Introduction 
Preservation of cells viability in adverse conditions has many applications, including 
protection of probiotics
1
 and live vaccines. Probiotic bacteria are considered essential 
for the normal intestinal microflora, enhancement of the immune system and 
improving the nutritional value of foods.
7,42-43
 The beneficial effects of probiotics are 
dependent on their viability as they go through the gastrointestinal tract at pH as low 
as 1.5 which has an adverse impact on the probiotics survival.
1
 Different strategies for 
microencapsulation of probiotics have been employed to preserve their viability and 
deliver sufficient amount of viable probiotics to the lower intestine.
4
 The later involve 
packaging of cells inside microcapsules, gel beads or other media formulated from 
synthetic materials and biopolymers.
5
 Shellac
70
 has long been used as coating material 
in pharmaceutical formulations and food supplement products as it is insoluble in 
water below pH 7.
7,8
 
 
Campbell et al.
9,10
 developed a method for fabrication of food-grade shellac micro-
rods with yeast cell inclusions which not only encapsulate the cells but also proved to 
be efficient foaming agents. Stummer et al.
11
 coated bacteria with shellac 
formulations and glycerol as plasticiser and studied the cells viability in the low pH of 
model gastrointestinal fluid. Hamad et al.
20
 recently reported successful encapsulation 
of yeast cells into sporopollenin microcapsules from Lycopodium clavatum.  
 
Very recently, Hamad et al.
12
 developed composite shellac-cells microcapsules by 
using two techniques: (i) Spray co-precipitating dispersion of native cells in 
ammonium shellac solution /in aqueous solutions of acetic acid or calcium chloride or 
(ii) spray drying of similar formulation. They demonstrated that those microcapsules 
can preserve the cells viability through highly acidic conditions (pH 1.5) similar to 
those in the stomach and to release them by disintegrating at pH around 7 as in the 
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lower intestine. In this “proof of concept” study,13 two different triggering 
mechanisms were programmed for the cell release from these composite polymer-cell 
microcapsules. The first mechanism involves doping of the shellac matrix of the 
microcapsules with pH sensitive polyelectrolytes which has the ability to swell upon 
pH increase. Sodium polyacrylate and carboxymethyl cellulose were used as effective 
swelling agents which allowed the hydrophobic shellac microcapsules to remain intact 
and to protect the encapsulated cells at low pH but facilitated the microcapsules rapid 
swelling and cell release at pH above 7. 
 
The second mechanism, as reported by Hamad et al.
13
 involves growth-triggered 
release of cells where the cells on the microcapsule surface exposed to culture media 
grow and are gradually released from the shellac matrix. The later also leads to 
complete disintegration of the microcapsules as the release of the surface layer of 
cells gives access of more encapsulated cells to the culture medium and further 
promotes their release. This approach is very versatile and could potentially find 
applications in a range of industrial pharmaceutical and medicinal food formulations 
for protection and triggered release of other cells, including probiotics, live vaccines, 
stem cells and cell implants. 
   
In the present study we develop a theoretical model of the kinetics of cells release 
from composite polymer-cells microcapsules and study the effect of the triggered 
release mechanisms on the evolution of the cells population in the aqueous media 
surrounding the microcapsules. We take into account (A) the pH triggered release of 
cells, (B) the growth of the cells and (C) the simultaneous action of release of cells 
and their growth in the medium. We also consider the effect of cell death on the 
evolution of the cells population as they may exhaust the culture medium or produce 
toxic metabolites. The pH triggered release of cells is schematically represented by 
Figure 7.1A. There is a distinct difference in the case when aqueous solution is a 
culture medium in which the cells can grow and multiply. In the case of individual 
cells (Figure 7.1B) this would result in an exponential growth in the early stage of the 
cell culture while the culture medium is still not exhausted by the increasing number 
of cells which growth is still not affected by release of potentially toxic metabolites. 
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The situation of growth triggered cell release or pH triggered cell release in the 
presence of culture medium would lead to increasing cell numbers in the aqueous 
solution as a result of two simultaneously occurring processes: 
 
(i) Release of cells from the surface of the microcapsules and (ii) growth and 
multiplication of the released cells in the culture medium. This process is 
schematically represented in Figure 7.1C. In all cases our model assumes that the 
composite microcapsules are not porous and dissolve continuously in a layer-by-layer 
manner. More complex mechanisms of cell release are possible in porous 
microcapsules or ones containing polymers capable of very fast swelling which we 
have not considered in this analysis. 
 
This chapter is organised as follows. In the theoretical background section we 
consider a kinetic model of the cells release due to pH and growth trigger from 
microcapsules and we discuss the analogy with the case of individual cells growth. 
We derive approximate analytical equations for the release rate constants and the 
capsules dissolution time as well as the cell concentration profiles in the aqueous 
medium. Short time kinetics experiments with yeast cell release from shellac-cells 
microcapsules were designed and experimental data were collected and analysed for 
the different trigger mechanisms. 
7.1.1.1 Theoretical Background 
Let us consider a suspension of composite microcapsules of average initial diameter 
0D containing encapsulated cells of an average diameter  and volume fraction   in 
the microcapsules. The shellac can be doped with other materials which would 
provide a trigger for release of the cells upon change in the pH or other external 
factor. The release of the cells in this case is facilitated by the gradual swelling of the 
shellac matrix on the surface of the composite microcapsules as its solubility increases 
at higher pH. In this case the microcapsules will gradually dissolve and release all 
encapsulated cells into the aqueous media.  
(a) pH triggered release of cells from microcapsules without further growth. We 
will consider the process of cell release from the microcapsules without further 
growth. For an aqueous suspension of volume V and number of composite 
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microcapsules mn  the total number of encapsulated cells will be denoted with 0N . 
The number of cells ( )RN t  released into the aqueous media due to the microcapsules 
disintegration will increase from zero at 0t   to 0N at full disintegration.  
 
 
Figure 7.1: Schematic diagram of stimulus triggered release of cells from composite 
shellac-cells microcapsules. (A) pH triggered release of cells in aqueous solution 
without cell growth. (B) Cell growth in a culture medium. (C) Growth triggered 
release of cells from the microcapsules in a culture medium. Note that although (C) 
illustrates only the effect of the cell growth on the microcapsules surface on the 
release rate of cells, a combination of (A) pH triggered release and (C) growth 
triggered release is also possible with bigger release rate constant. 
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We model the kinetics of this process assuming that the rate of cells release in the 
aqueous media around the microcapsules,  
 
R
R s
dN
k N
dt
          (7.1) 
is proportional to the number of cells sN on the microcapsules surface,  
/s m s cN n v v         (7.2) 
 
 
kR is the release constant of the viable cells from the composite microcapsules. 
 
Here sN can be estimated from the average volume of the cells sv in the surface 
layer of thickness  and the volume of a single cell 3 / 6cv  . The thickness of the 
surface layer is selected to be approximately equal to the average cell diameter . On 
the other hand, the balance of the number of encapsulated cells  /m m cn v v  and 
released cells, RN  in the system gives 
 
0
m
m R
c
v
n N N
v

          (7.3) 
 
Recalling that the volume of a single microcapsule is 3 / 6mv D  and the total 
number of encapsulated cells in the beginning of the process is 3
0 0( / )mN n D  , and 
by introducing the following variables 
 
0 0
( )
, ( ) , R
D t
y t k t
D D

          (7.4) 
 
Equation (7.3) can be transformed to read 
 
3
0( ) 1 ( )RN t N y t           (7.5) 
 
 Taking into account that the volume of the microcapsule surface layer is 
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3 3/ 6 ( ) / 6,sv D D            (7.6)  
 
eq (7.1) and eq (7.2) can be combined to yield 
 
 
33
0
R
R
dN
k N y y
dt
   
 
       (7.7) 
 
 
 
 
 
Figure 7.2: Schematic representation of a dissolving composite polymer-cells 
microcapsule of current diameter D containing encapsulated cells of diameter  and 
volume fraction   in the polymer matrix. The microcapsule initial diameter is 0D . The 
shaded area represents the surface layer of cells and polymer of volume sv in the 
process of the dissolution. The cells released into the surrounding aqueous media are 
not shown on this diagram. 
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Combining eq (7.6) and eq (7.5) we obtain 
 
2 3 33 ( ) , .R
dy
y y y k t
d
   

          (7.8) 
 
Equation (7.8) is to be solved with the initial condition, 
( 0) 1y    ,         (7.9) 
 
and has an exact analytical solution  
2
2 2
1 3 3 1 (2 ) 3 (2 ) 3
1 ln arctan arctan
2 3 3 3
y
y
y y
   
 
   
      
        
     
 . 
(7.10) 
 
Equation (7.10) is transcendental and gives the dependence ( )y   rather than
( )y y  . Here we focus on the limiting case of practical importance, where the 
initial microcapsule diameter 0D  
is much larger than the average diameter   of the 
encapsulated cells, i.e. 1 . This corresponds to the experimental parameters of our 
capsules where the average cell diameter is about 5 m and the microcapsules 
diameter ranges from 111 m, which gives values of 0.045  . However, for values 
of y not extremely close to   (i.e. D  ), the solution of eq (7.11) can be expanded 
in power series with respect to  : 
 
2 2( ) 1 ( ) 1 ( ), 1.Ry O k t O               (7.11) 
 
We checked numerically that at 0.01  , eq (7.11) is very close to the exact solution, 
eq (7.10) for all values of  the combination of eq (7.4), eq (7.5) and eq (7.11) yields 
 
3
0
( )
1 (1 )R R
N t
k t
N
   .       (7.12) 
 
Equation (7.12), although approximate and valid only at 0/ 1D  , allows one to 
relate the time dt  of complete disintegration of the microcapsules with the rate 
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constant of cell release Rk and the physical size of the cells ( ) and the microcapsules 
( 0D ). By using the condition, 0( )R dN t t N  (or ( )dy   ), i.e. all cells are released 
at dt t  and equation (7.12) we obtain, 
 
011,d R d d
R R
D
k t t
k k
 
 
    .      (7.13)  
 
The short time kinetics of cell release as predicted by eq (7.11) is 
 
0
( )
3 ,R R d
N t
k t t t
N
 ,       (7.14) 
 
which allows the average disintegration time dt of the capsules to be estimated from 
the initial slope of the relative number of released cells 0/RN N vs. time,
03 3 / 3/R R dinitial slope k k D t    , or alternatively to determine the rate constant 
of cells release Rk . For the shellac-cells composite microcapsules, the release rate 
constant would depend on the composition of the shellac matrix in the microcapsules 
and the swelling rate of this composite. Doping the shellac with polyelectrolytes 
which can swell upon pH change in the medium would effectively increase the value 
of Rk compared with the one of unmodified shellac. Alternatively the value of Rk
would increase if the pH of the aqueous medium is increased for unmodified shellac 
matrix as it has been shown in Figure 7.3. 
 
(b) Growth of individual cells in a culture medium. This is a classical problem of 
exponential growth, where 0N  individual cells are initially dispersed in a culture 
medium of volume V and they grow with a rate constant Gk . The equation describing 
this process is well known in the literature 
 
0, ( 0)
G
G G G
dN
k N N t N
dt
   .      (7.15) 
 
kG is the growth constant of the viable cells in the composite microcapsules. 
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The solution of equation (7.16) is an exponential function 
 
0
( )
exp( )G G
N t
k t
N
 ,        (7.16) 
Whose initial slope (versus time) is the cell growth constant Gk  
 
2
0
1 ( ), .G G G
N
k t O t initial slope k
N
         (7.17) 
Note that in this case 0N is the total number of free cells in the beginning of the 
process of their growth. 
 
 
 
Figure 7.3: Fraction of released cells 0/RN N  by pH triggered disintegration of the 
shellac-cells microcapsules. The different values of the release rate constants Rk  
depend on the ability of the shellac on the microcapsule surface to dissolve at 
different pH of the media and correspond to different initial slopes of the three curves 
and different dissolution times dt  of the capsules. 
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(c) Growth triggered release of individual cells in growth media. Let us consider a 
dispersion of composite shellac-cells microcapsules in a culture medium where 
initially there are no individual cells in the aqueous medium. 0N  is the total number 
of cells encapsulated in mn microcapsules dispersed in a culture medium of volume V. 
Here we will assume that there are enough nutrients in the aqueous media to sustain 
the growth of all cells released from the microcapsules.  If the pH of the solution is 
such that the shellac matrix of the capsule does not swell on its own (e.g. at pH below 
5) the only factor releasing the cells is the growth of the cells on the microcapsule 
surface exposed to the growth media. These “surface exposed “cells expand and 
gradually chip off the shellac matrix around them which exposed more cells to the 
culture medium which grow and are released from the microcapsules. 
 
This process we termed “growth triggered release” of cells and at constant agitating of 
the microcapsule dispersion its kinetics can be described as follows 
 
( )( )
( ) RG
dN tdN t
k N t
dt dt
   .       (7.18) 
 
Here ( )N t  is the current number of cells in the aqueous media, ( ) /RdN t dt  is the rate 
of release of cells from the microcapsules at time t since the start of the disintegration 
process, and Gk is the cell growth rate constant, identical to those in eq (7.16). In this 
case, the release of the cells from the microcapsules could be due to (i) growth 
triggered release only or (ii) a combination of growth triggered release and pH 
triggered release caused by the swelling of the shellac matrix. Both triggers can 
contribute to the release rate constant Rk of cells in this process as it appears in eq 
(7.12). Note that the growth of cells in the aqueous media does not influence the cell 
release process, while the accumulation of cells in the aqueous media is a result of the 
simultaneous action of both processes as implied by eq (7.18). The combination of eq 
(7.12) and eq (7.18) gives: 
 
    
2
0
( )
( ) 3 1 , ( 0) 0.G R R
dN t
k N t k N k t N t
dt
     
  
  (7.19) 
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This equation is an approximation valid only at 1 , which is well satisfied for our 
experimental parameters. More accurate version can be derived by combination of eq 
(7.7) and (7.8) with eq (7.19) but this is out of the scope of this analysis. 
By introducing the notations: 
 
0( ) ( ) / , /( ), ,G R Rz N N k k k t            (7.20) 
 
One can transform eq (7.19) into the following form 
 
 
2( )
( ) 3 1
dz
z
d

  

   , ( 0) 0z    .     (7.21) 
 
Where the initial condition reads corresponds to absence of cells in the mediums at
0t  . The analytical solution of equation (7.21) is 
 
 23
3
( ) ( 1) 2 2 (2 2)z e     

        
.   (7.22) 
 
The short time kinetics of this process can be obtained by expanding equation (7.22) 
in series at small values of   
 
2 31( ) 3 3 1 ( )
2
z O    
 
    
 
.      (7.23) 
 
Equation (7.23) predicts that the short time kinetics of number of cells in the aqueous 
media is dominated by the release of cells from the microcapsules 
 
2 2 2 3
0
( ) 1
3 3 1 ( )
2
G
R R
R
N t k
k t k t O t
N k
 

 
    
 
,     (7.24) 
 
The leading (linear) term in equation (7.24), for the short time scale kinetics of the 
cell population in the solution, 3 Rk t , looks practically identical with equation (7.14) 
for the short term kinetics of RN . 
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Figure 7.4: Ratio of number of cells released and grown to number of individual cells 
present in the medium. The plots related to equation 7.24, the value of Ɛ = 0.05, kR = 
0.7 h
-1
, but the values of kG was changed between 2 (blue), 7 (red), and 14 (green) h
-1
.  
 
 
Equation (7.22) also allows one to predict the cell population in the medium at the 
moment of complete disintegration of the microcapsules dt t  (or 1  ) 
 
 23
3
( 1) 2 2 2 .z e  

      
      (7.25) 
 
Note that for small values of 1  , which typically corresponds to fast cell release 
(very large Rk ), the asymptototic expression for equation (7.25) is  
 
23( 1) 1 ( )
4
z O      .       (7.26) 
 
On the other hand, for large values of 1  , equation (7.25) predicts exponential 
growth of the released cell population, 
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3
( 1) exp( ), 1.z   

         (7.27) 
 
One can compare the result from equation (7.27) with the exponential growth kinetics 
of 0N  free cells in the same culture medium as predicted by equation (7.16) for the 
same time, 1/( )d Rt t k   it takes 0N encapsulated cells to be completely released 
from the microcapsules, 
 
0
( )
exp( )G d
N t t
N


 .        (7.28) 
 
Hence at conditions of fast cell growth in the aqueous medium, 1  , the free cells 
would increase their population approximately / 3  times faster than the equivalent 
amount of microencapsulated cells at the same conditions. 
This is to be expected as the encapsulated cells are released gradually from the 
microcapsules and start multiplying exponentially only after they are released in the 
culture medium. In contrast, the sample of free cells would start multiplying 
immediately after contact with the culture medium. The number of cells in the culture 
media at the time of complete microcapsule disintegration will be completely 
dominated by the exponential growth of the released cells. Note the similarity of the 
exponential terms in equation (7.27) and equation (7.28) which dominate the long-
term kinetics of the cells released into the medium. However, the pre-exponential 
factors in equation (7.27) and (7.28) are completely different as in (7.28) the cells are 
free to grow from the very start of the process while in (7.27) only the released cells 
can grow and accumulate in the medium. It is possible to engineer pH triggered 
release of cells in the medium where the disintegration of the microcapsules is much 
faster than the growth of the released cells in the medium, i.e. kR << kG. This is the 
case of “explosive release” of cells (very large Rk ), or very slow growth of the 
released cells (very small Gk ) when the aqueous medium is nutritionally poor for 
them.  
In this special case although δ <<< D0, the parameter   in eq (7.25) may become 
small enough and give release dominated kinetics even at moderate times. 
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(d) Modelling of triggered release of cells with an account for the cell death. Here 
we will present more general model for the triggered cell release from the same 
microcapsules as in section (c) above but with the account for the fact that released 
cells can multiply or die with growth and death rate constants, Gk  and Dk , 
respectively. The modified kinetic scheme for this process is as follows 
 
L R
G L D L
dN dN
k N k N
dt dt
    ,       (7.29) 
 
D
D L
dN
k N
dt
  .        (7.30)
  
 
Here LN  and DN are the current number of live and dead cells, respectively, released 
in the culture medium. 
We will assume that all encapsulated cells in the microcapsules are viable prior to 
their release in the medium. Since the process of cell release starts with fresh medium 
without any cells, the initial conditions for the system of ordinary differential 
equations, equation (7.29)-(7.30) is 
 
( 0) 0, ( 0) 0D LN t N t     .      (7.31) 
 
The total number of cells released in the medium is 
 
( ) ( ) ( )L DN t N t N t   .       (7.32) 
 
The combination equation (7.13) with equation (7.29)-(7.30) yields  
 
 
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( ) 3 1 , (0) 0,L L L
dz
z z
d

  

         (7.33) 
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z z
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
 

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where  
 
0 0
( ) ( )
( ) , ( ) , ,L D G D DL D R
R R
N t N t k k k
z z k t
N N k k
     
 

     .  (7.35) 
 
Equation (7.33) is mathematically identical with equation (7.19) for   and both of 
them are valid for only at 1 . The exact solution of equation (7.33) reads 
 
 23
3
( ) ( 1) 2 2 (2 2)Lz e
     

        
.   (7.36) 
 
Which substituted in equation (7.34) with subsequent integration gives 
 
 2 2 2 24
3
( ) ( 1) 2 2 (2 2 / 3)Dz e
         

           
.    (7.37) 
 
Equation (7.36), similarly to equation (7.26) shows a linear increase of the number of 
live cells in the medium at short times, 
2( ) 3 ( ) 3 , ( 1, 1)L Rz O k t        .    (7.38)
 
 
However, equation (7.37) predicts that the short time kinetics of the relative number 
of dead cells increases quadratically with time  
 
2 3 23 3( ) ( ) , ( 1, 1)
2 2
D D Rz O k k t        .   (7.39) 
The long time kinetics of cell release when the growth rate dominates the release and 
dead rate is 
 
2
3 3
( ) , ( ) , 1.L Dz e z e
   
 
       (7.40) 
 
Hence the total number of cells z=N/N0 will be increasing exponentially 
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 
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    
(7.41) 
 
Note that in this case at the time of dissolution of the composite microcapsules, (t=td, 
=1), equation (7.41) predicts that the total number of cells will be an exponential 
function of (kG-kD)/ (kR), 
 
3
( 1) 1 , ( 1)z e

 
 
 
    
 
.      (7.42) 
 
This result shows a close similarity with equation (7.27), which is a particular case of 
equation (7.42) for kD = 0. In this analysis, which involves equation (7.40)-(7.42), we 
have assumed that kG> kD. Equations (7.36) and (7.37) describe the population growth 
of the individual cells released in the media from the capsules and takes into account 
both the growth and death events of the released cells. 
 
7.1.2 Results and Discussion 
We have monitored the release of encapsulated yeast cells in shellac/cells composite 
microcapsules by incubating the microcapsules in either 0.1 M phosphate buffer 
solutions of different pH for pH triggered release or using growth triggered process to 
release and grow encapsulated cells in the microcapsules by incubating the composite 
microcapsules in a culture media. 
7.1.2.1 pH-triggered release of cells from shellac/cells microcapsules 
We have counted the number of cells released from the microcapsules by using a 
haemacytomer in different times and the ratio of the released cells to the number of 
total cells encapsulated (NR/N0) was plotted against time to produce a graph similar to 
the one shown in Figure 7.6. We have used two pH values of 7 and 8 to observe the 
difference in the rate of disintegration of the microcapsules (release of the cells). 
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Figure 7.4 shows the composite microcapsules during the disintegration and releasing 
the yeast cells in 0.1 M phosphate buffer solution at pH 8. The yeast cells on the 
surface of the microcapsules start to free themselves from the microcapsules as the 
shellac matrix start to dissolve. 
 
We have measured the average diameter of the yeast cells (δ) and the composite 
microcapsules (D0) by Mastersizer which were found to be 5.3 µm and 111µm 
respectively (see Figure 7.5). Hence ε = δ/ D0 = 5.3µm/111µmm = 0.048<<1.  
At small values of the time, the relationship between (NR/N0) and time should be 
linear and the initial slope is given by eq (7.14), i.e.  
 
3 3/R dinitial slope k t           (7.43) 
 
Substituting the values of the known parameters in eq (7.43) allowed us to estimate 
the values of kR and td at pH 7 and pH 8 for shellac-cell microcapsules. At pH 7 we 
obtain kR = 0.031 min
-1
 and td = 675 min, while at pH 8 we estimate that kR = 0.118 
min
-1
 and td = 180 min.  
 
As expected, at pH 8 the rate of the cell release and the microcapsules disintegration 
is faster than the rate at pH 7 since shellac barely dissolves at pH above 7 and the 
dissolution rate is much faster at pH 8. 
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Figure 7.5: (a) Composite shellac/yeast cells microcapsules before being transferred 
into 0.1 M phosphate buffer at pH 8. (b)-(d) The microcapsules during the 
disintegration and release of cells while being stirred in the phosphate buffer. 
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Figure 7.6: Size distribution for native yeast cells (a) (average diameter, = 5.3 µm), 
and (b) for composite shellac/yeast cells microcapsules (average diameter, D0= 111 
µm) as obtained from Mastersizer measurements. 
 
 
 
Figure 7.7: Relationship between the relative numbers of released cells from 
shellac/cells composite microcapsules versus time in phosphate buffer at different pH. 
The released cells are not growing upon release due to lack of nutrition in aqueous 
media.  
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7.1.2.2 Growth-triggered release of cells from shellac/cells microcapsules 
We have observed the growth of yeast cells both individually and inside composite 
microcapsules by incubating individual yeast cells and yeast cells containing 
composite microcapsules in a culture media at 37 °C for a period of 10 hours with 
constant stirring. The number of grown cells in both cases was counted using a 
haemacytomer and a graph similar to Figure 7.7 was produced between the ratios of 
the cells grown: the number of the total cells present in the sample versus time of 
incubation in the culture media. 
 
2
0
1 ( ), .G G G
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   
    
 
According to the above equation in small time the initial slope of a straight line 
between NG/N0 in time is equal to the value of kG if we set the intercept to 1. The 
value of kG in this case is equal to 1.69 h
-1
 
 
 
Figure 7.8: Relationship between the numbers of yeast cells grown in culture media 
versus the incubation time at temperature 37 °C. Triangles represent relative number 
of growing individual cells, squares represent relative number of yeast cells released 
and grown from shellac-yeast composite microcapsules. Both samples of individual 
and microencapsulated cells have been incubated at identical conditions in the same 
growth media. The growth medium is adjusted to pH 5 to suppress the dissolution of 
shellac. 
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In case of the growth-triggered release of the encapsulated cells inside the composite 
microcapsules, different behaviour can be seen. We calculated the value of release 
constant (kR) due to growth-triggered release of the encapsulated cells by using the 
initial slope in equation (7.24) at small times. Therefore the initial slope of a straight 
line of N/N0 versus time and should equal to 3εkR. Therefore we obtain that kR = 0.74 
h
-1
. One sees that the value of the rate constant for the growth of individual yeast cells 
(kG=1.69 h
-1
) is much higher than the rate constant for the growth-triggered release of 
the encapsulated yeast cells (kR =0.74 h
-1
). The reason for that is that the individual 
cells are freely dispersed in the culture media and they have full access to the culture 
media while the encapsulated cells on the surface of the composite microcapsules are 
partially trapped in the shellac matrix and have limited access to the culture media, 
hence they are growing much slower compared to the free individual cells (see Figure 
7.1b-c for more details).  
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7.1.3 Conclusions 
We have done a theoretical analysis of the rate of triggered release of cells from 
composite polymer-cells microcapsules. Two different triggering mechanism have 
been considered, including: (i) pH triggered release of the cells which involves 
gradual dissolution of the polymer matrix of the polymer in the composite 
microcapsules which leads to build up of cells in the surrounding aqueous media; (ii) 
growth triggered release of cells which is a result of the local growth of the cell 
exposed on the surface of the microcapsules whose release allows more cells to be 
exposed to the culture media. 
 
In a more complex theoretical analysis we also take into account the cell death rate. 
The equations predict linear increase of the cells population at short times which is 
dominated by the rate of cell release from the capsules. We determine the release rate 
constants of the cells for both the case of (i) pH triggered release and (ii) growth 
triggered release. Our theory predicts that the long time kinetics of the released cell 
population follows approximately a power law for pH triggered cell release without 
further growth. In the contrary, growth triggered cell release from the microcapsules 
into a culture media leads to an exponential growth of the cell population but the pre-
exponential factor is limited by the ratio of the growth and release constant and the 
cell-to-microcapsule size ratio. 
 
In a ‘proof of principle’ experiment we determine the cell growth constant at fixed pH 
in culture media and compare its value with the rate constant of growth triggered 
release for cells. We also demonstrate that in the absence of growth media the 
experimental value of the cell release constant is increasing with the increase of pH. 
This model can help to predict and adjust microcapsule dissolution times and fine-
tune the rate of cell release in a variety of cell products, including cell implants, 
probiotics, live vaccines, etc. 
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Chapter 8.  
Summary of main conclusions 
 Microencapsulation method of living yeast cells into the exine of pollens from 
Lycopodium clavatum plant has been developed. The method is based on exposing 
a compressed sporopollenin pellet to a concentrated aqueous dispersion of cells in 
the presence of a biocompatible surface active agent. The process of efficient cell 
encapsulation is facilitated by the capillary suction of cells suspension inside the 
compressed sporopollenin microcapsules, inducing their ‘‘re-inflating’’ with the 
cells dispersion and closing the opened trilite scars. The viability of the cells was 
demonstrated after the encapsulation procedure and it was shown that the 
sporopollenin microcapsules contain a significant amount of entrapped viable 
cells. The method has applications for protection of probiotic cells and other cells 
from aggressive environments. 
 
 We have successfully grown encapsulated cells inside the sporopollenin 
microcapsules by using “in-gel” fermentation process which involves incubation 
of the loaded sporopollenin microcapsules into a starch gel in culture medium. 
The encapsulated cells inside the pollens can have a limited growth due to 
confined space restrictions.  
 
 We also developed sporopollenin microcapsules loaded with magnetic yeast cells, 
which allows remote manipulation, like fixation, removal or targeted delivery. 
 
 Composite microcapsules of shellac/yeast cells were fabricated by both spray co-
precipitating and spray-drying dispersions of yeast cells in aqueous ammonium 
shellac solution. Two alternative preparation techniques were used: (i) spray co-
precipitating a dispersion of yeast cells in aqueous solution of ammonium shellac 
at pH > 7, into either acetic acid or calcium chloride aqueous solution; or (ii) 
spray-drying the shellac-yeast dispersion. The pH trigger for cell release from 
these microcapsules and the time of their disintegration were controlled by (a) the 
shellac concentration and (b) by doping of the solution with pH sensitive 
polymers. 
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 We have demonstrated as a proof of concept how carboxymethylcellulose and 
sodium polyacrylate can be used to trigger the cell release from the microcapsules 
at neutral and higher pH and to speed up the “shellac-cell” microcapsule 
disintegration process. The inclusion of sodium polyacrylate in the shellac matrix 
resulted in much faster disintegration of the microcapsules upon increase of the 
pH above 7 and in some cases instant cell release. We show that the released yeast 
cells have preserved their viability during the microencapsulation and the release 
process from the microcapsules. The produced composite microcapsules were 
capable of protecting the cells at extremely low pH (pH 1) and still produce viable 
cells upon disintegration at neutral and higher pH. We discovered that shellac-cell 
microcapsules can produce triggered release of cells upon exposure to growth 
media, i.e. growth induced release. We believe that this is a novel mechanism of 
cell release from microcapsules, which is described for the first time in this thesis. 
 
 We also produced magnetically functionalised shellac-cell microcapsules which 
can be used for delivery of encapsulated cells directed by an external magnetic 
field. We demonstrate the robustness and the versatility of shellac as 
microencapsulating material for protection of cells in acidic environments. 
 
 We have done a theoretical analysis of the rate of triggered release of cells from 
composite polymer-cells microcapsules. Two different triggering mechanism have 
been considered, including: (i) pH triggered release of the cells which involves 
gradual dissolution of the polymer matrix of the polymer in the composite 
microcapsules which leads to build up of cells in the surrounding aqueous media; 
(ii) growth triggered release of cells which is a result of the local growth of the 
cell exposed on the surface of the microcapsules whose release allows more cells 
to be exposed to the culture media.  
 
 We succeeded in encapsulating living yeast cells in novel colloidosomes prepared 
from Pickering emulsion templates which where stabilised by cationic amidine 
latex nanoparticles. Two strategies were used to fabricate and interlock the 
structure of the Pickering water droplets in oil. (i) The first was to integrate 
magnetic nanoparticles with yeast cells in a gelled water phase with an agarose gel 
for their successful transfer from the oil into the water phase. (ii) The second 
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approach was to increase the droplet stability by interlocking the adsorbed 
amidine latex nanoparticles monolayer at the water/oil interface with either (a) 
polystyrene sulfonate from the inside of the droplets or (b) by utilising anionic 
polyelectrolyte pre-coated yeast cells to electrostatically bind to the cationic 
amidine latex nanoparticles from the inside of the droplets.  
 
 Water droplets produced from stabilised Pickering emulsions were successfully 
transferred into water to produce colloidosomes with encapsulated living yeast 
cells. We developed two main strategies for such a transfer: (i) by using an 
external magnetic field to collect the magnetic colloidosomes and (ii) by freezing 
the emulsion after addition of calcium carbonate microparticles as micro-spacers 
followed by filtration and redispersing in diluted acetic acid to dissolve the the 
spacer calcium carbonate microparticles. 
 
 Viability tests for the encapsulated cells were performed using both FDA and 
live/dead cells kit, which indicated viable cells inside the colloidosomes. We 
developed a special methodology which allows living cells like probiotics or cell 
implants to be successfully encapsulated and protected from the environment by 
microencapsulating in colloidosomes without impairing the cells viability. 
 
 In addition, we fabricated novel classes of bio-colloidal multicellular structures of 
living yeast cells by using water-in-oil emulsion templating technique where the 
water droplets contained the yeast cells and were stabilised by either surfactant or 
solid particles. The cells were assembled in cellosomes by shrinking the water 
droplets in dry octanol; the polyelectrolyte pre-coated yeast cells packed in water 
droplets were frozen followed by transfer of the frozen cellosomes from the oil 
phase into a water phase. Such 3D cellosomes structures are reported for a first 
time in this thesis. 
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Future work 
 For future work, living cells including probiotic bacteria can be protected by 
means of microencapsulation using polymerisation techniques such as emulsion 
polymerisation. A thin layer of copolymers can be deposited on top of individual 
living cells in an aqueous dispersion using polymerisation methods to produce a 
shell of plastic around the cells, which can be defined as plastic cells. 
 
 In addition by using emulsion polymerisation a layer of copolymer shell can be 
produced in water/oil interface and hence, produce copolymer microcapsules 
which will be harvested out of the oil by washing off with ethanol and re-
dispersing them in water. The water phase of the original emulsion can contain up 
to 30 % wt. living cells such as yeast cells or probiotic bacteria. The water phase 
can be emulsified into the oil phase stabilised by either solid particles or a suitable 
surfactant. 
 
 The kinetics of disintegration of colloidosomes loaded with yeast cells can be 
observed using various triggered release of the cells including pH-triggered and 
growth triggered. The latter can be done by incubating the colloidosomes loaded 
with yeast cells in an appropriate culture media.  
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Glossary 
µL     Microliter 
µm     Micrometer 
mM     Millimolar 
°C     Centigrade degree 
m     Meter 
cm     Centimetre 
% vol.     Percentage volume 
% wt.     Percentage weight 
HLB     Hydrophilic-lipophilic balance 
rpm     Rounds per minute 
PAH     Poly allylamine hydrochloride 
PSS     Polystyrene sulfonate sodium salt 
w/o     Water in Oil 
o/w     Oil in Water 
Span60 Octadecanoic acid [2-[(2R, 3S, `4R)-3, 4-
dihydroxy-2-tetrahydrofuranyl]-2-hydroxyethyl] 
ester 
FDA     Fluorescein Diacetate 
Tween20    Polyoxyethylene (20) sorbitan monolaurate 
SEM     Scanning Electron Microscopy 
FITC     Fluorescein IsoThioCyanate 
nm     Nanometre 
TRITC    Tetramethylrhodamine IsoThioCyanate 
DNA     Deoxyribonucleic acid 
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PAA     Polyacrylic acid 
Calcein-AM    Acetomethyl derivative of Calcein 
3 D     Three-dimensional 
2 D      Two-dimensional 
CMC Critical micelle concentration or 
carboxymehtylcellulose 
PBS     Phosphate Buffer Saline  
λabs     Absorption wavelength   
λem     Emission wavelength 
PI     Propidium iodide 
 w/v     Weight/volume  percentage 
 v/v     Volume/volume percentage 
 Tg     Glassifying temperature  
 mN     Milli-Newton 
 GI     Gastrointestinal tract 
 ALG     Alginates 
 POPL     Palm oil and poly-L-lysine 
 EPS     Exopolysaccharides 
 PLGA     Poly lactic-co-glycolic acid 
GLC     Gas-liquid chromatography 
AR     Analytical reagent  
GPC     Gel permeation chromatography 
PEG     Polyethylene glycol 
HPLC     High-performance liquid chromatography 
SDS     Sodium dodecyl sulfate  
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